ASHPOfficial: Recent Episodes
American Society of Health-System Pharmacists©
ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Obesity is a chronic disease affecting millions of people in the United States with projections indicating continued obesity rates and related comorbidities. Pharmacists are increasingly in the position to advise patients and provide safe and effective management of medications for healthy weight loss. It is imperative that pharmacists collaborate with patients and their providers to optimize weight management health outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode was planned to meet the educational needs of critical care pharmacists by increasing their awareness of the prevalence of opioid use disorder, common challenges encountered in managing pain control and sedation in patients with opioid use disorder, and how to implement best practices in this patient population. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Maria Blaze, mental health pharmacy practitioner at the Lt. Col. Luke Weathers, Jr. VA Medical Center in Memphis, Tennessee. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Susan Smith and Brian Murray discuss the AJHP commentary "The weight debate: Ideal versus total body weight for fluid resuscitation in septic shock” with host and AJHP Editor in Chief Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the benefits and challenges of implementing Ai into health system pharmacy workflows. It also offers insight into how health system pharmacists may guide utilization and potential best practices in AI use for those in leadership positions, as well as preceptors and learners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides health system pharmacists with comprehensive, evidence-based information about rotavirus disease and vaccination. The discussion covers the historical burden of rotavirus disease, clinical complications, current CDC/ACIP vaccination recommendations, clinical management protocols, public health reporting requirements, and the pharmacist's role in addressing caregiver questions. This episode clarifies current vaccination guidelines and equips pharmacists with the knowledge to support optimal immunization practices within their health systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we break down what it really takes to make data readily available and discoverable. Our guests explain how their teams use data catalogs, organize metadata, manage code, and build systems that make data easier to find, maintain, and update. From there, we explore the challenges of data management, such as fragmented data, lack of standardization, and low adoption. Finally, we explore what’s next for data discoverability strategies in the future. If you’re trying to make your organization's data easier to use, this episode offers a clear, practical look at what works, and what doesn’t.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Meet the recipients of the ASHP Foundation’s Professional Advancement Scholarship as they share what the support meant to them, their experiences at the 2025 ASHP Midyear Meeting, and how the opportunity is shaping their careers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses optimizing specialty pharmacy central services. Speakers highlight the successes and challenges of centralizing support services, fulfillment and clinical services, and discuss the specialty pharmacy blueprint to centralizing services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Through evidence-based counseling and open dialogue, pharmacists help patients make informed decisions, improve medication safety, and build trust — ultimately reducing the spread and impact of misinformation in healthcare. By understanding study design, bias, statistical significance, and clinical relevance, pharmacists can distinguish sound science from misleading claims. This episode highlights how to discuss this information in a respectful and patient-centered way, addressing concerns without judgment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Jen Arnoldi sits down with the Section of Pharmacy Educators Distinguished Service Awardee, Winter Smith, to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The third in a five-part series, this episode of Tools of The Trade discusses tools, tips, and tricks surrounding cleaning, preparing, and analyzing data.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Christine Tabulov discusses the AJHP Note "Creation and implementation of a transplant medication patient education game for adolescents by a pediatric pharmacist and pharmacy students” with host and AJHP Editor in Chief Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As questions about vaccines, evolving recommendations, and public health policy continue to grow, healthcare professionals and patients alike are seeking trusted information and guidance. In this episode, ASHP Executive Vice President and CEO Sam Calabrese is joined by Anna Legreid Dopp and Vicki Basalyga to discuss ASHP's position on vaccines, the advocacy and partnership efforts underway, and the resources available to support pharmacists and patients. Tune in for a conversation about how pharmacy professionals can help advance evidence-based patient care and informed decision-making.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This is second in a two-part feature on emergency medicine presentations from the ASHP Midyear Clinical Meeting. Members highlight topics such as sedation and analgesia in the setting of procedural sedation, managing patients in the emergency department in small and rural settings, and how to read and interpret echocardiograms.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Despite the passage of the Inflation Reduction Act, drug prices continue to rise. How are manufacturers using the patent, drug approval process, and courts to keep drug prices high, and what are the legislative solutions to these practices?
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses the side effects of GLP-1 agonists and the potential for drug-drug interactions. The episode also includes a discussion on how best to manage these issues when they arise.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacy services can impact various facets of healthcare, including improved patient outcomes, enhanced quality and safety measures, and significant cost avoidance or reduction. Join a panel of key leaders as they share insights on identifying, quantifying, and communicating the value and impact of clinical pharmacy services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The second in a five-part series, this episode of Tools of The Trade covers different options for data ingestion.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to inform listeners about opportunities and concerns in the pharmacy leadership pipeline across hospitals and health systems. Most health-system pharmacy leaders are satisfied with their decision to pursue leadership; however, many also identify opportunities for improvement, including leadership development and growth opportunities, mentorship, and work-life balance. The development of the pipeline for residents, mid-level managers, and upper-level pharmacy executives is also explored.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will focus on reviewing the role of an emergency medicine pharmacist, as well as characteristics of an emergency medicine pharmacist that will help them succeed in their practice. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This is first in a two-part feature on emergency medicine presentations from the 2025 ASHP Midyear Clinical Meeting & Exhibition. Members highlight their presentations including the role of bundled care in improving intracranial hemorrhage outcomes, clinical case scenarios to determine the appropriate medication, dosing strategy, and timing for magnesium, ketamine, and TXA based on patient presentation and available evidence, and the role of the pharmacists in cardiac arrest care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast ASHP Vice President of Member Relations Hannah Vanderpool interviews Daniel Cobaugh on his unique career path in pharmacy, challenges he confronted and overcame as a gay man, and his role as an advocate for LGBTQ people in pharmacy.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Immediate-Past Chair of the Section of Specialty Pharmacy Practitioners Erica Diamantides sits down with the Section of Specialty Pharmacy Practitioners Distinguished Service Awardee Kristel Geyer to discuss what membership within the section and with ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Lindsey Kelley and Daniel Cobaugh will discuss Lindsey’s journey as a pharmacy leader who also happens to be a lesbian woman. They will hit upon Lindsey’s career experiences, insights from her letter in Letters from Women in Pharmacy, and her guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Glen Gard and Daniel Cobaugh will discuss Glen’s journey as a pharmacy technician and leader who also happens to be a gay man. They will hit upon Glen’s career experiences, his leadership role in the ASHP Pharmacy Technician Forum, and his guidance for other LGBTQ pharmacy technicians, student pharmacists, residents, and pharmacists.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover how RFID is helping health systems become more agile, efficient, and future-ready. In this episode, we explore key insights, lessons learned, and emerging trends from early adopters who participated in an ASHP Foundation project.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pertussis is an easily transmissible disease that is prevented through appropriate vaccination. Infants, especially young infants, are susceptible to contracting pertussis, and are at highest risk of requiring hospitalization, supportive management, and encountering morbidity and mortality related to the infection. After this episode, listeners will be able to discuss the clinical presentation and management of an infant with pertussis and review the vaccination processes to prevent transmission of pertussis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Alexander Gilmer and Daniel Cobaugh will discuss Alexander’s journey as a pharmacist who also happens to be a transgender man. They will hit upon Alex’s experiences as a student and resident, his interactions with his patients, and his guidance for other LGBTQ student pharmacists, residents, pharmacists, and pharmacy technicians.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The podcast provides information relevant to the use of direct oral anticoagulants as the therapy relates to hospital discharge, maintenance therapy in the community setting, and managing patient access to mitigate gaps in therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Kelly Brunk and Daniel Cobaugh will discuss Kelly’s journey from a career as a professional dancer followed by a promising pharmacy career. They will hit upon Kelly’s’ career and life experiences, and his guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, ASHP's Daniel Cobaugh speaks with Jorge Garcia and Leyner Martinez, discussing their unique experiences as a couple who are leaders in health-system pharmacy practice. They will hit upon their early career experiences, navigating residency as a couple, balancing the demands of family and career, and their advice for LGBTQ people in pharmacy.
In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The first in a five-part series, this episode of Tools of The Trade discusses the importance of data literacy, practical pharmacy examples, and common data sources to get started in data analytics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Mr. David Chen, Dr. Lindsey Amerine, and Dr. William Kernan discuss the AJHP Practice Research Report "Pharmacy executive and mid-level manager perceptions of leadership in contemporary health-system pharmacy” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Emily Laswell and Dr. McKenzie Grinalds discuss the AJHP Therapy Update, “Rapid administration of antiseizure medications: Review of safety, effectiveness, and implications for pharmacy practice” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the evolving landscape of GLP-1 therapies, highlighting new formulations, emerging clinical uses and future directions of metabolic care. The episode reviews access and affordability while also providing a clear understanding of where GLP-1 therapy is headed in this rapidly changing field.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the urgency for pharmacists to transition from using Cockcroft-Gault eCrCL to non-race based estimated glomerular filtration rate (eGFR) to improve medication-related decision-making in persons with reduced kidney function. Listeners will learn how to transition from C-G eCrCL to eGFR adjusted for body surface area to improve medication effectiveness and safety in persons with chronic kidney disease.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Two wellness experts discuss ways that we can take care of our own well-being. They will share insights into how events in our workday interfere with wellness and what we can do to maintain and re-establish wellness.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how an interdisciplinary team of pharmacists, nurses, and providers redesigned frequently ignored and interruptive allergy review alerts within the electronic health record (EHR). By leveraging data from the EHR and incorporating frontline feedback, the team implemented changes to reduce noise and maintain patient safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Through practical discussions, expert insights, and real-world strategies, participants discuss best practices for keeping up-to-date and translating new information through practical discussions, expert insights, and real-world strategies. This podcast is designed to support pharmacists navigating rapidly evolving cardio-kidney-metabolic care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast breaks down key legislative updates and explores what they mean for new practitioners. Listeners will gain practical insight into how these changes impact day-to-day practice across care settings, along with actionable ways to apply new policies in their own roles. The episode also highlights opportunities for advocacy and engagement, empowering early-career professionals to get involved and help shape the future of the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
What does the future hold for the 340B Drug Pricing Program? In this episode, ASHP Executive Vice President and CEO Sam Calabrese sits down with ASHP Chief Advocacy Officer and Vice President of Government Relations Tom Kraus to discuss what health-system pharmacy professionals are hearing on the ground, the real-world value the 340B program brings to patients and communities, and ASHP’s latest efforts to safeguard the program. Tune in for an inside look at the challenges, opportunities, and advocacy shaping the road ahead.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
T-cell-engaging bispecific antibodies represent a major therapeutic and scientific advancement in the treatment of several types of cancer. However, they carry a risk of some unique acute toxicities, such as cytokine release syndrome and neurologic toxicity. This podcast reviews this emerging drug class and strategies for recognition and management of their unique adverse events.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the development of an innovative telehealth‑focused, virtual postgraduate year 2 ambulatory care residency program within the VA, highlighting how it expands access to specialized training, leverages a virtual precepting model, and prepares pharmacists for emerging virtual care roles. Speakers share insights and lessons learned from designing a virtual residency model, including strategies for overcoming implementation challenges and supporting resident success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process. Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.
Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the unique perspectives of pharmacy technician educators and their role in shaping the next generation of technicians. Listeners will gain insights into effective teaching strategies, current challenges in technician education, and innovative approaches to competency development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Ben Anderson and Dr. Mike Ganio discuss the AJHP ASHP Report "Proceedings of the ASHP Autoverification Work Group: Findings and Guidance” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Insights & Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.
Through conversations with ASHP Executive Vice President & CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.
Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Michael Wolcott to discuss how today’s pharmacy teams are navigating disruptions to resilience, from burnout and compassion fatigue to less visible challenges like “quiet cracking.” This episode explores how these dynamics show up across individuals, teams, and organizations offering a preview of the insights and strategies attendees can expect to learn in this session.
Listen in for a glimpse of what’s ahead, then register to join us at Pharmacy Futures and be part of the full experience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features Section of Pharmacy Practice Leaders Immediate Past Chair Kat Miller and 2025 Distinguished Service Awardee Rick Couldry discussing what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features, Justin Moore, Lucas Shultz, and Elizabeth Wade. They share what inspired them to pursue a career in pharmacy and offer insights into the role of a hospital and health-system pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Sara Panella sits down with the Section of Ambulatory Care Practitioners Distinguished Service Awardee Jamie Cavanaugh to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will focus on how pharmacists in the emergency medicine environment should identify and evaluate patients exposed to poisons. This presentation will cover the basics of exposure management to common poisons and medications to better prepare the pharmacist for quick initiation of therapy. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at Cone Health recognized for a program focusing on a pharmacist-led deep vein thrombosis clinic (DVT). The episode highlights how the DVT clinic was built, including how pharmacists centralized outpatient care through the inclusion of imagining, diagnosis, treatment, and dispensing at one location.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at the Fred Hutchinson Cancer Center who is recognized for a program focusing on pharmacist prescriptive authority and optimizing care through identifying and prescribing oral chemotherapy for patients. The initiative exemplifies ASHP’s new strategic plan and its patient care pillar, advancing innovative pharmacy practices that expand access, improve outcomes, and elevate the role of pharmacists as integral members of the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hear from the 2025 ASHP Foundation Pharmacy Residency Excellence Awardees as they discuss their best practices and career highlights.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode spotlights the South Dakota State University College of Pharmacy SSHP Professionalism MiniSeries, a collection of student-driven events designed to help pharmacy students strengthen their professional identity and prepare for postgraduate training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode dicusses the role of the 340B Drug Pricing Program in public health infrastructure, state and federal legislative reform of the program, the advocacy role of health systems and pharmacy teams, and the differing views shared by health systems and pharmaceutical manufacturers regarding 340B legislative reform. Listeners will learn the background and purpose of the 340B program, ongoing efforts to reform the program at the state and federal levels, and what actions are commonly undertaken to influence reform and the differing views held by 340B stakeholders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Lauren Ashton, a doctor of pharmacy student at Northeast Ohio Medical University. She shares what inspired her to pursue a career in pharmacy and offers insights into the experiences of a pharmacy student.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Joe Anderson to discuss the updated physical exam interactive workshop for pharmacists with a focus on blood pressure, test and treat diagnostics, the Medicare annual wellness exam, and specific techniques for assessing heart failure and volume overload.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system. This episode will review organizational considerations and strategies around these novel therapies including complexities and structures of supply chain operations, financial models and impacts, clinical operations needs and planning, and interdisciplinary alignment and collaboration. CE for this episode expires 3 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, Megan Adelman, PharmD, BCPS, BCGP, family medicine clinical specialist at the Cleveland Clinic Akron General, discusses opportunities and strategies to incorporate AI tools into the precepting workflow. These practical ideas can be implemented by attendees right away and immediately impact administrative efficiencies, allowing more valuable time with students and residents for in-depth discussions and learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Well-being, burnout, and resilience have been hot topics within the healthcare community. These topics are particularly relevant to new practitioners, especially in the age after the COVID-19 pandemic. This podcast aims to investigate potential well-being gaps they may face and how to address them with their manager and in their department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field of CIDP.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will overview important supportive care topics for cell-based therapies, primarily targeted for practitioners that have less exposure to these therapies but are now being introduced to their use. Specific topics will include tumor lysis syndrome and chemotherapy induced nausea and vomiting, anti-infective prophylaxis, cytokine release syndrome, and immune effector cell-associated neurotoxicity syndrome. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Amy Pasternak and Dr. Jamie Park discuss the AJHP Descriptive Report "Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for an inspiring session where we explore how the pharmacist's role in medication safety is evolving. Speakers will share how ASHP's Practice Advancement Initiative 2030 is being integrated into practice, artificial intelligence use in advancing medication safety, and tips for student pharmacists on how to get involved in medication safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses how pharmacists are expanding their roles in obesity management through collaborative practice agreements (CPAs) and innovative clinic workflows. Guests share their experiences launching and sustaining weight management services, highlighting operational considerations and billing strategies. Listeners will gain practical insights into establishing pharmacist-led obesity care models and supporting patients in achieving long-term success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will explore the concept of cognitive load, which describes the mental effort required to process information and directly impacts cognitive function. In the workforce, cognitive overload has been linked with occupational burnout. Addressing cognitive overload in the workplace is an available strategy to help manage occupational burnout. Listeners will learn about cognitive load theory, its linkage to occupational burnout, and strategies that may reduce cognitive load.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Luna Shi, chair of the New Practitioners Forum Executive Committee (NPF), sits down with the 2025 NPF Distinguished Service Awardee, Justin Moore, to discuss his leadership within the forum and ASHP and its impact on his professional journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This activity will discuss clinical and safety strategies for implementation that will translate to better care for patients and a safer handling environment for providers, patients, and caregivers. Additional details and discussion about collection, processing to final dose product, dose storage/preparation/administration, and safe handling may provide more insight and considerations applicable for pharmacy practice. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at the Veterans Administration (VA), recognized for a program focusing on pharmacist-led pharmacogenomics testing. Listeners will learn how the VA started and expanded the program including how they trained pharmacists, implemented the program, and expanded access to patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on PAH.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode focuses on the challenges and strategies surrounding the cost and insurance coverage of anti-obesity medications. Guests share insights on navigating Medicare, Medicaid, and commercial insurance barriers, as well as tips for utilizing manufacturer programs, savings cards, and coding strategies to improve patient access. The discussion highlights the pharmacist’s role in helping patients overcome financial obstacles and sustain access to effective obesity treatments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Immediate-Past Chair of the Section of Community Pharmacy Practitioners Courtney Isom sits down with the Section of Community Pharmacy Practitioners Distinguished Service Awardee Melissa Ortega to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will cover the background of cellular-based gene therapies from basic cell biology to genetic targets currently used in treatment. Experts will review the mechanisms for modifying cellular genetic material and the common viral vector platforms used in ex-vivo cellular therapy production. An overview of the steps and processes for cellular therapy preparation, manufacturing, handling and administration will be provided. Additionally, this presentation will discuss novel cellular therapy agents currently approved for use and the highly anticipated cellular therapies currently under investigation. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a review of current literature and expert consensus regarding the periprocedural management of glucagon-like peptide (GLP) medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field of Opioid REMS including appropriate treatment for pain management including opioids, non-opioid analgesics, and non-pharmacological therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode addresses the growing challenge of adolescent obesity, which now affects over 22% of US teens. The discussion highlights Food and Drug Administration-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features John Wood, Executive Medical Director, Primary Care and Population Health, Penn Medicine Lancaster General Health, and James Kelly, Regional Medical Director and Primary Care Provider, Penn Medicine Lancaster General Health, as they share their perspectives on the vital role pharmacists play in supporting patients. They discuss how pharmacists enhance care, improve outcomes, and strengthen the physician–pharmacist partnership.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Billing opportunities in ambulatory care can often be complicated to navigate, and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast provides an overview of the 2026 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features the 2025 ASHP Best Practice Award winning team at New York Presbyterian Hospital, recognized for their program focusing on ambulatory care pharmacist embedded in clinics improved access to patient care. Listeners will learn how ambulatory care pharmacists created a critical role in promoting equitable, patient-centered care, and how they improved care outcomes among underserved populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Drs. Joe DiPiro and James Hoffman discuss the ASHP/ASHP Foundation 2026 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how the Inflation Reduction Act’s (IRA) drug price negotiation program is reshaping the relationship between CMS, drug manufacturers, and providers. We’ll explore what the proposed IRA implementation framework means for our healthcare system, highlighting the financial, legal, and transparency implications for pharmacies and patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the Leader-Member Exchange (LMX) theory, offering pharmacy technicians practical strategies to strengthen relationships with leaders, advocate for their goals, and leverage networking and mentorship to advance their careers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode dives into the critical management strategies for drug-induced hyperthermia, exploring the underlying mechanisms, clinical challenges, and evidence-based interventions. Listeners will gain practical insights into recognizing early warning signs, implementing rapid cooling techniques, and optimizing pharmacologic approaches to improve patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists’ role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We’ll explore the pharmacist’s role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms. CE for this episode expires on November 29, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP’s newly updated strategic plan. Speakers share the story behind the plan’s development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting & Exhibition and there’s no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode explores why ASHP’s Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council’s secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists’ Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP’s stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss where 340B advocacy goes from here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it’s had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the Council on Pharmacy Practice to unpack ASHP’s newly approved policy on moral distress and moral injury. They’ll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA’s proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission. They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2) products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer’s expiration date? We’ll break it down, explore key insights from USP <797>, and highlight what every sterile compounder needs to know.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Kathryn Brown, senior vice president and chief operating officer for national pharmacy at Kaiser Permanente and Elizabeth Rebo, executive director of medication safety at Kaiser Permanente, as they discuss their upcoming sessions Embracing Innovation in Patient Care Services: Demonstrating Value Using Digital Tools, AI, and Integrated Technologies & Change Management in a Season with Generative AI.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode Kim Benner and Lauren Ashton discuss their experiences in the ASHP Guided Mentorship Program. They share how mentorship has shaped their professional growth, how the success of a Student Society of Health-System Pharmacy initiative implemented at Lauren’s school, and offer valuable advice for future mentor-mentee pairs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This is the final episode in a three-part series unveiling how pharmacy technology change requests are taken from idea to implementation. This podcast discusses the next steps required for build validation, testing, implementation, and post-implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. In part two of this series, we will explore what are the implications behind the numbers and what health systems can do to support the clinical pharmacists of tomorrow.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the vital role pharmacists play in addressing misinformation about medications. The discussion covers common sources of misconceptions, strategies for engaging patients in respectful, non-confrontational conversations, and challenges pharmacists face during these conversations. Listeners can learn practical insights on effective communication, the impact of misinformation on patient outcomes, and how health systems can better support pharmacists in promoting accurate, evidence-based medication information.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Venessa Goodnow, assistant vice president and chief pharmacy officer at Jackson Health System, as she discusses her upcoming sessions, Tackling the Revenue Cycle Challenge: Processes, Politics, Payers, and Patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast reviews system governance and other approval steps prior to the technology team begins building the request. Panelists discuss prioritization considerations and methods to incorporate system standardization into the original requests.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Heart disease related costs in the United States amounted to nearly $239 billion between 2018 and 2019, and heart disease contributed to nearly 700,000 deaths. This activity will review the pathophysiology and clinical presentation of acute coronary syndromes and categorize the guideline-recommended pharmacologic management strategies for the treatment of unstable angina and acute myocardial infarction. These summaries will be supported by a review of the evidence that played a role in the development of these recommendations. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast highlights how pharmacy technicians incorporate community health worker roles into their practice - breaking barriers, expanding access, and improving patient outcomes. Join us as we dive into real-world stories, innovative models, and the future potential of this dynamic, dual-impact workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Artificial intelligence (AI) is a prominent topic across all healthcare professions. As we continue to explore its potential to enhance patient care, it is imperative to remain vigilant about the ethical and moral challenges this technology may present. Join our expert panel as they discuss the integration of ethical decision-making in the adoption of AI at a large academic medical center.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Unpacking the CY 2026 Proposed Rules: PFS and OPPS Highlights, we break down key changes outlined by CMS in the 2026 Physician Fee Schedule and Outpatient Prospective Payment System proposed rules. We will offer insights on payment updates, policy shifts, and what these changes could mean for our members and their patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Eric Tichy and Dr. Matthew Rim discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2025” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an overview of the growing field of data analytics. Panelists discuss their career paths in data analytics roles as well as transferrable skills and training and education they've received that have led successful careers in data analytics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Why is enrollment in residency programs dropping? And what does this decline mean for clinical pharmacists? In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses the importance of serving as a mentor to junior faculty. Two faculty mentors review motivations for becoming a mentor and the benefits and challenges of mentorship.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Joshua Hammonds, PhD, chair & professor of communication at Rollins College as he discusses his upcoming session Innovative Leadership Strategies for the Entrepreneurial-Minded Leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s senior education director, Cindy Von Heeringen is joined by John Armitstead, vice president of Pharmacy Services at Lee Health, Jeffrey Reichard, system executive director at UNC Health, and Amy Gutierrez, chief pharmacy officer at John Muir Health, as they discuss their upcoming Midyear session that focuses on applying leadership strategies for system-level pharmacy leaders to generate value within a health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Zoe Ngo and Dr. Austin Wang discuss the AJHP Case Study "Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, community pharmacists share collaborative practice agreements that they use to improve access, ensure safety, and optimize patient care during transitions of care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In recent years, pharmacy school enrollment and pursuit of pharmacy residency has declined nationally. This trend has impacted specialty pharmacy residencies in particular because pharmacy students tend to have less familiarity with specialty pharmacy as a practice setting. This podcast will target specific strategies to recruit highly successful candidates for careers in specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Navigating the world of pharmacy academia can be challenging. Having mentors assist with your career development and provide guidance is beneficial for junior faculty. This episode will discuss the benefits of having multiple mentors and how to find a mentor in academia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a discussion from pharmacy and leadership perspectives about population health end of year efforts to meet quality measures.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the business of pharmacy, leadership growth, and career advancement, featuring expert interviews, practical strategies, and real-world experiences. Whether you're an established leader or preparing for your first leadership role, this podcast offers valuable guidance to support your professional journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides junior faculty members with guidance on how to navigate life as an early-career faculty member and how to best position themselves to successfully advance in rank. A diverse panel of faculty members discusses their own careers, provides advice to junior faculty on how to advocate for themselves to their supervisor, and shares ways colleges can provide support to junior faculty.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This is the first episode in a three-part series discussing how pharmacy technology change requests are taken from idea to implementation. This podcast introduces what pharmacy technology change requests entail, common request categories, and features of a clear request. CE for this episode expires on July 26, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Hesham Mourad, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2024, Julie Pawola, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as we explore providing data for specialty medication access. Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the use of Platelet Factor 4, which has several roles for applicability, limitations, and emerging areas for use. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode discusses the benefits of ASHP membership from the perspective of a student, seasoned practitioners, and professors. Speakers hope to inspire others to continue their involvement throughout their pharmacy career as a way to gain skills and further their careers and contribute to the advancement of the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, members of the New Practitioners Forum speak with pharmacy administrators and practitioners to explore the evolving landscape of hybrid pharmacy practice. Guests share insights into both inpatient and outpatient roles and discuss the benefits, opportunities, and challenges of hybrid work models.
The National Pharmacist Workforce Study is a systematic, nationwide survey of licensed pharmacists in the United States and provides data and trends over time and on contemporary issues. This most recent study includes information on job satisfaction, advancement opportunities, and workplace culture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Kathy Parrinello, CEO and President of University of Rochester Medical Center Strong Memorial Hospital and Highland Hospital as she shares what drew her to a career in nursing, and her perspectives on the critical contributions of pharmacists within the health system setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode highlights changes made to the resource and revised categories of biomarkers and provides a resource for evidence-based application of biomarkers in clinical pharmacy practice. CE for this episode expires on June 21, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the critical elements of physical wellness, offering tips for maintaining a healthy body through exercise, nutrition, and self-care. The episode also discusses building resilience and strategies for bouncing back from failure, highlighting the importance of mental fortitude and perseverance in both personal and professional growth.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices. They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 & PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts on treatments for patients with obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting. These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode reviews the viral replication process, common viral vectors for in vivo gene therapy, and Food and Drug Administration-approved therapies. The episode will also highlight novel in vivo gene therapies in the development pipeline. CE for this episode expires on May 25, 2027.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina’s expertise, dedication, and care improved her health and changed her life for the better.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we are joined by expert Kenneth A. Richman, professor of philosophy and health care ethics at MCPHS University. Join us as we discuss real-world dilemmas, ethical decision-making frameworks, and how pharmacists can uphold integrity while navigating complex healthcare systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join the TPTS Board of Directors as they walk through TPTS’s first strategic plan. Hear directly from the Board as they break down the key goals tied to each pillar and share what excites them most about the road ahead.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts on treatments for patients with obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Follow ASHP Career and Leadership Advisory Group members as we discuss what we learned during our APPE rotations and internships, from applying to finding leadership within the new roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Julie Dagam sits down with Tiffany Pon to discuss the upcoming session entitled “A Whole New World: Navigating Resident Selection Processes”. This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from UNC Health Medical Center discusses their award-winning submission to the ASHP Best Practices. They share how their precision oncology program allowed clinicians to integrate evidence-based personalized therapies into their practice to improve patient outcomes by reducing barriers to precision oncology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty experts highlight USP <797> and discuss opportunities to reduce medication errors, with respect to sterility, stability, and compatibility when compounding parenteral nutrition and assigning a beyond use date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Community-based residency training programs provide unique opportunities to provide patient care, establish and expand pharmacy services, and conduct targeted research and other projects relevant to community pharmacy. This podcast features three residency directors of community-based residency programs sharing insights and perspectives on the value of community-based residency training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Julie Dagam sits down with Janet Cooley and Suzy Larson to discuss their upcoming session entitled “Up your game: an interactive board game addressing preceptor challenges”. This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from St. Elizabeth Physicians and the University of Cincinnati discuss their award-winning submission to the ASHP Best Practices. They share how leveraging remote certified pharmacy technicians in ambulatory care helped expand clinical pharmacy services, improve value-based care, and impact their organization’s high performance on quality measures.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the intricacies and scope of suicide, review key research findings on the risk factors and warning signs for suicide, outline recommendations for suicide prevention, and provide guidance on addressing suicidal crisis or response.
Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease. Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
If you didn’t make it to the 2024 Midyear Clinical Meeting & Exhibition or didn’t catch all of the emergency medicine related content, we have you covered! Presenters will give pearl-style recaps of their talks and provide additional insight into application and implementation into practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Navigating a pharmacy residency can be overwhelming, but resilience and support can make all the difference. Hear from Brody Maack and Jerica Lam as they reflect on the challenges they've faced, how they’ve prioritized wellness, and the lessons they’ve learned along the way. Whether you’re starting residency or supporting someone who is, this episode offers valuable insights and encouragement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Alfred Awuah, chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2024 NPF Distinguished Service Awardee, Charnae Ross, to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
This podcast will empower new pharmacists to transform innovative ideas into impactful evidence. From developing research questions to navigating the peer-review process, this team will break down the steps to conducting meaningful studies and successfully sharing your findings. Join us as we uncover tips, tools, and expert insights to elevate pharmacy practice through research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don’t miss this preview of one of the most anticipated events of the conference!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers will provide practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Indrani Kar, manager, formulary and drug policy at University Hospitals as she shares what drew her to a career in pharmacy, her experiences behind the scenes in a health-system setting, and the interdisciplinary team she works with to shape drug policy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members with an analysis of the Trump Administration’s Executive Order (EO) on drug pricing. We’ll talk through what the EO means for the 340B program, the Inflation Reduction Act’s negotiated drug pricing program, and site neutral payment, and what ASHP will be watching in the coming weeks.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Dor Partosh and Dr. Dovena Lazaridis discuss the AJHP Practice Research Report, “Reducing readmissions with pharmacist-integrated care in Medicare value-based programs,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP welcomes Sarah Stephens and Drew Stivers as they discuss two medication safety sessions planned for the ASHP Pharmacy Futures meeting June 7–11 in Charlotte, NC. Both active in the medication safety community, they share reflections on the benefits of the meeting’s networking offerings as a genuine highlight of their personal and professional satisfaction with attending the event.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast focuses on member research and scholarly activity along with pearls and best practices for pharmacist-driven research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Brandon Bookstaver and Dr. Kayla Stover discuss the AJHP theme issue on management of infectious diseases with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Allison Porter is joined by the Section of Inpatient Care Practitioners 2024 Distinguished Service Awardee, Linda Spooner, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is joined by Brody Maack for an overview of two interactive programs planned in Charlotte at the 2025 ASHP Pharmacy Futures Meeting. Along with Bonnie Kirschenbaum, Brody will present Cracking the Code: Transforming Practice with Improved Billing Strategies.
Joined By Evan Frasure, Dr. Maack will tackle Bridging the Gap: Leveraging Implementation Science to Strengthen Controlled Substance Diversion Prevention Practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s Practice Advancement Initiative (PAI) 2030 provides pharmacists with the tools and guidance they need to continue to lead and shape the profession through 59 unique recommendations. This podcast highlights 3 pharmacist success stories in health systems across the country where they have implemented changes utilizing the PAI 2030 recommendations. Our guests were able to implement new services in New York, North Dakota, and South Dakota, strengthening patient care for their health systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we explore the unique challenges pharmacy students and residents face during their training, including the risk of burnout, and discuss practical strategies for maintaining balance, building resilience, and fostering a sense of community. Our conversation highlights real-life experiences, expert advice, and actionable tips to help pharmacy learners prioritize their well-being while thriving in their professional journey. Whether you're navigating the demands of rotations, studying for boards, or managing the pressures of residency, this episode offers a refreshing perspective on sustaining your passion and purpose in pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Billing opportunities in ambulatory care can often be complicated to navigate and annual changes in the physician fee schedule can both add opportunities and create confusion. This podcast will provide an overview of the 2025 physician fee schedule as it relates to current billing practices, potential new opportunities for pharmacy billing, and other information relevant to ambulatory practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight opportunities for pharmacogenomic testing in solid organ transplant. The speakers will discuss their experiences and challenges with utilizing pharmacogenomic testing in this patient population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is joined by Megan Adelman as she describes the multidisciplinary workshop planned for Wednesday June 11th. Hands-on weight management instruction will be provided by two pharmacists, a nutritionist, a movement specialist, and a behavioral health expert. Learners will engage in active learning, including case studies, role-playing motivational interviews, gaming, and design of personalized care plans.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on the pharmacist’s role in Myasthenia Gravis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight common pain issues that may arise in the ambulatory care setting, providing recommendations and tools on how to appropriately triage and make recommendations. The speakers for this podcast are expert pain management practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Allison Given, PharmD candidate at the University of Charleston, College of Pharmacy as she shares what drew her to a career in pharmacy, her experiences with clinical pharmacists as a cystic fibrosis patient, and the patient interactions she’s already had as a pharmacy student. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Sandra Kane-Gill and Katie Suda to discuss changes in research including open access requirements, getting funding, and artificial intelligence and implications for pharmacist researchers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Cher Enderby sits down with the Section of Pharmacy Educators Awardee Lea Eiland to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on the pharmacists role in Myasthenia Gravis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Patricia Kienle, Cardinal Health, and Mike Ganio , ASHP , join us to discuss the compounding educational line up at the ASHP Pharmacy Futures meeting in June and explain the unique opportunity to participate in the Designated Person Program that offers a live skills workshop on Wednesday June 11th.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Nancy MacDonald, Immediate Past Chair of the Section of Clinical Specialists and Scientists sits down with Distinguished Service Awardee Bhavik Shah to discuss his service and leadership within ASHP.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy’s recent ML model research, key findings, and the potential applications of these models across different patient populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Emily Bryant, Clinical Pharmacist and Residency Program Coordinator at Aurora Health Care, as she shares insights on her pharmacy career journey, her experiences working with pharmacy students and residents, and the various roles of pharmacists as medication experts in a hospital setting. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast dives into the innovative PGY2 Medication-Use Safety and Policy (MUSP) residency programs at City of Hope. These groundbreaking programs, developed in collaboration with Chapman University and Becton Dickinson, offer residents unique opportunities in academia and medical technology, providing comprehensive training that redefines advanced pharmacy education. Join us as we explore how these residencies are shaping the future of medication safety, hear firsthand experiences from current residents, and discuss the impact of blending academic and industry expertise.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Kelli Johnson sits down with the Pharmacy Technician Forum (now The Pharmacy Technician Society) Awardee Charlotte Hook to discuss what forum membership, TPTS, and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on opioid REMS.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Drs. Rena Gosser, Christopher Scott, and Johnathan Watanabe discuss the ASHP/ASHP Foundation 2025 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Creating interprofessional experiences between didactic pharmacy students and perscribers can be challenging for all schools/colleges of pharmacy, yet these experiences remain an important part of the student experience and accreditation standards. Some schools face additional geographic and institutional barriers based on their physical location and the programs offered by their colleges/universities. Join us as we hear from a panel of faculty and administrators who have implemented creative solutions to successfully deliver exceptional interprofessional experiences.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for this podcast episode where four 2024 ASHP Fellows discuss their journeys in pharmacy leadership. They’ll share valuable insights and advice for pharmacists, especially for new practitioners, who aspire to become leaders in the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. Hosted by Rachel Hawley, this month's episode features Linda Gordon, System Director of Diversion Prevention at UC Health, as she shares insights on her pharmacy career journey, the collaborative nature of interprofessional care teams, and the growing impact of AI in pharmacy practice. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
NIOSH published an updated list of hazardous drugs in healthcare settings in December, 2024 – its first update in nearly 8 years. The new list includes significant changes that affect how USP Chapter <800> can be applied to some hazardous drugs. Experts discuss the updated list and its implications for pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we explore the evolving role of pharmacy technicians and how PAI 2030 is shaping the future of pharmacy practice. Our guests discuss advanced technician responsibilities like technician product verification, regulatory compliance, and the importance of formal career paths and certifications. Tune in to hear insights on how these changes are positively impacting patient care and the dynamics of pharmacy teams.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Descriptive Report, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Solid organ transplant pharmacy is a multi-faceted field that offers opportunities to practice in either the inpatient or outpatient setting. This discussion focuses on what the role of a transplant pharmacist may look like in an ambulatory care setting, considerations when initiating or expanding outpatient pharmacy services, as well as the potential obstacles faced by solid organ transplant pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform pharmacy practice. This podcast will outline and discuss how artificial intelligence is and how can it be utilized within the profession of pharmacy and pharmacy education
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of We’re Your Pharmacist podcast series, ASHP sits down with Ashley Ramp, Multi-Site Director of Pharmacy at Children's Hospital Colorado. Ashley shares her journey of becoming a pharmacist, where she draws inspiration, and her experience transitioning careers from being a high school teacher to health-system pharmacist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There’s Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
According to the CDC, nearly 42% of Americans have obesity, with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Explore the essential contributions of health-system pharmacists through engaging interviews with pharmacists and other healthcare team members who witness their impact firsthand. Nearly one in three pharmacists work beyond retail settings, bringing their specialized expertise in medications to hospitals, clinics, and outpatient facilities. As trusted partners on the healthcare team, these pharmacists work to ensure that medications are safe, effective, and accessible, playing a critical role in each patient’s journey. Listen in as we uncover the many ways pharmacists make a difference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor). The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform.
In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&M University and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman, Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs.
The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform.
In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for an insightful episode where experts Brian W. Gilbert, PharmD, MBA, BCCCP, FCCM, FNCS, Lance Ray, PharmD, BCEMP, BCPS, and Ruben D. Santiago, PharmD, BCCCP, BCPS discuss an upcoming educational session at the Midyear Clinical Meeting and Exhibition focused on the current state of illicit drug use in the United States. The session will cover both nonpharmacological and pharmacological management strategies, offering valuable insights for pharmacists via engaging case-based scenarios. Don’t miss this opportunity to stay informed on critical trends and treatment approaches!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Jared White, manager, pharmacy data analytics at UCSF and Ben Michaels, data science pharmacist at UCSF Medical Center at UCSF as they discuss their upcoming sessions AI for Pharmacy Leaders, Part 1 and Part 2. They will provide background information and forward-facing strategies expressly curated for leaders to stay abreast of this ever-changing landscape.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Part 2 of this podcast series discusses the background for current barcode formats used on medication packages. Our speakers provide insight into regulations currently affecting barcoding practices, as well as changes that are needed for the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for an insightful episode featuring an expert speaker, Megan Adelman, PharmD, BCGP, BCPS, CDCES from the upcoming Midyear Clinical Meeting and Exhibition. She will explore generational differences in the pharmacy workforce, offer strategies for precepting the newest generation, and highlight the unique skills and perspectives they bring to the field. Don’t miss this opportunity to learn how to foster collaboration across generations in your pharmacy practice!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the 2024 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Denise Scarpelli, vice president and chief pharmacy officer at University of Chicago to discuss the upcoming session, How Strong is Your Bench? Developing Future Pharmacy Leaders with Strategic Succession Planning. Denise will give an overview of the session design and share a bit of her own story with this creative process for developing future leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join a conversation about unique education planned for a needed and sensitive topic at the upcoming conference for pharmacy leaders. Bill Kernan, a seasoned leader is joined by health system HR professional Adriana Ciltara as they give a preview of the program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the Ohio State University Wexner Medical Center to discuss their award-winning submission to the ASHP Best Practices. They will share how their program demonstrated improvements in opioid utilization, reduction in medication errors and an increase in patient safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast examines issues surrounding current requirements for barcodes on unit-of-use medication packages and provides insight into the opportunities available for utilizing updated barcoding practices. Speakers discuss what is needed from vendors, federal agencies, and pharmacies to facilitate a change in current practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Zoe Karavolis and Dr. Antoine Douaihy discuss the AJHP Practice Research Report, “Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacy preceptors often face the emotional strain of balancing their clinical responsibilities with the need to provide meaningful, constructive feedback to their learners. In addition, they often struggle with navigating learners’ emotions while delivering constructive feedback, aiming to be supportive yet honest in a way that doesn’t discourage growth. Join us at the National Pharmacy Preceptors Conference on October 2-3 to learn more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Harnessing the plethora of data is a critical success factor for hospital and health system executives and the sources of data are continually growing in complexity and reliability. This podcast will provide insights and instruction from two hospital and health system C-suite executives on examples and lessons learned on leveraging data to improve outcomes and decision making in a multi-hospital health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we discuss how PBMs have co-opted specialty pharmacy practice to maximize their profits at the direct expense of patients, how policymakers can address these practices and how pharmacists can push back against these actions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on how generative artificial intelligence (AI) impacts outpatient pharmacy practice. The speakers discuss how AI can help augment patient-centric and administrative functions to help pharmacists improve their outpatient practice, both presently and in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session, presented at the 2024 virtual National Pharmacy Preceptors Conference, will define the fundamentals of artificial intelligence (AI), apply AI utilization strategies to experiential learning, and discuss potential pitfalls and ethical challenges when using AI within pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, listeners will hear from a pharmacy leader about the pioneering experience of her health system’s pharmacy drone delivery program. Discussion will include implications for the medication-use process, lessons learned, and future considerations for pharmacy drone deliveries.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the increase in high-cost medication utilization in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the drug budget. Hospitals may vary in the resources dedicated to performing these assessments. Please join us as we discuss strategies for managing high-cost medications with pharmacy leaders from across the continuum of hospital/health-system sizes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The podcast explores the integration of gaming in pharmacy education, highlighting how interactive and immersive games can enhance student engagement and learning. Speakers discuss the benefits of gamified learning experiences in understanding pharmaceutical concepts and improving problem-solving skills in a dynamic educational environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, we will be discussing strategies to gain approval of potential new positions to an existing department or the creation of new clinic or service that would include pharmacy support. These positions are typically approved by the C-Suite of an organization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
When your patient list seems insurmountable, how do you prioritize your patient care activities for the day? Join us to hear from pharmacy leaders in the informatics field who have experience with developing and implementing a scoring system within the electronic health record to triage patient care, identify intervention opportunities, and prioritize clinical pharmacy services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The goal of this podcast is to help describe specific productivity, clinical and operational benchmarking metrics that are utilized in hospitals throughout the US. Listeners should walk away with a new understanding of meaningful metrics and how to develop them.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the advent of artificial intelligence, groundbreaking advancements are changing the landscape of drug diversion prevention. Advanced analytics are uncovering proactive strategies to prevent and address drug diversion more robustly. This transformative technology has reshaped the perception of drug diversion to one that requires a collaborative, interdisciplinary approach. In this podcast, we delve into the imperative for pharmacists, nurses, and other healthcare professionals to unite, taking collective responsibility for tackling this escalating challenge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. William Hammond and Patricia Valdez discuss the AJHP Descriptive Report, “Impact of a pharmacy technician on an interprofessional antithrombotic stewardship program at an academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the increase in high-cost oncologic medications being utilized in the inpatient setting, pharmacy leaders need to develop a systematic approach to evaluating, procuring, and accounting for these medications in the departmental budget as well as ensuring optimal patient outcomes. Hospitals may vary widely in the resources dedicated to performing these assessments. Please join us in this series as we discuss strategies for managing high-cost oncologic medications with pharmacy leaders from two large academic medical centers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is the second in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources. Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, speakers will discuss both the tangible and intangible benefits of creating, implementing, and facilitating a comprehensive advanced-level ASHP/ACPE accredited pharmacy technician education and training program. Topics such as job satisfaction of preceptors, retention of graduates, and continual professional development of pharmacy technician colleagues will be explored and discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As the residency year comes to a close, many new practitioners are preparing for their first 90 days as a manager. This podcast features current PGY1 & PGY2 health-system pharmacy administration and leadership (HSPAL) residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative interviewing experienced pharmacy leaders about potential pitfalls and opportunities to succeed in your first 90 days as a manager.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Amanda Jo Shigle and Dr. Blake Hays discuss the AJHP Descriptive Report, “Pharmacy residency training program increases residents’ confidence in inpatient medical emergency response,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is part of a series unpacking harmful pharmacy benefit manager (PBM) practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform.
This episode provides a high-level overview of key findings and conclusions from the Federal Trade Commission’s Report Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. The speakers will also discuss how the report can be leveraged to fight back against PBM practices that strain patient affordability, jeopardize patient safety, and imperil pharmacy sustainability.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the fast advancement of artificial intelligence (AI) and its widespread use, it is important to understand how residency programs can incorporate AI to improve administrative efficiency, residents’ learning experience, and recruitment and interview processes. This podcast will dive into the specifics of how AI can transform the current processes in residency programs from the field experts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
This podcast is the first in a 4-episode miniseries exploring the careers pharmacists can have in hospital pharmacy administration. In these episodes, pharmacy students will be interviewing a variety of professionals in different pharmacy admin fields and delving into how they got where they are and the intricacies of their jobs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, created for students, by students, serves as a starting point for discussion about student well-being and resilience. A panel of students representing various backgrounds, geographic locations, and times in their pharmacy career journey, discuss mental health, work/life/family balance, self-care, and support systems to improve overall well-being.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The COVID-19 pandemic accentuated longstanding workforce issues and perpetuated a need for change. Burnout and well-being became a greater focus around the world but especially for healthcare workers. We will share ways in which leadership styles and focuses have changed since our teams have been impacted by the COVID-19 pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast highlights experiences of pharmacy practice providers who did not get their “dream job.” Panelist share how they overcame perceived setbacks, and how they used their resilience to carve an authentic path forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Discover the ins and outs of utilizing hepatitis C positive donor organs. Why do we utilize, how do we protect the recipient’s liver from hepatitis related chronic injury, methods for prevention and treatment of hepatitis in organ recipients, and how to get insurance coverage of the medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listeners will learn about technician experiences and opportunities within the information and technology role. Three panelists from diverse backgrounds will discuss their career paths, advice for fellow technicians and where they envision additional opportunities for pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. David Kao discusses the AJHP Descriptive Report, “Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this interview-panel of 4 student pharmacist leaders, we will discuss how they have promoted practice advancement within their schools of pharmacy, as well as the successes and room for improvement they have identified within their chapter for future implementation. We will dive deep into how other SSHP leaders can utilize these examples to successfully implement PAI 2030 initiatives at their chapter.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With USP <800> and revisions to USP <797> becoming official on November 1, 2023, sterile compounding experts have received numerous questions from hospital pharmacy leaders inquiring about the new standards. In this podcast, we answer the top 10 questions received across the country providing valuable information regarding current sterile compounding hot topics including: procedural areas, competencies, cleaning, lab reporting, COA (Certificate of Analysis) and DVO (Dose Vial Optimization).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast features a panel discussion regarding handling medication errors as a new practitioner, providing self-help resources, and discussion around how a medication error can impact institutional policy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts on compliance with USP Chapter <797> in all size facilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices. They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Pride Month in June, we are sharing the voices of our AJHP authors and their perspectives and experiences. In this episode, Carolanne C. Wartman and Carol A. Ott explore the mental health disparities faced by SGMs individuals and discuss strategies to promote better mental health outcomes for this population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an interview with one of the first pharmacist hospital CEOs, Bill Evans, retired CEO of St. Jude Children’s Research Hospital, and one of the first health system Vice Presidents of Pharmacy and author of the 2005 AJHP paper “Rationale for having a chief pharmacy officer in a health care organization”, Marianne Ivey. They will explore the evolution of pharmacy executives and the path of pharmacy practice and the opportunities still ahead.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast aims to explore what health disparity and equity is, examine their connection to Pharmacoequity and discuss how the P&T committee can address these issues within the formulary review process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Tyler Darcy sits down with the Pharmacy Technician Forum Awardee Julia Becker to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on the current status and future of COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The US Food and Drug Administration (FDA) implemented Risk Evaluation and Mitigation Strategy (REMS) programs to ensure benefits outweigh the safety risks of particular medications. With over 60 medications with REMS programs and varying requirements for each, operationalizing to comply with requirements can be challenging. In this podcast, we talk about some of those challenges and how to operationalize recommendations for those who routinely see these medications in practice, as well as for those who come across them sporadically.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Pride Month in June, we are sharing the voices of our AJHP authors and their perspectives and experiences. In this episode, Jacinda Abdul-Mutakabbir and Takira Morrison discuss the intersection of racism and SGM health and the health disparities observed in individuals who hold these identities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Benjamin Anderson, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2023, Maritza Lew, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores pharmacists’ perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Pride Month in June, we are sharing the voices of our AJHP SGM Theme Issue authors and their perspectives and experiences. In this episode, Sally Arif and Paul O’Donnell discuss providing culturally competent, affirming, and inclusive care for SGM individuals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Any legal information included in this podcast is for our listeners' educational purposes only. It is not intended as legal advice. If you have specific legal questions, you should contact the legal department of your organization or outside counsel.
ASHP Official hosts Amy Gutierrez for a discussion about a unique session planned for the ASHP Pharmacy Futures focused on pharmacist recruitment and retention strategies. Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results will feature Amy and two additional experts and provide actionable takeaways specifically crafted for pharmacy leaders by pharmacy leaders. This session is eligible for live CPEL recertification credit.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Pride Month in June, we are sharing the voices of our AJHP SGM Theme Issue authors and their perspectives and experiences. In this episode, Kyle Wilby discusses coping strategies for sexual and gender minority individuals in pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP Official welcomes Sara Stallworth and Timothy Aungst for a lively discussion about a session they collaborated on for the inaugural ASHP Pharmacy Futures in Portland. Using the future focused theme of AI, Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting, Sara and Tim have creatively designed strategies for preceptors to engage with learners using technology, and provide background knowledge for preceptors to guide safe use and adoption of new platforms in their experiential learning plans.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Alex Mills, Dr. Kevin Astle, and Dr. Kyle Melín discuss their commentary, “From ally to accomplice: A call to action to advance LGBTQIA+ health equity” and the AJHP special theme issue on healthcare considerations in sexual and gender minorities with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast features a conversation about engaging the next generation of pharmacy leaders. As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the Atrium Health System discuss their award-winning submission to the ASHP Best Practices. They will share how their program implemented a novel pharmacist-led DPYD testing program with CDS integration and demonstrated pre-treatment testing with genotype-guided fluoropyrimidine dosing improves patient safety by mitigating severe toxicities and hospitalizations in DPYD variant carriers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP National Meetings team education director Cynthia von Heeringen joins faculty member and licensed clinical social worker Kristy de Vries from Nationwide Children’s Hospital to discuss the upcoming Pharmacy Futures workshop on Second Victim Program Implementation. This half day program is included with registration and will provide attendees with background knowledge and skills to provide second victim support as well as a strategic toolkit to implement a second victims support program at their own facility.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode of the series will provide an overview of the history of Polio, eradication, and the effect of vaccination on global health.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Eliana Abboudi and Dr. Emily Messing discuss the AJHP Practice Research Report, “Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform the way pharmacists practice. In the first of a three-part series, this podcast will lay the foundation of knowledge for what artificial intelligence is and how it is being utilized within the profession of pharmacy and pharmacy education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on the current status and future of COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts on compliance with USP Chapter <797> in small and rural hospitals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the Impact Wellbeing Guide, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Kelley, Christy Norman, and Suzanne Shea will share their insights on their professional journeys as pharmacists and executive leaders and what it means to lead with authenticity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Women’s History Month 2024, ASHP Official is highlighting three pharmacist member leaders who volunteered to serve our Nation through federal service. In this episode, we speak with Rear Admiral (retired) Pamela Schweitzer, Captain Kailee Fretland, and Lieutenant Colonel Margaret (Maggie) Felix about their personal experiences and perspectives on opportunities for women in leadership.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2023 Awardee, Megan Dorrell, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on pharmacotherapy for obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacy leaders discuss tips for both HSPAL residents completing job applications following residency and current practicing pharmacists looking to move up within their organization. Discussion points include strategies for looking for jobs, reference selection, CV preparation, and what to make sure to include- and leave out- of your applications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Policies in support of pharmacy technician product verification enable pharmacists to spend more time on clinical and cognitive functions, create advanced opportunities for pharmacy technicians and streamline workflows. This podcast highlights recently developed advocacy resources for organizations seeking to leverage pharmacy technicians for product verification.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Pete Johnson, Dr. Avery Parman, and Dr. Jamie Miller discuss the AJHP Commentary, “Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on pharmacotherapy for obesity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A look at the career, service, and legacy of ASHP’s first Black president.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Healthcare leaders across the country continue to address disparities in the workplace caused by barriers and inequities related to diversity, equity, and inclusion (DEI). Pharmacy leaders committed to skill development, mentorship and creative strategies to address these challenges are crucial to ensuring best practices within their respective organizations. This podcast will provide the perspectives from three pharmacy executives on their personal journeys and experiences with supporting and investing in progressive change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Health care in the United States is one of the most robust and advanced delivery of care systems in the world. However, the nation is plagued by health disparities, leaving many in our society with suboptimal outcomes and quality of life. The concept of health disparities is complex and is evolving as research continues. This podcast will discuss the role of pharmacy in supporting and caring for patients experiencing health disparities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Denise Scarpelli, the Chair for the Section of Specialty Pharmacy Practitioners, sits down with SSPP’s Distinguished Service Awardee Matt Rim to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Amy Barton Alston chats with Drs. Kamakshi Rao and Katie Cho after their presentation titled The Way to Begin is to Begin: Writing Yor First Research Proposal at the Midyear Clinical Meeting. In this episode, they identify tips and trips for students who are interested in pursuing research projects.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses the residency ranking process, how the process works, and tips for finalizing your Rank Order List for the Match. Current health-system pharmacy administration and leadership residents share their personal experiences with the ranking process and advice to residency candidates.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Job negotiation is more than salary negotiation. In this podcast, we explore considerations for post-residency positions, including personal finance and budgeting, salary and benefits, start date, additional items to negotiate, and negotiation timeline and principles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Over the last year, Congress has considered proposals to reimburse hospitals and out-patient medical centers at the lower rate of free-standing sites, hoping to reap savings. Unfortunately, these proposals fail to comprehend the significant differences between the pharmacy care and services as well as regulatory framework of care provided in out-patient medical centers in contrast to free-standing sites.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Health care in the United States is one of the most robust and advanced delivery of care systems in the world. However, the nation is plagued by health disparities, leaving many in our society with suboptimal outcomes and quality of life. The concept of health disparities is complex and is evolving as research continues. This podcast will discuss the role of pharmacy in supporting and caring for patients experiencing health disparities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Philip Almeter and Dr. Robert Lodder discuss the AJHP Primer, “Screening for quality with process analytical technology in a health-system pharmacy: A primer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our expert panel as they delve into key aspects of residency interview presentations. This podcast covers crucial topics such as structuring impactful presentations, selecting compelling topics, handling challenging questions, and empowering advice for those navigating their residency interview journey. Don't miss this valuable advice to enhance your presentation skills and approach your residency interviews with confidence!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations. Wendy Horton, Tad Gomez, and James Klauck will share their insights on their professional journeys as pharmacists, hospital executives, and association leaders. This discussion will include essential skills to becoming an effective leader and perspectives on being successful in today’s health care environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Prioritizing wellbeing and mental health throughout the stressful season of residency applications and the match process can easily become overlooked. In this podcast, current and past residents will provide advice and tips to help guide current pharmacy students through this season.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Two leaders with twenty years’ experience each in pharmacy and leadership roles chat with a current HSPAL resident about lessons learned and areas to consider and grow in during a career progression. Everyone can benefit from a reflection on what you know now and how it could have helped you earlier in your career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During pharmacy school, we had one lecture on solid organ transplantation. With this podcast, we hope to provide tips and tricks to help non-transplant pharmacists decide the best course of action when they come across a solid organ transplant recipient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Drs. Denise Scarpelli, Katie Derry, Mandy Leonard, and Suzanne Shea discuss the ASHP/ASHP Foundation 2024 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The emergence of healthcare delivery during the COVID-19 pandemic demonstrated the potential advantages of leveraging technology to bring the clinician to the patient. Telehealth remains a viable and sustainable option for patients that have limited access to in-person care. Palliative care teams can utilize technology to optimize access and delivery of clinical pharmacy services to patients in palliative care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As many new adalimumab biosimilars have been hitting the market, three experts discuss current market trends and how their organizations are projecting the future impact of these biosimilar products. During this podcast, speakers discuss modeling strategies, planning for resources, and operational changes needed to support biosimilar adoption.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, David Chen sits down with the Section of Pharmacy Practice Leaders Distinguished Service Awardee Kristi Gullickson to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Care of the transgender and gender diverse community, or persons who do not identify with the sex or gender assigned at birth, presents opportunities for pharmacist involvement in all patient care settings. Understanding of therapeutic and psychosocial factors is paramount to creating and maintaining a gender-affirming environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Care of the transgender and gender diverse community, or persons who do not identify with the sex or gender assigned at birth, presents opportunities for pharmacist involvement in all patient care settings. Understanding of therapeutic and psychosocial factors is paramount to creating and maintaining a gender-affirming environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on the process related to submitting educational session proposals for ASHP Midyear to provide the audience with greater understanding of what is involved. Examples for prior Midyear presenters will be provided to outline processes they each followed from session idea generation through proposal submission, presentation drafting, and final presentation at Midyear.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Residency application and interview season is right around the corner! This podcast features current PGY1 & PGY2 HSPAL residents from the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) to discuss the residency application process, interview tips & tricks and post interview follow up for those interested in pursuing an administration and leadership residency program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and anticipated novel drug approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Angela Cheng-Lai and Angela Slampak-Cindric and learning more about their session, Simple Acts of Inclusion: Practice Advancement Begins with You. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Imagine the Possibilities is the theme for Midyear Clinical Meeting 2023 and the possibilities are endless! Join experienced conference attendees and upcoming speakers presenting at the meeting and learn more about all Midyear has to offer!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this dynamic session from the 2022 Midyear Clinical Meeting, content matter experts present pearls of knowledge focusing on medication safety and quality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Christina Song, Dr. Kim Redic, and Dr. Michelle Yu discuss the AJHP Practice Research Report, “Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the editors of Get the Residency, 3rd Edition share their expertise and discuss the importance of residency preparation. They delve deep into the top 4 tips from their book that have proven to be instrumental in achieving residency success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
CDC recently released the Core Elements of Antibiotic Stewardship for Health Departments to outline the structure and activities of state and local health department antibiotic stewardship programs. The podcast will highlight opportunities for pharmacists to partner with state and local health departments to optimize antibiotic use in their communities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Describe the evolution of the pharmacy enterprise and the changes necessary for sustainability. Share challenges in designing workforce models and techniques to overcome these challenges. Recognize the resulting workforce models and factors that impacted these changes. Provide examples of communication techniques for success model change. Identify future needs for the pharmacy profession to address landscape changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Medication safety issues continue to cause harmful or fatal errors across all settings. Recently, The Institute for Safe Medication Practices (ISMP) published new guidance on best practices for medication safety in the community pharmacy setting. Join Dr. Brooke Hudspeth as she interviews Dr. Alex Swick and Dr. Shanna Whitwell to discuss this new document and mobilize widespread adoption of these consensus-based best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Antonia Akrap, Delaram Bahmander, and Samantha Roberts and learning more about their session, It's a Small World After All: Diversion Prevention Software Challenges. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Dev Chatterji and Lois Lee discuss role the oral-beta lactams may serve in the treatment of Gram-Negative Rod bloodstream infections, the data behind the recommendation and identify the patients who may be ideal candidates for this therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There are many career avenues one can take as pharmacist. One area within clinical pharmacy that many individuals do not get much exposure to in pharmacy school or practice is solid organ transplant. This podcast will review what a career as a solid organ transplant pharmacist looks like and potential career avenues if one was to pursue this track of pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day 2023, ASHPOfficial is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with John Spain, Eugene de Lara, and Stephen LaHaye about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Patti Kienle and Dr. Michael Ganio and learning more about the sessions related to sterile compounding .If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As we prepare for the ASHP Midyear Clinical Meeting & Exhibition in December, we're sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. This special short-form podcast series highlights the impact attending career-focused events at the Midyear meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Kate Cozart and Lisa Buss Preszler and learning more about their session, The Art and Science of Compassion. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Niaz Deyhim and Dr. Anita Saini discuss the AJHP Case Study, “A hospital within a hospital: An innovative pharmacy model to improve the continuum of care,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As we prepare for the ASHP Midyear Clinical Meeting & Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode covers the ins and outs of developing and presenting a professional poster at the ASHP Midyear Clinical Meeting. New practitioner speakers share their personal experiences presenting posters and offer invaluable tips on presentation delivery, poster design, and networking strategies. Gain practical advice to ensure your research presentation is a success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Marylyn Ritchie and learning more about her session, AI and Direct-to-Consumer Genetic Testing: The Good, the Bad, and the Ugly. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this ASHP podcast, Pharmaceutical Industry Fellowship Program Directors provide valuable insight on the role of Personnel Placement Services (PPS) and how to effectively prepare for industry interviews at Midyear. Find out how to navigate the fellowship recruitment process at Midyear and hear strategies on how to succeed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As we prepare for the ASHP Midyear Clinical Meeting & Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Andrew Gainey and learning more about his session, The New Age of Phage Therapy: Utilizing Viruses to Treat Antimicrobial Resistant Infections. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As we prepare for the ASHP Midyear Clinical Meeting & Exhibition in December, we are sharing success stories from members who attended the Residency Showcase or Personnel Placement Services and either matched with a pharmacy residency or landed their dream job. Through a 1:1 interview, a short-form podcast will be published as part of a special podcast series highlighting the impact attending career-focused events at the Midyear Clinical Meeting can have on the future, career, and goals of pharmacy professionals at all stages in their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three hospital executives who are pharmacists, have successful careers, and contributed significantly to health system professional associations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Arjun Srinivasan and learning more about his session, New CDC Requirements for Antibiotic Use Reporting and Opportunities for Antibiotic Stewardship. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Drs. Jennifer Clements and Diana Isaacs and learning more about their session, Another Great Debate — Semaglutide versus Tirzepatide for Type 2 Diabetes and Obesity. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This 2023 revision of the American Geriatric Society’s Beers Criteria for Potentially Inappropriate Medications (PIMs) in older adults includes major recommendations for the safe use of anticoagulants and for avoiding the initiation of aspirin for primary cardiovascular disease, oral and transdermal estrogens in postmenopausal women, sulfonylureas as first, second or add-on therapy for diabetes, and the use of highly anticholinergic medications. Additional areas that have been updated include how PIMs can exacerbate drug-disease and drug syndromes, important drug-drug interactions, and drugs that require alterations in dosing in renal impairment. Pharmacists should be cognizant of these changes to the AGS Beers Criteria so that they can use this tool to help optimize their older adults’ medication regimens.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss Drs. Lindsay Davis and Erin Raney’s upcoming sessions titled “Precepting Effectiveness: A Habits of Preceptors Workshop” at ASHP’s National Pharmacy Preceptors Conference and “Kaleidoscopes: Viewing Self/Team Enhancement Frameworks Through the Lens of Pharmacist Practitioners.”
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP expert, Michael Ganio, shares highlights from his recent testimony before the House Energy and Commerce Committee regarding drug shortages.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In anticipation of the Midyear Clinical Meeting, ASHP is hosting a series of podcasts focused on highlighting key sessions, hot topics and “can’t miss moments.” Hosted by Cynthia Von Heeringen, Education Director on the National Meetings Team at ASHP. On today’s episode we are sitting down with Dr. Ryan Haumschild and learning more about his session, Putting Oncology into Practice: Modern Treatment Approaches in Women's Health. If you haven’t already, register for the Midyear clinical meeting today at midyear.ashp.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a discussion with ASHP's 2023 summer interns, Quinn and Jordan, as they share their unique perspectives and experiences during their internship. Dive into their pharmacy backgrounds, the essential skills they've developed throughout pharmacy school, and their motivations for choosing an internship with ASHP. Get a behind-the-scenes glimpse of the internship and hear about their daily experiences, standout moments, and valuable advice for aspiring interns.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss Dr. Slampak-Cindric's upcoming session titled “Cooking Up Experiences and Evaluations that Nourish Learners Without Poisoning Preceptors” at ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field as they discuss opportunities and key strategies for developing and conducting a medication use evaluation for the treatment of skin and soft tissue infections (SSTIs) in the emergency department/urgent care setting. They will share how new evidence, new drug approvals, changing resistance patterns, and patient-specific considerations can be integrated into the MUE. You will gain insights into optimizing the patient experience and outcomes by applying MUE findings as part of their outpatient antibiotic stewardship strategy. This podcast is part of a project supported by a grant from Paratek.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Charlene Williams and Dr. Mary Douglass discuss their upcoming session titled “ARISE and Shine: Preceptors’ Role in Mitigating Bias and Responding to Exclusionary Behaviors” at ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will update members on ASHP’s ongoing efforts to advance pharmacist provider status. We’ll cover the new bills making their way through Congress and the latest developments in the states.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featuring Specialty Pharmacy practitioners presenting at the 2022 Midyear Clinical Meeting, our content matter experts will share the role of the specialty pharmacist in providing vaccine education and how they design vaccination plans for a patient on specialty medication.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Following pharmacy residency, many new practitioners seek to obtain board certification in a pharmacy specialty to demonstrate their expertise in a defined area of pharmacy practice. In this podcast, board certified pharmacists share practical tips for preparation and maintenance of specialty board certification.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, a student pharmacist and two recent graduates discuss their experiences completing a dual degree PharmD program. Panelists explore areas related to time management, the pros and cons of pursuing dual graduate degrees, and the changing role of pharmacy professionals today.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, three PGY1 pharmacy residents join us to discuss their specialty pharmacy-focused research projects. Topics to be discussed include the impact of pharmacist interventions on treatment outcomes in patients with hepatitis C, the impact of specialty pharmacist interventions in the treatment of multiple sclerosis, and the impact of specialty pharmacy services on medication access for asthma biologics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Joel Marrs discusses the AJHP Practice Report, “Description of patient questions received by clinical pharmacists in the Nudge Study,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode that features presentations from the 2022 Midyear Clinical Meeting, our content matter experts discuss the ISMP Targeted Medication Safety Best Practices for Community Pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides an overview of continuous glucose monitors (CGMs). We discuss the different brands and models of CGMs available, and how to determine which one is right for the patient. We explore who typically qualifies for using these devices and what patients can do if their insurance doesn’t cover them. We also explain the data that CGM’s provide and how healthcare teams can access and review this information to better inform patient care. We conclude with practical counseling points on using CGMs day to day.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this pharmacy technician focused session from the Midyear Clinical Meeting, our speakers identify key attributes of a residency-based learning experience in the development of valued technician leadership behaviors and give examples of an intensive technician leadership residency through the modification of an established pharmacy residency program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, listeners will hear an interview with a pharmacy leader whose health system experienced a cyberattack in 2017. Discussion will include how the attack occurred, how patient care services were maintained and recovered, and lessons learned from the attack.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting our content matter experts discuss strategies that improve the quality and cultural appropriateness of patient health education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode focusing on Well-Being and Resilience presentations at the 2022 Midyear Clinical Meeting, our content matter experts discuss burnout and the indicators and influences of burnout in yourself and other and apply strategies to promote well-being and resilience to minimize burnout.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featuring Specialty Pharmacy Faculty presenting at the 2022 Midyear Clinical Meeting, our speakers will describe the quality and compliance process for health system specialty pharmacies and evaluate the use of audits to assess compliance.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the Midyear Clinical Meeting in Las Vegas, our content matter experts discuss the characteristics of high-reliability organizations (HROs) and how high reliability impacts safety and quality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Other disciplines have used telehealth in the past with much success and the current healthcare landscape necessitates flexibility & innovation in delivery of care. This podcast will describe how pharmacists have incorporated telehealth into practice and how practitioners can use it to improve access to care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three outpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the outpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The podcast will discuss challenges with clinical decision support implementation, including common problems and solutions to ensure effective and timely implementation. We will cover working with third party data, maintenance considerations, prioritization and governance, and communication strategies to support implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast focuses on how to place value on the services that emergency medicine pharmacists provide and how to use that data to expand services in the emergency department. Both EM pharmacists and their leaders will find this podcast of value when evaluation services in your institution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featuring speakers from the ASHP Midyear Clinical Meeting in 2022, our content matter expert discusses the goals of emotional awareness and regulation and shares the key ingredients to becoming a reset master in your pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Practice Journeys, Juliana Zschoche shares her experiences working at a large outdoor music festival as a part of the Emergency Medical Team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the Kettering Health to discuss their award-winning submission to the ASHP Best Practices. They will share how their COVID-19 treatment referral program has proven to be highly successful at addressing several challenges associated with outpatient treatment selection for patients with COVID-19 including fair allocation of resources, patient access to inventory, and drug-specific considerations through a pharmacist-driven and collaborative approach to care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Skin and soft tissue infections are commonly seen and treated in the emergency department. While most practitioners are comfortable with the typical infections it is important to consider unusual exposures and environmental factors that may result in atypical skin and soft tissue infections. This podcast will discuss some of these infections that may be seen due to exposures to water (salt & fresh) and soils and how to identify and manage these situations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pneumococcal vaccination recommendations are arguably some of the most difficult to maneuver. With the approval of two new pneumococcal vaccines, guidelines have significantly changed. This podcast aims to discuss these changes in vaccines and recommendations, and provide resources to ensure patients are receiving the right vaccine at the right time.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Recruiting and retaining pharmacists and pharmacy technicians has become increasingly challenging for pharmacy leaders. This podcast explores strategies for optimizing the pharmacy workforce, addressing recruitment and retention challenges, sharing success stories, and offering practical tips from two hospital pharmacy leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featuring technician focused programming at the Midyear Clinical Meeting our content matter experts describe successful elements of career ladder and share career ladders that have resulted in the retention of pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Population health is a growing practice setting within the field of pharmacy. Have you considered becoming involved with population health in your practice? If so, join us for this podcast where we hear from population health experts who have boots on the ground as it relates to management, billing/benefits, IT/analytics, and clinical pharmacy support roles in the field. After listening, we trust you’ll feel more ready to embark on your own population health venture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
RX for Success focuses on pharmacy productivity and metrics in small and rural hospitals. We will be evaluating and discussing the differences between quantitative and qualitative metrics, survey results from commonly utilized metrics in small and rural hospitals throughout the country, and metrics that hold particular value to C-suite staff.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Residency programs often provide residents the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare various types of project methodologies, reviewing benefits and opportunities for each. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three inpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the inpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Please join us on this week’s pharmacy leadership episode as leaders in the field provide insights and guidance on the peer review podcast. Hear their story of how they first got introduced to the peer review process and the benefits they experienced. In addition, they answer frequently asked questions one might have who is considering becoming a peer reviewer and why you too should consider trying it out!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our Specialty Pharmacy content matter experts share best practices for compliance and maintenance of dual/tertiary specialty pharmacy accreditation including dual and tertiary certifications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. The episode will discuss their journey exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, leaders from five different health system specialty pharmacies share examples of disasters and emergencies that their specialty pharmacies have encountered. Speakers will share their experiences, and describe the business continuity plans they implemented to sustain operations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, presenters from the 2022 Midyear Clinical Meeting analyze the difference between race, ancestry, and genetics and how the over-simplification of race in clinical practice and education can propagate healthcare disparities and how pharmacists can address these to improve patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Leadership is often associated with a leader taking charge at the frontline. Oftentimes we describe these types of leaders as strong, inspirational, or courageous, however, the biggest impacts don’t always come from the individuals leading the charge. Although they sometimes go unrecognized, “Little L” leaders can be found scattered within the group where they work behind the scenes to empower their teammates and steer them towards success. That is why the concept of “leading from behind” is such a crucial component of ensuring effective team dynamics. If you apply this philosophy to the healthcare landscape, it becomes apparent that the nature of our profession allows pharmacists to act as a prime example of how this leadership style can be effectively utilized.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital.
Show notes:
- R3 Report Antibiotic Stewardship: https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf
- The Joint Commission Antibiotic Stewardship Resources: https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with a seasoned pharmacy leader to provide listeners with an overview of successful project management. All too often, new leaders and frontline staff involved in projects can become overwhelmed with the steps involved to see a project through. Tina Do, of Yale New Haven Health, will take us through the basics of creating a strong project plan.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2022 Midyear Clinical Meeting, our content matter expert reviews what artificial intelligence is (and isn’t) and identifies opportunities in health-system pharmacies where artificial intelligence (AI) can be used.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Mpox, formerly known as monkeypox, has been reported in all 50 states. The Navigators discuss how lessons learned from COVID-19 can be applied to manage this latest outbreak and provide insight on current efforts by departments of health and pharmacies to address this newest public health need.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Kenneth Komorny and Nicole Bennett discuss the AJHP Commentary, “Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting, our speaker discusses the lessons learned for improving vaccination rates within racially and ethnically minoritized communities and identifies resources available to assist pharmacists in combating vaccine hesitancy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on Pharmacoequity; what it is and ways to address it.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the UNC Health to discuss their award winning submission to the ASHP Best Practices. They will share how they established a comprehensive Pharmacy Revenue Integrity program for outpatient medical benefit claims within pharmacy services, aligning financial, clinical and operational areas to ensure department and institutional long‐term financial strength.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In a short period of time, the “metaverse” has become a buzzword in the technology industry and beyond. The question in many people’s minds is, “when will the metaverse hit me?” Join us as we explore what the metaverse is today and how pharmacy could be impacted.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode focuses on pharmacy workforce issues. Listen in to learn more about key takeaways applicable to the pharmacist workforce from the SPPL Virtual Roundtable: Technician & Pharmacist Recruitment, Retention, and Engagement that occurred on April 20, 2023. Additionally, listen in to learn about specific successes for addressing common concerns and additional insights from our guests.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As approaches to pain management evolve, it is a natural progression to consider the influence and role pharmacogenomics play in optimizing patient medication regimens. In this episode, our content matter experts discuss pharmacogenomic testing, resources and education surrounding pain management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2022 Midyear Clinical Meeting, our content matter experts differentiate the most common interstitial lung diseases and recommendations in supportive care and future directions for this patient population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join this three-part conversation with Dr. Shareen El-Ibiary, Dr. Blake Porter, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Autumn Zuckerman, Dr. Jennifer Donovan, and Dr. Melissa Ortega discuss the AJHP Practice Research Report, “2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, listeners will learn about the many roles Specialty Pharmacy Accreditation & Compliance positions play in specialty pharmacy leadership and operations. In addition, listeners will be provided with examples of duties and responsibilities coordinated and/or managed by these positions that necessitate advocacy for these roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight a recently added ASHP resource center on interprofessional education (IPE). Discussion will cover the need for an IPE resource center, how to use the resource center, and some best practice from our experts' experience. Access the ASHP Interprofessional Practice and Education Resource Center.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting content matter experts compare and contrast the models of disability including the medical model, functional model and social model and describe a framework for approaching individuals with a disability in a clinical encounter.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members a refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as track and trace. We’ll get recommendations from two leading experts on preparing for full DSCSA implementation in November 2023 and talk about what to expect as we approach that date.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field as they discuss barriers and key strategies for developing and conducting a medication-use evaluation (MUE) for the direct oral anticoagulant reversal agent, andexanet alfa. In addition to sharing the process for building a meaningful MUE, presenters will provide insights into navigating medication use evaluations with clinical controversy and local considerations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today’s podcast will be about promoting joy as an active form of well-being among Black men. We will share practical ways Black men find joy and insist on making it daily practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Craig Pedersen and Dr. Michael Ganio discuss the AJHP Practice Research Report, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight a recently enacted North Dakota law requiring health plans to cover comprehensive medication management services provided by clinical pharmacists. The legislation, developed in collaboration with and supported by ASHP, will increase patients’ access to team-based services, better enabling pharmacists and clinicians to collaboratively optimize medication use and improve outcomes. Building on the success of the North Dakota bill, ASHP has drafted model legislation that other states can adopt to ensure patients have access to CMM services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Interested in ASHP policy but don’t know where to start? Heard of the House of Delegates but unsure of what it is or how to get there? Please join host Elyse MacDonald as she chats with the House of Delegates Chair, Melanie Dodd, as well as Delegates Mindy Burnworth and Brittany Tschaen, for a discussion of the House, ASHP policy, and how you can get involved!)
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Two experts in pain management in patients with Sickle Cell Disease (SCD) will discuss the causes of pain in patients with SCD as well the best practices in approaches to managing pain from pediatric patients and as they transition into adulthood. Challenges in pain management for patients with SCD will also be discussed including some strategies to overcome these challenges.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Radio frequency identification (RFID) technology is utilized in health systems throughout the medication use process, primarily for inventory management and revenue capture. In this episode, health-system pharmacy leaders delve into the results of previous research and explore the potential impact of RFID on patient and medication safety. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about what it is like to be a PGY1 pharmacy resident. This podcast will cover the day-to-day of a pharmacy resident and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this series, our content matter experts will present and discuss patient cases and management of vaccine preventable diseases. In this episode Norm Fenn reviews a patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featuring content from the 2022 Midyear Clinical Meeting, content matter experts discuss the developing trends in the Medicaid reimbursement of the 340 B Program and available resources.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast dives into Health-System Pharmacy Administration and Leadership residency programs to provide current pharmacy students with information about this specialized residency program. Members of ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) Leadership Committee share their knowledge and experiences with students interested in learning more about a career in health-system pharmacy administration.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Meredith Oliver and Dr. Lizbeth Hansen discuss the AJHP Descriptive Report, “Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
IPPE learners present unique challenges in designing and implementing experiences that allow them to explore health-systems practice, while growing towards independent practice. This podcast explores implementation of a layered learning system that involved pharmacy residents and third-year student pharmacists learning from one another and advancing practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Stephen Deptola, PharmD, and Bri Hemmann, PharmD BCPPS, join us today to share their experience of creating, implementing, and continuing to challenge or adjust their resident wellness curriculum at his Cincinnati Children’s Hospital Medical Center. Resident well-being is a major aspect of ASHP’s new standards and successful, tactful integration of these programs is critical to preventing burnout and creating well-rounded, successful practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2022 Midyear Clinical Meeting, our presenters describe the science behind implementation science and the Pharmacogenomics Accelerator Program, successful implementation strategies identified through the Pharmacogenomics Accelerator Program and will summarize the benefits of collaborative community including coaches and subject matter experts for implementing pharmacogenomics at your site.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our experts as they review the current epidemiology of Clostridioides difficile infection (CDI), discuss the risks and complications associated with recurrent CDI, and compare and contrast live biotherapeutic products (LBPs) and traditional fecal microbiota transplantation (FMT).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this fast-paced feature from the 2022 Midyear Clinical Meeting, content matter experts discuss medication management strategies in difficult or controversial patient populations and clinical scenarios that might not be widely used or published within hematology/oncology pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Charnae Ross sits down with the New Practitioners Forum 2022 Distinguished Service Awardee, Kellie Musch, to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we will explore employment opportunities for pharmacy students within health system specialty pharmacies. This podcast will also provide the framework of how to design and establish such opportunities within a health system specialty pharmacy. Lastly, this podcast will review enrichment opportunities for pharmacy students employed within a health system specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists are medication experts and have an important role in conducting research studies. In this podcast, Dr. Sarah Spinler, a past ASHP Foundation Literature Award for Sustained Contributions recipient, and Dr. Laney Jones discuss making research relevant to practice and building a research career through mentorship and interprofessional collaboration.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join this panel of pharmacists for a review of the difference between burnout and stress, examples in the community pharmacy setting, and ways to cope with stress and burnout on the individual and organizational level.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, the team from the Duke University Hospital discuss their award-winning submission to the ASHP Best Practices. They will share how establishing a pharmacy technician training program provides a mechanism to ensure continuity and uniformity as health care continues to evolve. By providing a source of well-trained pharmacy technicians, the program allows the profession to continue to achieve its overarching aims.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Oral anticancer medications are increasingly being incorporated into cancer treatment regimens and pharmacists may be encountering patients on these medications in their practices more frequently. This podcast episode will explore common questions that pharmacists may be asked about oral anticancer medications including potential interactions with other medications patients may be taking.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Hannah Kim Vanderpool, Deepak Sisodiya, and Arpit Mehta will share their insights on their professional journeys as pharmacists and association leaders. This discussion will include essential skills to becoming an effective leader, career transitions, and the power of networking through organizations. In this special edition, we would also like to highlight their personal views and heritage as an Asian American/Pacific Islander leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, Scott Canfield sits down with the Section of Specialty Pharmacy Practitioners’ Awardee, Autumn Zuckerman, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The purpose of this podcast is to highlight the skills that all pharmacists have to assist in the creation and maintenance of CDS. Listeners will learn about how to be involved in CDS, and why it is important for pharmacists to be involved in CDS.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Cindy Jeter, Chair of the ASHP Pharmacy Technician Forum Executive Committee sits down with the Pharmacy Technician Forum’s Awardee Mary Mercer to discuss what membership within the Forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Management Case Study feature, ambulatory care pharmacists share their processes that promoted the optimal allocation of COVID-19 therapies that were in limited supply and discussed the pharmacist skill sets that benefit managing workflow triage of COVID-19 therapies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join current and past members of the ASHP Pharmacy Student Forum as they share advice for the 2023 ASHP Summer Meetings & Exhibition in Baltimore, Maryland. We will discuss everything from what to wear, what to pack, navigating the student educational track, networking tips, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will aim to review various indications of ketamine use within the pediatric population. Relevant dosing, adverse effects, and contraindications will be discussed. Listeners will become familiar with appropriate monitoring parameters to safely use ketamine for pediatrics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of atopic dermatitis.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our presenters at the 2022 Midyear Clinical Meeting review the signs and symptoms of Monkey Pox along with the current pharmacological options for treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, anesthesia and pharmacy leaders explore the potential impact of implementing radio frequency identification technology on patient and medication safety in care settings where sedation is administered. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will explore the recent advancements in community pharmacy practice in the northwest and their implementation into practice. Discussions will include independent prescribing, test-treat protocols, preventative health services, disease state management, and the medical billing necessary to sustain these services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Major Depressive Disorder (MDD) is common psychiatric condition that causes significant disability and disease burden. Treatment for this condition may require multiple medication trials. Up to thirty percent of individuals with MDD do not receive adequate benefit from several antidepressant drug trials and are considered treatment resistant. The management of treatment resistant depression (TRD) often requires novel approaches. One such approach is to use N-methyl-D-aspartate (NMDA) receptor antagonists such as ketamine or esketamine. This session will review the use of ketamine and esketamine for TRD.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, expert faculty discuss the answers to questions that pharmacists may receive about the management of alopecia areata.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2022 Midyear Clinical Meeting, our content matter experts share updates to the NIOSH guidance and practical implications surrounding USP 800.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide an overview of the parenteral multivitamin shortage and the impact this shortage has on neonatal and pediatric nutrition. Additionally, the use of alternative vitamin products and their availability will be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the era of illicit fentanyl, the approach to buprenorphine induction has been adapted. Starting with low doses of buprenorphine can be applied to anyone taking a full agonist opioid, including cases of buprenorphine for chronic pain. We will discuss why, how, and what to consider as part of realistic implementation of low-dose buprenorphine induction therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Does risk level “C” always mean “continue”? Join us as we delve into the current state of immune checkpoint inhibitor drug interaction reporting in common drug information resources and discuss how these interactions may be interpreted in daily clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Despite being developed in the late 1980s, Intrathecal pumps have been underutilized clinically for pain management for multiple reasons. With the opioid crisis and the significant increase in the proportion of the population with refractory pain, intrathecal pumps are gaining popularity. Intrathecal pumps may be an appropriate option for improved pain control while minimizing side effects from systemic opioids.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from pharmacy technicians who lead technician education and training in their institutions as they discuss advancing pharmacy technician career development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide an overview of excipients and dyes used in medications that often consumed by children. Topics will include an overview of specific excipients and dyes, allergies vs intolerance to substances, and an explanation of regulatory oversight.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting. This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, subject matter experts in health system organizations discuss the impact and changes in their organizations, due to accreditation updates in the specialty pharmacy space. This podcast is presented by members of the Accreditation and Compliance Section Advisory Group of the Section of Specialty Pharmacy Practitioners.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the release of the revised USP guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ Awardee, Kate Schaafsma, to discuss what membership within the Section and ASHP means to her and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Ashley Bowden and Dr. Carlie Wilke discuss the AJHP Commentary, “Implementation of radio-frequency identification technology to optimize medication inventory management in the intraoperative setting,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ketamine has experienced a recent resurgence in utilization, particularly in the Emergency Department setting. This agent has several indications, each with different considerations and adverse effect profile and our guests on this episode review and discuss these and example patient cases from an Emergency Medicine pharmacist perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, speakers explore cyber-attacks in a pharmacy setting. Listeners will be given a general overview of cyber-attacks, phases of cyber emergency management, and common best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as we hear from Dr. Brooke Griffin, Vice Chair of Clinical Services and Midwestern University and implementation coach for the Well-Being Ambassador Program. Brooke has led many initiatives in her career to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce and mentoring to inspire bold ideas from within. Dr. Griffin will share her journey to becoming a career coach and how it informs her engagement style with Well-Being Ambassadors.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Developed by the Section Advisory Group on Medication Safety, members discuss Patient Safety Awareness Week and share ideas that organizations can use to bring more awareness to medication safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with four pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Amerine, Lindsey Kelley, Alexsandra Nilges, and Noemie Kanene will share their insights on their professional journeys as pharmacists and association leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide an overview of Opioid Stewardship including rationale for program development, a description of the critical stakeholders in these programs, and the role of the pharmacist in Opioid Stewardship.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Nada Farhat and Dr. Jamie George discuss the AJHP Clinical Report, “Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will explore the recent updates to the ASHP accreditation standard for post graduate residency programs. Members from the ASHP Commission on Credentialing discuss the process for updating the standards, key changes, and helpful resources for residency programs nationwide.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, SICP Chair, Sarah Stephens, sits down with the Section of Inpatient Care Practitioner’s Awardee Daniel Degnan to discuss what membership within the section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on various models of technician training programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, listeners will hear perspectives from key players required to create and maintain meaningful collaborations between colleges of pharmacy and health-system institutions. Successes and challenges, and tips for successful collaboration will be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacogenomics can be daunting to pharmacy practitioners who may not have much experience in the area. This podcast will explain the role of a pharmacogenomics clinical specialist and how to successfully implement the service into practice. In addition, the podcast will include the learner’s perspective on the pharmacogenomics rotation experience and integration into research, as well as tools pharmacists can use that provide additional education and training in pharmacogenomics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists must be seen as both generators of biomedical literature and consumers of literature in order to be at the table when major decisions regarding healthcare are made. In this podcast, Craig I. Coleman, Pharm.D., FASHP, the recipient of the 2022 ASHP Foundation Literature Award for Sustained Contributions, will describe how he started his career and how he trains his research fellows to succeed in the research environment. He will describe some of his highest impact work and then describe how researchers need to pivot into new areas to maintain long term research viability. If you are just starting out or have had success but wonder what is next for your research career, this podcast is for you.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series is a follow up to the June 2022 ASHP continuing education webinar, “Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care”. Each podcast series will feature one webinar speaker with additional information about working with the medically underserved, refugees & immigrants, and sexual & gender minorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Renee Robinson, Cathy Oliphant and Mary Spatafore discuss the INTERACT program, whose goals are to better prepare rural healthcare providers to provide safe and effective COVID-19 outpatient treatment, improving healthcare service utilization and health outcomes of patients diagnosed with COVID-19. This includes assessing and meeting unmet drug-drug training and support needs for pharmacists treating patients for COVID-19 in the outpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members an overview of where FDA draft guidance for hospital and health system compounding stands. We’ll provide a refresher on the guidance, as well as a discussion on how the revised USP chapters might impact practice compliance and what comes next with FDA advocacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we will be discussing how telehealth has been utilized to deliver pharmacy services within the ambulatory care setting and its impact on outcomes. This podcast also explores ASHP’s strategic initiatives and efforts in the areas of telehealth, digital health, and data driven healthcare as pharmacists and other providers begin to think innovatively about how care is delivered now and in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Many practitioners find as they grow in their practice that they move into leadership roles. These roles can come after completing a PGY2 in Emergency Medicine or during their career. This podcast will the transition two pharmacists have done as they moved from practicing as emergency medicine pharmacists into taking leadership roles over emergency medicine pharmacy practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders meet during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Acute pain management can be challenging, especially in patients receiving chronic opioid therapy. Multimodal therapy using a combination of pharmacologic and non-pharmacologic interventions provides a synergistic approach to treating moderate to severe pain versus use of opioid monotherapy for pain control. This session will review multimodal interventions recommended for acute pain management and highlight approaches for acute pain control in the opioid tolerant patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on therapies for HIV management. The primary focus will be on new and emerging pipeline therapies in addition to what pharmacists can do to promote access and adherence.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Health system mergers and acquisitions provide unique opportunities for pharmacy leadership as well as unique challenges. This podcast is going to address how different pharmacy leaders have approached governance and assigning responsibilities during these transitions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Francesca Cunningham, Dr. Joseph DiPiro, and Dr. Scott Nelson discuss the 2023 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series is a follow-up to the June 2022 ASHP continuing education webinar, “Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care.” Each podcast series will feature one webinar speaker with additional information about working with the medically underserved, refugees & immigrants, and sexual & gender minorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Lea Eiland, Dr. Meghan Swarthout, and Sara White discuss the AJHP Commentary, “Women in pharmacy leadership: The journey continues,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders met during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2022 Awardee, Mollie Ashe Scott, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hajer Ibrahum was part of a pharmacist-led 10-session Transgender Men Health Education Group integrating gender-affirming and mental health topics was created. In the episode, she shares her team-based approach to caring for this patient populations and identifying mental health barriers to receiving care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The opioid epidemic continues to be problematic across the country with increases in deaths from addiction leading to overdose. In an effort to minimize use of opioids postoperatively, the ERAS society developed guidelines and protocols pre-,intra-, and postoperatively to enhance recovery from surgical procedures while limiting use of opioids. Pharmacists play an integral part in the development of individual hospital protocols for ERAS, monitoring patients postoperatively, and preparing appropriate and individualized regimens for pain management on discharge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom Kraus, Vice President of ASHP Office of Government Relations, discusses with current members of the Advancement of Professional Practice Advisory Group how and why students should get involved with state and federal advocacy efforts, as well as how local SSHP chapters can help their members to advocate for the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series is a follow up to the June 2022 ASHP continuing education webinar, “Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care”. Each podcast series will feature one webinar speaker with additional information about working with the medically underserved, refugees & immigrants, and sexual & gender minorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides a review of ISMP Best Practice #17 recommendations for safeguards against errors with oxytocin use. Speakers discuss how to understand the risks involved in oxytocin utilization with antepartum and postpartum management and describe considerations for implementing such safeguards.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Dr. Brittany Meilinger joins us to talk about one health system’s experiences using drones for delivery of specialty medications – including a discussion of their policies, challenges and opportunities related to their drone delivery program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Pharmacy Leadership Episode, Doug Slain sits down with the Section of Clinical Specialists and Scientists Awardee Curt Collins to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The lead author team for the recent 2022 ASHP Survey of Health-System Specialty Pharmacy Practice – Clinical Services discuss key findings from the survey, as well as challenges and opportunities for the future of health system specialty pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With new guidance from the United States Preventive Services Task Force that recommends against the use of some vitamins for disease prevention, it can be difficult to know when vitamins should and should not be encouraged. This Podcast will summarize the new recommendations and review clinical situations when vitamins may be helpful or harmful.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we will discuss alternate routes of analgesic administration for when intravenous and/or oral access is not available. This will include sublingual, subcutaneous, intranasal, inhalation, and others as well as what medications are best suited for these routes based on their pharmacokinetics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we will be discussing how digital health will further expand the patient-doctor relationship and its potential impact on disease prevention, management of chronic illnesses, and reducing healthcare costs. Digital health technologies offer a holistic view of the patient by providing access to data in real-time, bidirectional communication between provider and patient, and a more personalized approach to care.
In this excerpt from the Midyear Clinical Meeting, the Section of Clinical Specialists and Scientists present an update to the 2020 American College of Rheumatology Guideline for the Management of Gout and evaluate nonpharmacologic therapies and lifestyle modifications in the treatment of gout.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This featurette from the 2021 Midyear Clinical Meeting presentation “More than Just a Hill of Beans: Clinical Controversies Related to Acute Kidney Injury in the ICU” summarizes the clinical usefulness of furosemide stress testing in acute kidney injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include inpatient management of a pulmonary embolism, management of coagulopathy with liver disease, and management of anticoagulants in acute kidney injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Brittany Tschaen as she sits down with Joe Marchiano and Nancy Macdonald who will share their lessons learned and best practices for returning to in-person Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the full midyear experience. Later in the episode, Brittany and Joe sit down with program chairs from the 2022 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this two-part episode, presenters from the 2021 ASHP Midyear Clinical Meeting present real-world anticoagulation clinical cases and their reasoning and approach to managing their care. In this episode, our patient-specific cases include cancer-associated thrombocytopenia, spinal hematoma and apical thrombous.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Interested in learning how to maximize your time at the Midyear Clinical Meeting? This podcast episode features two New Practitioners sharing their tips and tricks on how to successfully navigate the Midyear Clinical Meeting and Residency Showcase.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette episode from the 2021 Midyear Clinical Meeting, listeners will learn about the “four D’s” of fluid therapy in appropriate fluid stewardship, review individual changes to fluid therapy that can improve patient outcomes, and hear about a real-world experience in developing a protocol and policy for the systemic adoption of fluid stewardship program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode highlights the key takeaways from the 2021 Midyear Clinical Meeting on how pharmacists can apply data supporting pre-exposure prophylaxis (PrEP) and guideline-based testing to implement PrEP prescribing and monitoring into your existing practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In a sneak peak for the upcoming Midyear in Las Vegas, the SCSS Advisory Group on Emergency Medicine sits down with some can’t-miss educational session presenters to discuss what attendees can hope to learn about new and emerging areas of practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In honor of U.S. Antibiotic Awareness Week November 18-24, 2022, join us for a podcast discussion on the CDC National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. The availability of this Option is another opportunity to improve antimicrobial use for patient and public health.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about industry PharmD Fellowships. This podcast will cover the process of applying for a fellowship and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a career in industry.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tailored to the unique needs of pain providers, this podcast jumps in the deep end of urine drug screen (UDS) discussions. Speakers will talk about some of the more complicated situations that arise secondary to urine drug screening.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In a sneak peek for the Midyear 2022, Gift Neweke from the SCSS Advisory Group on Emerging Sciences sits down with some of the can’t miss educational session presenters to discuss what attendees can hope to about new and emerging areas of practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In a sneak peak of everyone’s favorite collegially contentious Midyear session – Therapeutic Debates – Karen Whalen sits down with SCSS Educational Steering Committee members Kellie Goodlet, Amy Sipe, and Jessica Star to preview this can’t-miss educational session. This year’s debates are management of patients with penicillin allergy, provision of safe supply to patients with opioid use disorder, and monitoring of anti-Xa levels in patients receiving DOAC therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day 2022, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with W. Mike Heath, Heather Rovey, and Amanda Ferguson about their stories, reflections, and perspectives on how their military experience helped shape their pharmacy careers and how their stories provide an inspiration for the next generation of pharmacy professionals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom and Jillanne discuss recent conversations ASHP has had with the U.S. Department of Health & Human Services regarding the role of pharmacists in primary care. We touch on the types of services pharmacists are providing and highlight the pressing need for reimbursement and residency training support to sustain those models, and discuss the importance of partner organizations to our overall advocacy strategy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Maintaining wellness while pursuing your Doctor of Pharmacy degree can be challenging. To address this, Student Societies of Health-System Pharmacists (SSHPs) are actively promoting wellbeing and resilience within their chapters. Through this podcast, we hope to highlight examples of how to incorporate wellness and wellbeing into SSHP initiatives, as well as share some tips on how to foster and sustain well-being and resilience during pharmacy school.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The opioid epidemic is a dynamic multi-layered situation with regulatory changes affecting patients and providers in a variety of ways. Although many regulation changes were designed with the best intentions, unintended consequences have surfaced in acute pain management for pediatric patients. This podcast will discuss some of the implications and safety issues while providing information regarding appropriate pediatric medication therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacdynamic characteristics a pharmacist must take into consideration when designing.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
USP recently published final revisions to the nonsterile compounding chapter and the sterile compounding chapter . ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter with compounding expert Patti Kienle.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September. They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this presentation from the 2021 Midyear Clinical Meeting, our content matter experts will share their recommendations on how to design strategies for diversity, equity and inclusion as a part of personnel recruitment, develop initiatives that support a culture of DEI within your department, share ways to engage all pharmacy staff in self-development and self-awareness surrounding DEI and create policies and procedures that create sustainable integration and advancement of DEI.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This curated feature from the 2021 Midyear Clinical Meeting focuses on the impact that pharmacy technician vacancies have on pharmacy department operations and how Hartford Healthcare’s development of a yearlong internship with their local Community College created an effective pharmacy technician talent pipeline.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this preview from the 2021 Midyear Clinical Meeting, our content matter experts will review the best practices for establishing a specialty patient management program, strategies for assessment, education, reassessment and identifying measures for a successful clinical pharmacy specialty service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast focuses on the perspective of two Residency Program Directors who have extensive experience with residency training and the Match process. Speakers share their experiences and guidance on how applicants can align their expectations and goals with a program that best matches their aspirations. This podcast episode will help future applicants prepare for the process of identifying and applying to their best fit residency program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will highlight advanced roles for pharmacy technicians in outpatient primary care and anticoagulation clinics. Listeners will learn about the work that pharmacy technicians do in these clinics and how they interact with pharmacists and patients in these settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this curated feature from the 2021 Midyear Clinical Meeting, our content matter expert from University of Louisville Hospital shares the organizational approach to specialized technician opportunities and advancement within a multi-site health system and technician career ladder implementation, staff perception of change, and re-assessment strategies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Simon Taxel will discuss his experience in the prehospital setting with a brand new bupenorphine induction strategy protocol. Additional discussion on analgesia management in patients with opioid use disorder.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the great clinical content at the 2021 Midyear Clinical meeting, our content matter experts will be discussing managing transition of care in the COPD patient care population and identifying strategies to overcome the challenges that comorbidities present when managing a COPD exacerbation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Amy Gutierrez, chief pharmacy officer at UCHealth, talks about the path that led her from working alongside her mother in a community pharmacy to overseeing pharmacy practice, strategy, and policy for large health systems. Gutierrez discusses the people and experiences that inspired her path to leadership and offers advice to the next generation of Latina/Latino pharmacy leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting. They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this curated feature from the 2021 Midyear Clinical Meeting, the University of Virginia shares the role the Medication Utilization Strategy Team’s advanced technician plays in managing drug shortages, nonformulary management, recall management, and refrigerator and temperature management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss strategies for reducing implicit bias and increasing cultural alignment throughout the recruitment and selection processes for incoming residents. Dr. Todd A. Walroth will share some successful recruitment elements for improving inclusion, in advance of his upcoming session during the ASHP National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this sneak peak from the 2021 Midyear Clinical Meeting, our content matter experts review the pharmacological profiles of antipsychotic medications, describe their side effects, and how pharmacists can design a therapeutic monitoring plan for a patient receiving these medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home. This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on treatment and management of C diff infection. Topics will include treatment plans and management strategies for our patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Specialty pharmacy is a rapidly growing practice area within pharmacy, and has many unique career opportunities for students and new practitioners. In this episode, pharmacy students who currently work at health system specialty pharmacies discuss their roles and experiences in specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this fun, informative, debate-style presentation from the 2021 Midyear Clinical Meeting, our content matter experts debate the use of gabapentin as an agent for pain in opioid-sparing multimodal pain regimens or is it a wolf in sheep’s clothing?
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers' practice journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hospitals that are looking for alternate ways to provide acute-level care to select patients can consider the Hospital at Home program where patients can be safely monitored and managed from their home. This podcast will review the benefits, challenges, and technologies that have been used by organizations that have successfully implemented this service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will review the current guidelines and summarize recent literature evaluating the use of aspirin for primary prevention. Additionally, the speakers will discuss how to talk with patients about the use of aspirin in primary prevention and when to desprescribe vs. continue therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom and Jillanne will discuss recent developments in manufacturer efforts to undercut the 340B program, as well as the recent Supreme Court ruling that requires CMS refund 340B underpayments to hospitals. We’ll cover ASHP’s advocacy strategy and touch on how covered entities can protect themselves in the current climate.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monkeypox was first detected in the United States in May and earlier in August, the Department of Health and Human Services (HHS) declared monkeypox a public health emergency (PHE), signaling increased urgency as the Biden administration broadens the push to contain the virus. The World Health Organization (WHO) declared monkeypox a global health emergency on July 23, and health officials in many states, including New York, California, and Illinois, have made similar declarations. This podcast will highlight what you need to know for yourself, your community, and your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this next episode with the Navigators, Vicki Basalyga sits down with Jason Briscoe, Director of Pharmacy Operations with Discount Drug Mart and Dave McCormick, Division Director, Immunization Division of the Indiana Department of Public Health to discuss their initial experiences with vaccination roll out at the beginning of the pandemic and the best practices they implemented to vaccinate their patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast takes a deep dive into a student’s perspective on a myriad of residency application topics including reference letter writing, role of the Midyear Clinical Meeting, and factors to consider when choosing the best fit residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we will be interviewing a pharmacy leader to discuss their Pharmacy Technician Training programs at their respective site. We will discuss the structure of their program, the successes they found in having a program, and the challenges they’ve faced along the way.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss strategies used in small and rural hospitals to improve medication safety and address barriers that may accompany small sites when implementing safety initiatives. Speakers will also touch on how to implement select ISMP Targeted Medication Safety Best Practices for Hospitals and how implementation may look different in the small or rural sector.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A conversation with the 2022-2023 Chair of the ASHP Section of Specialty Pharmacy Practitioners (SSPP), Dr. Scott Canfield. Listeners will learn about Scott’s pharmacy practice experience and practice journey thus far, as well as his experiences as a leader in health system specialty pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Matthew Rewald, Tom Woller, and Dr. Mark Sullivan discuss the AJHP CPO Perspective, “Stabilizing the Pharmacy Technician Workforce as an Imperative for the Chief Pharmacy Officer,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will explore palliative care as a specialty and why and how all pharmacists should incorporate palliative care principles into their practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss how to incorporate project management principles for student precepting. Dr. Kathryn Sawyer will share validated project management tools applicable to pharmacy education, in advance of her upcoming session during the ASHP National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Please join Brittany Tschaen and Joe Marchiano for a SCSS and NPF collaboration as they speak with New Practitioner Brooke Barlow, PharmD and clinical leader Cassie Bellamy for new perspectives about the unique wellness challenges posed by COVID-19. This podcast will add to the existing COVID-19 resources by showcasing a conversation between a New Practitioner and clinical leader to better understand how members of our profession can come together to maintain wellness.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide insight on how to establish and maintain wellbeing during the first year of pharmacy school. Listeners will here from three rising P2 students that were able to create support systems that helped them be successful academically and mentally.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, we host Dr. Melody Berg, ASHP’s editorial director for medication information. The discussion will explore ASHP’s Safemedication.com page as a source of information about prescription and over-the-counter medications for patients. Written by pharmacists, the easy-to-read articles include information about vaccines, tips for taking or giving medications, and answers to common safety questions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Opioid analgesic therapy is a common treatment for severe pain in the palliative care population. As the population ages, more patients with a history of opioid misuse are experiencing chronic, severe, difficult to treat pain, often related to cancer. This session will review various pain therapies for severe pain in the palliative care population and outline strategies for pain management in patients with comorbid use disorders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this dynamic presentation from the 2021 Midyear Clinical Meeting, our content matter experts review the barriers and challenges under-represented minorities face as student pharmacists, pharmacists and pharmacy technicians, describe the value and impact of mentorship, and provide strategies that pharmacists, technicians and departments can implement to cultivate diversity, inclusion and equity within pharmacy practice settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will address opportunities to develop relationships with payers to optimize patient outcomes. With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Incorporation of Diversity, Equity, and Inclusion is important now more than ever. In this podcast, listeners will hear from a DEI expert relay his/her experiences of DEI in pharmacy practice and share his/ her knowledge to how to best approach DEI in local chapters.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Midyear Clinical Meeting, our content matter experts will provide listeners with resources available with medication access for underserved patient populations, outline the provider role in improving care for these patients and design preliminary initiatives for enhanced medication access within your practice setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are currently in high impact roles within their organizations. Discussion will involve their career paths, current or past activities they most enjoyed, advice for fellow informaticists, and where they envision informatics in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode highlights the key take aways from the ASHP Section of Clinical Specialists and Scientists’ 2021 Midyear Clinical Meeting presentation on how pharmacists can help to counteract health misinformation with patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the Management Case Study, our content matter experts discuss the need for remote work for a world-wide pandemic, identify metrics used to elevate the sustainability of a central pharmacist stagging work model and describe the elements of a successful remote work model for a hospital or health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode focuses on the journey to obtaining pharmacist provider status from pharmacy leaders in Minnesota, North Carolina, and Wisconsin who have been advocating on the frontlines. Listen in to learn about the growing need for pharmacist provider status, speakers’ experiences, and advice for those interested in getting involved in pursuing provider status.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the recent weeks since the Supreme Court issued a decision in Dobbs v. Jackson, there have been widespread media reports of patients experiencing new barriers to access to medication therapies that are seemingly unrelated to reproductive health care or abortion services. During this podcast, we are going to explore the basis of these reports, provide background on the current status of state and federal laws governing access to abortion services, and discuss potential implications for pharmacist practice and patients’ access to medications. Further reading: https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Abuse of and addiction to opioid medications continues to be a growing issue worldwide with opioid abuse often beginning with prescribed products in medical care. Multimodal pain management uses alternatives to opioids to prevent the initial exposure that may lead to addiction and abuse. This podcast is focused on describing the management of acute and chronic pain conditions with opioid sparing modalities and analgesic optimization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers’ practice journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field as they discuss barriers and key strategies for biosimilar adoption.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During the COVID19 pandemic, primary care and specialty office practices in Michigan were closed or consolidated with laboratory services in outlying clinics closed or experienced a significant reduction in hours. In this episode, our speakers share how their practice continued to see patients during the COVID19 pandemic without any interruption to services provided by offering curbside INR checks and monitoring of INRs remotely while preserving patient and employee safety. Through implementing a practice model that included incorporating pharmacy technicians into workflows and leveraging telehealth visits, ambulatory care clinics can manage stable INRs to better serve patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss strategies to develop pharmacy practice infrastructure in population health and service line settings, discuss options to measure this practice success on patient outcomes, and opportunities to utilize this data in organizational payer engagement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ambulatory care pharmacy practice has evolved greatly throughout the COVID-19 pandemic. As healthcare begins to think about life beyond COVID, ambulatory care pharmacists are evaluating their role and what practice may look like as services continue to develop to meet the healthcare needs of the ever growing pool of patients who have experienced COVID19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will explore how to incorporate gaming into residency/institutional teaching to help foster engagement for the learners. Dr. Megan Adelman will share some key strategies and instructional techniques, in advance of her upcoming educational session during the ASHP National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this next episode in our series of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the Jude Aldean and Renee Robinson who will discuss the Vaccines for Children Program and how this program can support public health goals for childhood immunization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will explore leadership strategies and skills needed to stay relevant in healthcare. The speakers will describe how they keep up with the changes in managing healthcare technology. They will describe how ASHP has contributed to their ability to keep pace with these changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this Management Case Study from the 2021 Midyear Clinical Meeting, our content matter experts, describe the concepts related to diversity, equity and inclusion, share considerations for developing a meaningful and sustainable DEI program within your pharmacy department, and discuss a toolkit that can be used for implementing DEI initiatives.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Shipping validations are a requirement for many accrediting bodies of health system specialty pharmacies. However, a lack of industry guidance and minimal packaging solutions available on the market pose many challenges for specialty pharmacy teams. In this episode of Hot Topics in Pharmacy, we talk about the process undergone by one health system specialty pharmacy to create and validate packouts for room temperature medication shipping.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses the journey that resulted in Ohio’s Provider Status Law. Listeners will learn about provider status, the challenges that were overcome to have Ohio’s Provider Status Law signed, future directions, and how to get involved.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom Kraus, ASHP’s vice president of government relations, and Jillanne Schulte Wall, ASHP’s senior director of health and regulatory policy provide an update on the top policy issues impacting pharmacy practice that are being considered by congress and regulatory agencies this month.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physic
This episode from the 2021 Midyear Clinical Meeting explores practice models that include pharmacists as a part of the health care team in the primary care setting and foundational elements of practice for mental health and pain management where pharmacists play a pivotal role.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our content matter experts describe how they identified and procured the necessary technology to facilitate remote work for medication history technicians. This included developing procedures for contacting patients/caregivers remotely to conduct medication history interviews, and training technicians on new technology and workflow and metrics related to the services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The draft revision of the ASHP Accreditation Standard for Postgraduate Residency Programs was released for comment on 12/9/2021. One notable addition to the harmonized draft standards is the focus on resident wellbeing. This podcast is intended to highlight how some programs have worked to incorporate residency wellbeing into their program structure and how that could positively impact residency training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will cover current challenges and best practices for hospitals and health systems looking to maintain multistate pharmacy and pharmacy workforce compliance.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential. However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately. This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations.
Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listeners will be introduced to the background and purpose of the Specialty Pharmacy Outcomes Literature Library, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast, produced by ASHP’s Pharmacy Administration and Leadership Resident Collaborative, provides an engaging interview with two pharmacy leaders who have had successful careers after completing a Health System Pharmacy Administration and Leadership residency. Although both leaders have completed the same type of residency training, they have pursued different career paths, one being traditional and the other being non-traditional. David Dawka and Samm Anderegg will share their insights on their professional journeys after residency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this pediatric-focused presentation planned in cooperation with the Section of Clinical Specialists and Scientists, our content matter expert reviews the neonatal and pediatric requirements for macronutrients and micronutrients and the characteristics of this population’s specific parenteral nutrition products affect the solubility and stability of the formulation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Finding and engaging a mentor can be one of the most intimidating and challenging parts of pharmacy school. During this podcast, Megan Wright, PharmD Candidate at the UNC Eshelman School of Pharmacy and Dr. Katelynn Granger, a PGY-1 resident at MUSC Health, will talk discuss their own personal mentorship relationship and how it can be fostered and maintained through busy times.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides an overview of treatment options for acute pain in patients taking buprenorphine and how pharmacists can provide optimal care for patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There are a wide variety of student internship programs across the country. This podcast, hosted by the New Practitioners Forum, focuses on unique summer internship programs and shares advice for practitioners to consider when establishing or enhancing internship programs at their institution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We speak with three pharmacy leaders that have organizational responsibility for pharmacy and other clinical service lines. This is a growing phenomenon in healthcare and this podcast episode shares their insights and learnings with managing additional service lines.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are currently in high impact roles within their organizations. Discussion will involve their career paths, current or past activities they most enjoyed, advice for fellow informaticists, and where they envision informatics in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features a conversation with Alsean Bryant, an HIV pharmacy specialist with the AIDS Healthcare Foundation. Listeners will learn about his thriving pharmacy practice as well as his work with national recording artists, a professional football team, and mentees. Alsean will share how he is able to explore all of his interests and leave a lasting impact on the community.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast features excerpts from the presentation at the 2021 Midyear Clinical Meeting where Bryan McCarthy and Lalita Prasad-Reddy discuss the effects of work-related stress on productivity during the COVID-19 pandemic and identify methods that can prevent occupational burnout in the pharmacy department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we discuss the development of an innovative partnership model between a department of pharmacy within a health system and an external community pharmacy network.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Chronic pain is one of the main reasons patients seek medical care in the United States. Cannabis is being investigated as an alternate to opioid therapy due the potential to decrease opioid requirements and a better safety profile compared to opioids. This session will review cannabis use as an analgesic and highlight the pharmacist consultative role in cannabis education for pain.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we will discuss how artificial intelligence machine learning, data science and analytics are being incorporated into pharmacy education and how pharmacists can be better prepared to enter the ever-changing workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom and Jillanne will cover a recent communication from Medicaid to the states, directing them to allow providers authorized under the PREP Act to order and administer vaccines to enroll in Medicaid. We’ll discuss what this tone shift signals for pharmacists and how it intersects with broader provider status efforts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The first of many new and emerging long-acting antiretroviral therapy (LA ART) regimens recently received FDA approval for the treatment and prevention of HIV infection. The panel discusses LA ART and its impact on clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Residency program directors (RPD) from across the country will discuss successful personal and health system resiliency strategies across the spectrum for supporting individual well-being and cultivating organizational cultures committed to mitigating occupational burnout. Content will include members sharing experiences related to individual and organizational resiliency, implementation of solutions, and strategies for self-care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listen to our Advocacy Roundtable Discussion with ASHP’s government relations team regarding our top advocacy priorities. This discussion with Tom Kraus, vice president of government relations, Jillanne Schulte Wall, senior director of Health and Regulatory Policy, and Kyle Robb, director of state policy advocacy, provides ASHP members with an inside look at federal advocacy topics impacting the practice of pharmacy. Topics discussed include pharmacist provider status, 340B, elimination of the X-waiver for buprenorphine prescribing, white bagging, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Pamela Phelps - System Director, Pharmacy Clinical Services, M Health Fairview – will share her perspectives as the parent of an LGBTQ person.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses strategies to ensure pharmacy technicians have a voice in pharmacy, associated committees, and outcomes. With the heightened national issue around the pharmacy technician workforce the conversation shares how these processes impacts professional satisfaction, engagement, and retention for pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Practice Advancement Initiative (PAI) 2030 provides aspiration guidance and is intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. Student Societies of Health-System Pharmacists (SSHPs) are actively promoting the pillars of PAI 2030 within their chapters. In this podcast episode, we will highlight examples of how to incorporate PAI into SSHP initiatives.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, listeners learn about establishing a professional identify as a new practitioner. Speakers include new practitioner members ranging from new graduates to practitioners with a few years of experience. Speakers share their insight and advice on crafting a professional identity and how that identity can evolve throughout your training and career. For additional resources related to establishing a professional identity, check out the ASHP Professional Identify Formation Worksheet, developed by members of the New Practitioners Forum.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast Liv Swonger, a P4 student at Idaho State University College of Pharmacy, and Dr. Daniel Cobaugh will discuss Liv’s experiences as LGBTQ person and the intersection with her career path.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will feature mentor-mentee pairs that participated in the inaugural cohort of the ASHP Guided Mentorship Program. Mentors and mentees will share insights of their experience with the program, reasons for pursuing a professional mentoring relationship, and tips for candidates considering the program.
This podcast is an offering from the Black women on ASHP’s staff to the Black women in ASHP’s membership. Featuring strategies sourced from several Black ASHP staff members, the discussion centers on joy as an active form of well-being among Black women. It is a love letter that encourages members to be intentional about choosing joy and nurturing it as a daily practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Harms from opioid misuse continue despite significant attention to this public health crisis. Symptoms of acute opioid withdrawal are incredibly disabling and a leading driver in returning to use. Numerous methods exist to palliate withdrawal symptoms and improve the likelihood a patient who uses opioids may achieve long term recovery.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode is an interview with five speakers recognized in 2021 as ASHP Fellows (FASHP). Fellows provide advice and encouragement for new practitioners in their career transitions, including recommendations on staying up to date with practice changes, professional involvement, and other timely topics such as burnout and resilience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast Dean James Scott of Touro University California College of Pharmacy and Dr. Daniel Cobaugh will share Dean’s Scott’s life experiences and his academic leadership journey as a gay man.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
For a school of pharmacy, developing a cohesive PGY-1 residency program can be challenging when faculty work across a large number of different health systems. With the growing demand of post-graduate training opportunities, what can these institutions do to help meet that demand? In this episode of Educator Essentials, we talk about some innovative approaches in creating a PGY-1 residency experience utilizing multiple learning sites.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A conversation highlighting updates to the 2021 CHEST guideline updates on antithrombotic therapy for venous thromboembolism (VTE).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2021 Midyear Clinical Meeting, our content matter experts share their experiences with advanced pharmacy technicians in the ambulatory care setting. They will also discuss the benefits and barriers for advanced pharmacy technician roles, best practices for training, monitoring, evaluation, documentation and practice models.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP has set the vision of advancing pharmacy practice with the Practice Advancement Initiative (PAI) 2030. This podcast will discuss how Wisconsin Health-System Pharmacy Administration and Leadership residents through the Practice Advancement Leadership Team (PALT) collaborated with the Pharmacy Society of Wisconsin (PSW) to support Wisconsin hospitals in filling out the PAI 2030 Self-Assessment Tool and raise awareness of PAI 2030.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Shipping for specialty pharmacy patients is becoming increasingly more difficult. Compliance with cold chain and room temperature accreditation requirements, managing lost or delayed items, and managing rising costs are critical to ensure patients are receiving medication in a timely manner. This podcast episode covers current challenges in managing shipping operations and offers insight on how three Health System Specialty Pharmacies address these challenges.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses results from a recently completed pragmatic, prospective, randomized controlled study evaluating a patient-tailored intervention to improve specialty medication adherence. Listeners will learn how this rigorous study design was executed and the significant impact it had on patient outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ongoing opioid epidemic in the United States (US) is entering a new phase with the Covid-19 pandemic. Overdose deaths are increasing in the US and opioid use disorder (OUD) is one of the main contributors to this issue. Naloxone is a life saving medication for opioid reversal but requires timely administration. Unfortunately, due to cost and other limitations such as prescription status, naloxone is not always available when it is needed most. Emergency Departments (ED) and hospitals can play a vital role in establishing naloxone distribution services and put this life-saving medications directly into the hands of patients that may need it.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.
Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With several choices for oral anticoagulation in Nonvalvular Atrial Fibrillation (NVAF), it is critical for pharmacists to be able to account for patient specific factors when selecting the most appropriate anticoagulant.
To learn more, visit www.ashpadvantage.com/nvaf
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new resource outline developed the New Practitioners Forum.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides an overview of the available weight loss medications and walks through how to approach a patient case.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients.
This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation.
To learn more, visit www.ashpadvantage.com/nvaf
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation).
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, Dr. Jacinda Abdul-Mutakabbir, Dr. Vibhuti Arya, and Dr. Lakesha Butler discuss their commentary, “Acknowledging the Intersection of Gender Inequity and Racism: Identifying a Path Forward in Pharmacy,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This conversation surrounds the topics of diversity, equity, and inclusion (DEI) as they relate to ambulatory care pharmacy practice. Speakers will discuss ‘real world’ experiences with DEI and will share opportunities for improvement, goals towards greater equity, and actionable steps that can lead to more inclusive care in their practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode of educator essentials explores the use of escape rooms for evaluating candidates during pharmacy residency interviews. Our panelists explore this creative approach to interviewing as a way to evaluate candidates’ communication, collaboration, and clinical skills, while having fun.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As technology advances and you continue to automate your pharmacy, have you ever asked yourself if your software solutions are the right fit for the patient population you serve? This podcast seeks to open your eyes to potential biases that could be present in your use of artificial intelligence, machine learning, and clinical decision support. Join our mixed clinical and industrial panel of experts as we discuss challenges associated with bias and potential mitigating strategies to overcome.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Matt Baker, Dr. Megan Musselman, Rachel Rodgers, and Dr. Richard Hellman, discuss their cross-disciplinary effort to implement continuous glucose monitoring in the inpatient setting with host and AJHP Editor in Chief, Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Maintaining wellness throughout the pursuit of a Doctorate of Pharmacy degree is challenging. Students must have open conversations about the difficulties of staying well so that we can normalize feeling unwell. In this episode, students from across the country share their experiences and tips to encourage others to maintain healthy lives and relationships throughout their pharmacy school careers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the second part of this 2021 Midyear Clinical Meeting featurette, Dr. Lakesha Butler shares strategies to pursue anti-racism and equity at the individual, interpersonal, organizational, community and policy level. Through case studies, Dr. Butler demonstrates how pharmacists can be active and involved in anti-racist actions that eliminate barriers to quality care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join ASHP President Elect Paul Walker in this featurette from the 2021 Midyear Clinical Meeting as he describes the components for advancing health equity and anti-racism practices and offers some practical next steps to impact health disparities and affect change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This frank and engaging conversation sheds light on the ways diversity, equity, and inclusion principles impact practitioners, patients, and professional organizations. The guests also highlight actions student pharmacists can take to support ASHP's advocacy efforts related to DEI.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from the experts what suspected allergens factor in eosinophilic esophagitis (EoE) and the role of allergy testing. Dietary interventions used in EoE are discussed, including a review of efficacy and challenges with implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Preparing students for introductory pharmacy practice experiences (IPPEs) can be difficult with only didactic classroom learning. An interactive skills fair can help bridge the gap between the classroom and practice, setting a foundation for successful IPPEs. In today’s episode of Educator Essentials, we’re speaking with Dr. Jacqueline Wasynczuk about how her institution helped revamp and improve IPPE-readiness for their students, and the impact of the program on both students and preceptors.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies. Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode focuses on leadership journeys of board members of state affiliate societies. Listen in to learn about the speakers’ experiences, tips, and pearls on how to become leaders in organizations. The goal is to support sharing of information with ASHP members to promote awareness of leadership opportunities and to learn how some members have chosen to be involved.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode looks at the health equity research, the impact of the recent social justice movement on this field, and ways pharmacists can bridge gaps in access to medications, resources, and health information.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses the impact of systemic racism on pain management. Speakers review current literature and how systemic racism may affect patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with two pharmacy leaders who have really leaned in to volunteering and serving in leadership roles, as well as pursuing Health-System Pharmacy Administration & Leadership Residency Training. Dr. Scott and Dr. Andoh will share their insights on their professional journeys as students, pharmacists and association leaders, as well as their perspectives on leadership opportunities to support the advancement of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Specialty Pharmacy Conference: Speaking Clearly: Inclusive and Bias-Free Negotiations, our content matter expert outlines strategies to identify commonly used language that may cause a perception of bias in specialty pharmacy negotiations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
For many student pharmacist leaders, the transition from in-person to remote leadership in March 2020 was a jarring experience. From re-planning an organization’s traditions to resolving conflicts through a screen, pharmacy students adapted to new leadership styles and ways to maintain their mental well-being. This podcast episode interviews second, third, and fourth year student pharmacists about their experiences navigating the pandemic as student leaders. Discussion topics include practical ways to organize remote leadership tasks and how to promote resiliency by relying on mentors around you.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is committed to advancing the field of pharmacogenomics and educating members on patient specific pharmacogenomics testing, dosing and monitoring of medications to improve health outcomes. This podcast episode explores the important role pharmacists play in pharmacogenomics from a practice and research perspective and leading pharmacogenomics services implementation at Mayo Clinic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Shortages in medications have become common place, however we are now dealing with a shortage of diluents such as sterile water, dextrose and normal saline. This podcast episode discusses alternatives and conservation methods needed to combat these shortages.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode offers insight on clinician burnout from a physician expert and senior advisor to the office of the Surgeon General. In an over-regulated industry and a work harder culture, how can we simplify our work lives to achieve well-being among leadership and staff. Well-being priorities from the office of the Surgeon General are discussed including components of an ideal healing healthcare system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this educator essentials podcast episode, we speak with Dr. Kelly Gable and Dr. Suzanne Harris about their unique academic leadership roles as directors of well-being and resilience within their institutions. This episode explores their career journeys, role innovations, and the importance of prioritizing the well-being of the pharmacy workforce through formal leadership.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This discussion is meant to be informative for pharmacists who are less familiar with immunotherapy-related adverse events, as well as to offer insight into decision making in challenging situations related to managing irAEs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Management of heart failure (HF) has evolved over the past few years, prompting the American College of Cardiology (ACC) to release a 2021 Update to Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment to provide guidance and recommendations on clinical care of HF patients with a reduced ejection fraction (HFrEF). New therapies for HFrEF have emerged that expand the arsenal for this patient population, particularly angiotensin receptor-neprilysin inhibitors (ARNI) and sodium glucose cotransporter-2 (SGLT2) inhibitors. However, use of guideline directed medical therapy (GDMT) is still suboptimal, and there is a need for pharmacists to assist in improving medication adherence. This podcast episode provides general practitioners an update on new evidence for pharmacotherapy and provides guidance on how to initiate GDMT in patients with HFrEF successfully in both inpatient and outpatient settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast episode, we talk with two pharmacy-based social media influencers. We hope that through learning about their experiences, students may gain insight into how to leverage these platforms for their own professional development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast we discuss with Dr. Andrea Luebchow, Program Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, we meet with Ashlee Klevens Hayes, pharmacist and executive career strategist to discuss self-trust, a key component to the value of wellbeing and resilience. Ashlee shares 10 tangible tools to help develop this skill through new habits, conquer imposter syndrome, and help you excel through transitionary phases in your career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode highlights the key takeaways from the ASHP Section of Clinical Specialists and Scientists’ 2020 Midyear Clinical Meeting presentation on how pharmacists can recommend therapy interventions for a patient with COPD to reduce exacerbation or hospital readmission.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode describes how ASHP incorporated yoga practice into the workplace, the benefits, and how you can bring the practice into your workplace and life.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
COVID-19 required the pharmacy referral service within the Family Medical Practice at Penn Presbyterian Medical Center to move to a virtual platform. This podcast episode, originally presented at the 2020 Midyear Clinical Meeting, describes the implementation of the pharmacy services as well as results of the transition for maintaining patient care visits and pharmacy residency training during a pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode reviews updates to the Physician Fee Schedule and their effect on ambulatory care pharmacy practice. Listeners will receive an overview of the Physician Fee Schedule and its impact on various scenarios pharmacists may encounter in practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode provides members with an overview of FDA’s new draft hospital and health system compounding guidance. We cover what’s changed from the previous draft guidance, what it means for practice and compliance, and what comes next with FDA advocacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, we explore the importance of paying it forward by serving as poster mentors for student pharmacists and residents. We discuss best practices in coaching learners through the research process and tips on how to effectively evaluate poster presentations to assist learner’s professional development.
For those interested in inspiring and motivating learners in the ASHP Midyear Clinical Meeting and Exhibition 2021 Poster Hall, sign up to be a poster mentor by November 15.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day 2021, ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our nation. In this episode, we speak with Carol Labadie, Tim Ekola, and Kelly Lunsford about their stories and the remarkable journeys they embarked on to become pharmacists that all began with their decision to enter the military. This special episode is part reflection, part inspirational, and all entertainment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best anticoagulation strategy for patients on ECMO.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listen in as our content matter experts from Section of Clinical Specialists and Scientists present at the 2020 Midyear Clinical Meeting, where they summarized some of the available digital medicine technologies for cardiology, endocrinology, and oncology, and identify the barriers to implementing digital medicine technologies. Don’t Worry, Be ‘Appy!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A conversation between an ASHP fellow and extern describing their experiences and projects and how they relate to ASHP initiatives.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Medication-related emergencies occurring in the operating room or peri-procedural areas include malignant hyperthermia and local anesthetic toxicity. In each instance, time is of the essence in recognizing and treating life-threatening drug reaction.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this feature from the 2020 Midyear Clinical Meeting, our content matter experts from the ASHP Section of Clinical Specialists and Scientists discuss the importance of emotional intelligence in daily life and why improving emotional intelligence can help pharmacy staff lead their industry’s transformation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode highlights real-world strategies to implement well-being and resilience as a value into your clinical practice from our friend and colleague who recently transitioned back into a leadership role in patient care. A great listen for those feeling burnt out, or who have recently transitioned roles during the pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this excerpt from the 2020 Midyear Clinical Meeting, our content matter experts help you to evaluate a basic metabolic panel to determine the cause of common electrolyte derangements and interpret a basic metabolic panel to assess a patient’s volume status.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This excerpt from the 2020 Midyear Clinical Meeting will describe the phases of fluid administration in critically ill patients, discuss approaches to passive de-resuscitation with fluid restriction and active de-resuscitation and help pharmacists determine an appropriate regimen for diuresing critically ill patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this fast-paced debate style presentation from the 2020 Midyear Clinical Meeting, content matter experts debate the best oral P2Y12 antiplatelet agents for your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Drs. Brittany Bissell, Rebecca Smith, and Mojdeh Heavner discuss the issues of gender inequity and sexual harassment in the pharmacy profession. They provide an overview on their article approach and findings, examples of gender inequity in the workforce, and recommend steps the profession needs to take to achieve gender equity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode features excerpts from the presentation at the 2020 Midyear Clinical Meeting in which Bonnie Kirschembaum discussed the impact of macro-level data on local and regional health systems, as well as how to identify opportunities for growth and innovation resulting from COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode features excerpts from the 2020 Midyear Clinical Meeting focusing on the 2020 Joint Commission elements of performance for National Patient Safety Goal for anticoagulation safety. This episode should help pharmacists design an outline for care system to allow appropriate individualization of management plans while still standardizing critical aspects of care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts will review the key literature on both Alteplase and Tenecteplase and their roles in the management of acute ischemic stroke and how their pharmacokinetic and structural differences play a role in therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this featurette from the planned by the Section of Ambulatory Care Practitioners for the 2020 Midyear Clinical Meeting, content matter experts will identify opportunities to talk to patients about sexually transmitted disease (STD) risks and prevention and given a patient at risk for STDs, summarize the appropriate testing strategy to detect STDs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode featurette from the Section of Clinical Specialists and Scientists' presentation at the 2020 Midyear Clinical Meeting, Joel Marrs presents the definitions of hypertriglyceridemia based on the 2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol and help pharmacists identify risk factors for the development of hypertriglyceridemia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This session provides a practical approach to managing patients on factor Xa inhibitors with life-threatening bleeding or those needing emergent surgery including guidance on patient selection, indication restrictions and advances in point of care testing. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Visit https://elearning.ashp.org/products/8728/intensive-studies-for-recertification-critical-care-pharmacy-cert-l219022 to purchase the recertification product.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode reviews the ISMP Targeted Medication Safety Best Practices for Hospitals #2 on oral methotrexate safeguards. Speakers will discuss one institution’s experiences with assuring that dosing is accurate in electronic systems when medication orders are entered and providing specific patient and/or family education for all oral methotrexate discharge orders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Small and rural hospitals offer an exciting opportunities for students and a special growth opportunity for staff who serve as preceptors in this practice setting. Listeners will hear about how to get started precepting pharmacy students, how to develop well-rounded rotations, and unique rotations and opportunities available in rural hospitals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
At the peak of the pandemic crisis, safety from exposure to COVID-19 for healthcare workers became the driving force in reconfiguring and renaming the kits and trays utilized across departments, nursing stations, and in the OR. The goal was to mitigate exposure risks caused by the potential contamination of carts, kits, and trays utilized in areas caring for COVID-19 patients. In this Case Management Study from the 2020 Midyear Clinical Meeting learn how the Pharmacy Department leveraged RFID technology to cope with new challenges presented by the COVID-19 crisis by providing a quick and efficient mechanism to reconfigure and rename kits and trays in order to minimize exposure.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for this practice journeys podcast episode as we chat with Kellie Musch, Site Manager of Pharmacy Services at OhioHealth Medical Center. Kellie shares her impressive journey as a pharmacy leader, and how her involvement with ASHP has impacted her career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Dr. Joshua Raub talks about his Hodgkin’s lymphoma diagnosis, undergoing treatment, and managing the wide-ranging effects of the disease.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Biohacking has been defined as “do-it-yourself biology” or “do-it-yourself citizen science merging body modification with technology.” Biohacking is performed by biology enthusiasts, citizen scientists, and other like-minded individuals to improve oneself or treat a disease. This podcast episode describes this emerging topic and what the pharmacy workforce needs to know.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Review the latest data and recommendations for pre-exposure prophylaxis in this highlight from the 2020 Midyear Clinical Meeting Presentation. Our content matter experts from the Section of Ambulatory Care Practitioners summarize data supporting use of pre-exposure prophylaxis (PrEP), review the guideline based testing for the care of patients on PrEP, and will help you evaluate strategies to implement PrEP into your existing practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode explores how corporate/centralized pharmacy resources organize themselves within their health systems to support hospital pharmacy departments. Three leaders from different sized hospital systems discuss the topics of pharmacy goals, accountability, and outcomes and how all are impacted by the organizational structure. Speakers also highlight successes and drawbacks with their organizational structure.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Angela Cassano chats with Mr. Dom Bracero and Dr. Luis Pagan about one health system’s journey to insourcing compounded sterile preparations, specifically parenteral nutrition.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Angelica Berni and Justin Culshaw come together to share both their personal and professional experiences in caring for the Hispanic/Latinx community during a pandemic. They delve into gaps in care and provide tips on empowering pharmacists as we move forward together as a profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode highlights the work of the National Academy of Medicine Clinician Well-Being Collaborative as they enter the third and final phase of work, which in the end will total 6 years of striving to raise the visibility of health workforce burnout, improve baseline understanding of challenges to health workforce well-being and resilience, and advance evidence-based, interprofessional solutions to improve patient care by caring for the care team. The work of this collaborative supports our nation’s health care workers and aligns with ASHP’s mission to improve patient outcomes through optimal medication use.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode explores the issues ASHP members discussed as they met with Congress during 2021’s Virtual Legislative Week. Tom Kraus discuss the issues, the impact, and the future of these priorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode will review the ISMP targeted medication safety best practices for hospitals #9 to ensure all appropriate antidotes, reversal agents, and rescue agents are readily available, have standardized protocols and/or coupled order sets, and have directions for use/administration. Speakers will discuss organizational resources to consider for implementation and will share lessons learned from collaborating on learner assignments regarding this best practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Digital therapeutics is an emerging class of therapies that utilizes technology and software to treat disease, both as a standalone or for treatment optimization. Diabetes is one such disease state that can be managed from the advent of digital devices, including continuous glucose monitoring (CGM) systems. CGMs automatically track blood glucose levels and translate the data for current and historical trends and allow the patient and care team to modify treatment and behavioral decisions. As digital health devices are becoming more common, this podcast will ensure you are equipped to answer questions about glycemic management and make the best recommendation for your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Angela Cassano chats with Mr. Dom Bracero and Ms. Patricia Kienle about common questions asked about insourcing CSPs and explores the intricacies of insourcing that should be considered before implementing or expanding an insourcing program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Jo Ann Stubbings and David Chen discuss the 2020 ASHP National Survey of Health-System Specialty Pharmacy Practice, going over key findings from the survey and what challenges and opportunities lie ahead in specialty pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode explores the role and advancement of technicians in a specialty pharmacy setting. We will discuss how to best prepare to join this field, as well as how to advance yourself in your current role.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, listeners will learn about unique specialty pharmacy roles such as quality/performance improvement and outcomes research. Both roles are essential to improving patient care and demonstrating value to each of our stakeholders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on personal financial literacy topics such as understanding retirement vehicles and how to make sure you are on track. This episode is the second release of a three-part series.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learn about implementation of ISMP targeted medication safety best practices for hospitals #4 and #5 regarding packaging of oral liquid medications and dosing devices that only display the metric scale. Hear from both pharmacy and nursing medication safety specialists share their insights about how one health system made the conversion to ISO 80369 compliant EnFit syringes and other lessons learned regarding oral liquid dosing devices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses clinical pharmacist productivity and why organizations measure it. The speaker gives examples on how to develop productivity models, ways to collect and report measurement data, avoid barriers, and increase internal support for varying productivity measures.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will share the experiences of the 2021 ASHP Summer Interns as they discuss adapting to their education, learning styles, and internship to a virtual model during the COVID-19 pandemic. Additional discussion topics will include maintenance of personal well-being and connections with others.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
PGY-1 pharmacy residents are essential members of the pharmacy team and play an important role in patient care. When utilized appropriately, pharmacy residents can serve as an invaluable resource in the process of disaster planning and response while simultaneously achieving the objectives of their respective programs. Listen in as Lori-belle Stone shares her successes during this unprecedented time at the 2020 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Although there is no gold standard to teaching in high acuity settings, the purpose of this podcast is to discuss the tools needed to provide a well-rounded high-acuity learning experience to pharmacy/medical students and residents. The podcast will include how best to prepare yourself and your learners for a successful learning experience. Lastly, the podcast will discuss how learners should be valued as part of the team as they can help expand services within the department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Host Daniel Cobaugh discusses the recent PBS documentary, Vaccination from the Misinformation Virus, with the Producer and Director Chris Schueler and RADM Pamela Schweitzer, retired assistant surgeon general and 10th chief pharmacist officer of the United States Public Health Service.
To view the trailer, schedule a screening or learn more about the recent PBS documentary, Vaccination from the Misinformation Virus, please visit: https://themisinformationvirus.com/
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, expert faculty discuss the importance of timely identification and management of immune-related adverse events (irAEs) in patients being treated with immune checkpoint inhibitors, including commonly asked questions.
To learn more about this initiative visit www.ashpadvantage.com/irae
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we speak with expert faculty and pharmacist clinicians about the state of care for sexual and gender minorities, actionable steps on creating an affirming environment, and care considerations for persons seeking gender-affirming therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
In this podcast episode of Educator Essentials, we invite Dr. Timothy Brown to discuss ways that faculty and preceptors can incorporate LGBTQ+ health education. Dr. Tim Brown is the Director of Interprofessional Education for the University of Georgia’s (UGA) College of Pharmacy and a Professor in Pharmacology and Toxicology for Augusta University Medical College of Georgia and UGA Partnership, participating in the education of student pharmacists and student physicians.
Are you inspired by this podcast? If you have additional ideas, curricular programs, and other initiatives relevant to diversity, equity, and inclusion in education, please consider submitting your proposal through this survey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
An in-depth discussion of ASHP’s ongoing push to expand pharmacists’ authority to order and administer therapeutics to non-hospitalized patients for prophylaxis and treatment of COVID-19 infection. Speakers will discuss state and federal advocacy strategies to achieve expanded scope of practice for pharmacists, along with the role of pharmacist-provided COVID-19 therapeutics within broader pandemic response efforts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the ISMP Best Practice #16 recommendations for minimizing risks associated with the use of overrides in Automated Dispensing Cabinets (ADC). The speakers discuss the pros and cons of use of overrides with ADCs and recommendations to safely implement and maintain this medication distribution process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Experts will discuss strategies for meeting the several aspects of the ISMP Opioid Best Practice, including:
- Identifying and documenting the patient’s opioid status (Tolerant vs Naive)
- Mitigate issues regarding unsafe prescribing and storage of Fentanyl patches
- Defaulting to the lowest starting dose of long-acting opioids
- Alert prescribers of pertinent dose adjustments
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we speak with Matthew Boyd, Pharm.D. about his career journey and transition from ambulatory care pharmacy practice to becoming a medical science liaison. Listeners will learn about his current role as well as a few of the factors that went into his decision to enter into a non-traditional area of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists who listen to this presentation from the 2020 Midyear Clinical Meeting will be able to describe evidenced-based strategies that can impact individual health and wellness, identify resources and tools that can influence well-being in the workplace and select an individual self-care habit action plan to implement over the next 30 days.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As pharmacists, we are extensively trained on the intricacies of evaluating medical literature, but how can we do it more efficiently? In this podcast episode, we interview Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic - Rochester and Dr. Scott Nei, Cardiovascular Critical Care Pharmacist and PGY1 Residency Program Director at Mayo Clinic - Rochester to learn tips and tricks for quickly evaluating literature.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Get the Medications Right Institute (GTMRx) believes that through team based comprehensive medication management (CMM), we can save lives, save money, and restore health through personalized, patient-centered, coordinated approach to medication. ASHP works closely with GTMRX to develop best practices, payment models, and policy to support CMM and to impact patient care. Every good healthcare team needs a good pharmacist to guard against medication misuse and open the path to achieving positive health outcomes from the use of medications. This podcast will explore ASHP’s role in GTMRx which works to optimize medication outcomes for patients through CMM.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a Well-being Wednesday conversation for our third installation of the financial wellness series. This series is a collaboration with the Section of Clinical Specialist and Scientists (SCSS) and the New Practitioners Forum (NPF) where we discuss areas of personal finance most pertinent to pharmacists and student pharmacists. In this episode, we discuss key strategies and tips for members who want to learn more about investing.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In a rapidly changing healthcare system, keeping up with the evidence-based practice change is a challenging task for healthcare teams. Pharmacists have an opportunity to invest in system wide educational outreach to serve as agents of knowledge translation for high reliability organizations. Opportunities to adopt new practice patterns for antibiotic prescribing and address safe medication practices is knocking at the door for your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast highlights the utility of the Practice Advancement Initiative (PAI) 2030 Self-Assessment Tool designed to help respondents determine how well their practice settings align with the PAI 2030 recommendations. ASHP’s PAI 2030 provides pharmacy teams with guidance for advancing healthcare, patient outcomes, and pharmacy practice through 59 recommendations. The PAI 2030 Self-Assessment Tool identifies areas for improvement and a list of priorities for implementing change can be developed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This mini-series will focus on how to get started in using data to drive decision-making, and highlight institutions with successful implementations. This podcast is intended to provide tips on how to begin selecting pharmacy metrics pertinent to improving workflow and outcomes for front-line staff.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The targeted medication safety best practice for hospitals #13, eliminating injectable promethazine from the formulary, will be discussed. Faculty will describe the process used at one health system to address this safety recommendation. Hear tips that you can apply to your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on personal financial literacy topics such as understanding retirement vehicles and how to make sure you are on track. This episode is the second release of a three-part series.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Residency directors at an academic medical center will discuss precepting and developing their PGY1 and PGY2 residents during COVID-19. Speakers will share lessons learned during COVID-19 and strategies that will be carried forward to subsequent residency classes. Current PGY1 and PGY2 residents will discuss opportunities COVID-19 has afforded them and resiliency strategies employed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Speakers will discuss ISMP Best Practice #3 regarding weighing patients and using only metric units. This best practice is to prevent inaccurate dosing that can lead to medication errors. The process used at one health system to implement these recommendations will be shared.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Recent updates to asthma guidelines suggest that treatments may be used ‘as needed’ in certain patient populations. Additionally, newer monoclonal antibodies are providing an alternative to systemic glucocorticoids for severe asthma control and exacerbation prevention. The rapid release of multiple agents and changes to national/international guidelines requires a review of asthma management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There are multiple pathways to pursuing a career in pain management. During this podcast, listeners will hear from pharmacists who participate in pain management in different settings and will learn of their different career paths and practice models.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this AJHP Voices Interview, Tyler Vest, Kayla Waldron, and Adrienne Simmons discuss the methods behind the development of their institution’s acute care clinical pharmacist productivity model, providing overviews on the model’s framework, validation, and application.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode will review the experiences of two clinical pharmacy specialists as they established their own pharmacy practice site. In addition to transitioning from a pharmacy resident to a clinical specialist, each speaker has demonstrated the need for a clinical pharmacist to medical teams who previously practiced without this resource. The speakers will discuss the challenges they faced and how they overcame these barriers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will be a two-part series, the first focused on pharmacists and the second on technicians. The goal is to discuss the impact of the pandemic on pharmacy staff working remotely both now and in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ISMP Targeted Medication Safety Best Practices for Hospitals #1 is to dispense vinCRIStine and other vinca alkaloids in a minibag of a compatible solution and not in a syringe. This best practice is to prevent intrathecal infusion, which can be lethal. Learn how one health system implemented this best practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Increasing vaccine confidence within our patients and our communities is critical to improving immunization rates and preventing COVID-19 infections. In this podcast, we chat with Dr. Sarah Uroza about her experiences with building relationships of trust and collaborative partnerships within the community and ambulatory-based settings, to help boost COVID-19 immunization efforts.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we will define compassion fatigue and explore its components, including unresolved grief. We will discuss ways to recognize, name, sit with, and share the emotions we experience in patient care. We will practice self-compassion as an essential strategy for clinician well-being.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Over the last year, the COVID-19 pandemic has required and introduced many innovations and advancements within the healthcare industry, to include the production and administering of vaccines, as well as some long-term implications that will go beyond 2021.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will review notable state legislation from the first half of 2021 with a specific focus on laws that expand pharmacists’ scope of practice and laws requiring insurers to reimburse pharmacists for clinical services. Speakers will also discuss how state efforts fit into the larger national push for pharmacist provider status.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum and guest speakers as they share advice for pharmacy students, residents and new practitioners on how to develop your CV to pursue non-traditional career paths in medical writing and informatics.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss the development, implementation, barriers and successes surrounding starting a new substance use disorder clinic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum (NPF) and guest speakers as they share their experience and advice on how to develop your student and resident rotations prior to the rotation, during the rotation, and follow up after completion
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This mini-series will focus on how to get started in using data to drive decision-making and highlight institutions with successful implementations. This podcast is intended to provide tips on how to begin gaining support for data and analytics resources within a pharmacy department.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide listeners with perspectives and case study on effective methods to improve a pharmacy department's team engagement and management of the front-lines. In this podcast, we will share practical examples used at both a large academic facility and a smaller community hospital to improve daily communication, manager feedback techniques, and encourage staff engagement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Rapid sequence intubation and management of the recently intubated patient is a common scenario faced in any emergency department. This podcast will discuss the role of the EM pharmacist, potential strategies for success, and potential pitfalls and controversies regarding the management of these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a Wellness Wednesday conversation for our second installation of the financial wellness series featuring members of the Section of Clinical Specialist and Scientists (SCSS) and the New Practitioner's Forum (NPF). This podcast will share insights into things to begin thinking about for retirement including savings, differences between retirement plans, and how different types of employment can lead to different strategies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We chat with Dr. Paul Szumita and Dr. Jeffrey Pearson, both of Brigham and Women’s Hospital in Boston, MA about updates on the use of antiviral therapies, anti-inflammatory management, as well as supportive care in patients with COVID-19. For more on this topic, please see https://elearning.ashp.org/COVID-19 and Expert Insight articles at https://ashpadvantage.com/expert-insight/.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast discusses the value of integrating a pharmacist into a multidisciplinary team. Over the evolution of the profession of pharmacy, different departments and disciplines have identified the need and benefit of the addition of a pharmacist. As opportunities continue to flourish and expand, pharmacists have discovered traditional and non-traditional leadership roles amongst other health care professions all throughout different health-systems.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In today's episode, we discuss the importance and benefits of embracing DEI, while also exploring how continuous learning and intentionality can be the impetus for impactful change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Recent updates to asthma guidelines suggest that treatments may be used ‘as needed’ in certain patient populations. Additionally, newer monoclonal antibodies are providing an alternative to systemic glucocorticoids for severe asthma control and exacerbation prevention. The rapid release of multiple agents and changes to national/international guidelines requires a review of asthma management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is the first of three Wellness Wednesday conversations focusing on financial wellness. During this episode, members from ASHP New Practitioners Forum and the Section of Clinical Specialists and Scientists (SCSS) discuss personal finances, specifically key strategies and insights related to student loans. If you are student pharmacist or pharmacist wanting to learn more about navigating your loans including options for repayment, consolidation, or refinancing this podcast is a must listen.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of AJHP Voices, Dr. Eric Tichy and Dr. Michelle Wiest discuss the AJHP Special Feature on National Trends in Prescription Drug Expenditures and projections for 2021, focusing specifically on the forecast’s findings, uses, and the impact of COVID-19 on drug expenditures this past year.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode of Educator Essentials, we talk with residency program directors and preceptors regarding the impact of COVID-19 on resident onboarding. Listeners will learn how clinical training variations affect incoming residents, and how to foster a positive culture amongst the challenges of the pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The RAPID Alliance seeks to advance implementation science-informed strategies for protecting and improving US population health and wellbeing through pharmacists and pharmacies working in collaboration with connected stakeholders during and after the COVID-19 pandemic. Expert scientists based at the University of Louisville School of Public Health and Information Sciences within the Center for Health Organization Transformation are creating an enhanced research infrastructure that aims to enable all stakeholders to work collaboratively to optimize medication therapies. Members of the research team will participate in this podcast.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is committed to advancing the field of pharmacogenomics and educating members on the pharmacogenomics-based selection, dosing and monitoring of medications to improve health outcomes. This podcast explores a clinician’s perspective working with patients in ambulatory psychiatry and how pharmacogenomics enhances her practice and patient care. This podcast also explores ASHP offerings that advance practice and optimize medication outcomes through the use of pharmacogenomics including the refreshed ASHP certificate and a recap of the AMA/ASHP Pharmacogenomics Virtual Summit Series.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the continued expansion and growth of healthcare, pharmacists continue to experience pressures affecting career satisfaction. Pharmacists have been tasked with taking on more responsibilities to meet the growing needs in healthcare in addition to serving as preceptors for students and residents, which can increase the risk of burnout. This podcast will provide wellbeing strategies to maintain resilience as a preceptor.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The World Health Organization, in its 11th revision to the International Classification of Diseases, classifies burnout as an occupational syndrome associated with risks in the work environment. Recognizing this, and the literature demonstrating the need for a systems approach to preventing burnout in the healthcare workforce, proactive steps can be taken to redesign work systems that support and prioritize well-being. Join us as we discuss strategies in this podcast.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In today’s episode, ASHPOfficial hosts a conversation with the research grant teams from the ASHP Foundation New Practitioner Pharmacists Leadership Grant.
Listen in as our speakers discuss lessons learned during their project using a web-based app to affect stress, mindfulness, and burnout on pharmacy students. Topics include future implications, and further implementation for research, and the impact of the ASHP Foundation grant in the project as well as advice for those submitting for this grant and the impact of the research.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide information on continuous professional development (CPD) and its importance to practitioners. The podcast will also provide perspectives from pharmacy leaders on the value and importance of ASHP’s Fellows (FASHP) and how achievement is recognition of longitudinal commitment to practice advancement. Additionally, the podcast will explain how utilization of the FASHP guidelines for application can serve as a road map for CPD.
Navigating Purposeful Career Growth: Using the FASHP Criteria to Lead Your CPD
Updated on July 14, 2021. An earlier version of this podcast has been edited to clarify the interpretation of criterion 2 and criterion 4 of the ASHP Practitioner Recognition Program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As part of their response to the COVID-19 pandemic, Harris Health System leveraged their existing home delivery platform to continue to provide medications to patients in a safe and timely manner. This included filling over 120,000 prescriptions and minimizing exposure to patients and staff by limiting the volume of patients on-site while still providing optimal patient care. This Management Case Study from the 2020 Midyear Clinical Meeting will also identify the challenges of rapid expansion of home delivery service in an indigent population and discuss the impact of these services on an existing delivery program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The Infectious Diseases Society of America (IDSA) has recently published a position paper on recommended changes to the SEP-1 sepsis early management bundle. The panel discusses IDSA’s recommendations for broad-spectrum antibiotic administration and their potential impact on practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The SARS-CoV-2 pandemic has affected many pediatric patient's access to health care professionals. As a result, patients may now be off schedule for their immunizations. This podcast aims to review the various CDC charts describing vaccination schedules, discuss the application of the catch-up immunization chart in clinical practice, explain the impact of the COVID-19 vaccine on other vaccines, and provide additional resources for unique clinical situations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Learners have a variety of unique learning styles, needs, and personalities which encourage preceptors to create custom experiences to best suit the learner. Preceptors are challenged to adapt to the changing needs of learners on each rotation and devote resources to time-consuming process of learning-experience development to suit each students’ needs. This podcast will discuss some typical difficult learner scenarios and strategies to maintain resilience as a preceptor.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Yee-Ming Lee and Dr. Lisa Corbin discuss their involvement in the development of a pharmacogenomics program within an executive health setting, providing overviews on how the program works within an executive health system and what the program offers to patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join the author team of the 2018 AJHP article entitled Navigating the residency application process for lesbian, gay, bisexual, and transgender student pharmacists as they discuss key questions and topics that LGBT candidates may want to consider as they navigate the pharmacy residency application and match processes. Hear from Clay Daniels, Lindsey Kelley, Christopher Scott, and Tate Trujillo as they discuss their perspectives and strategies for identifying residency programs that will provide a supportive learning environment. This is the fourth and final episode in our 2021 ASHP Pride podcast series.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Rebekah Bartholomew, Aaron Hutchins, discuss their journeys as LGBTQ pharmacy students and residents with Daniel Cobaugh, Editor in Chief of AJHP. In a wide-ranging conversation, they talk about their careers so far, life experiences, and their guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tom Kraus talks with Nic Pottebaum, Health Policy Advisor to Senator Chuck Grassley about the Pharmacy and Medically Underserved Areas Enhancement Act and the benefits of the legislation to Medicare beneficiaries.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast focuses on appropriate care for gender non-conforming patients. The primary focus is on appropriate use and monitoring of hormone pharmacotherapy, but it will also include a brief discussion of the health disparities facing this unique patient population and other types of care they may need.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast is part of a two-part series, the first focused on pharmacists and the second on technicians. The goal is to discuss the impact of the pandemic on pharmacy staff working remotely both now and in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with two pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. This special edition of ASHP’s podcasts recognizes Father Day and the special role fathers have at work and at home and includes the children of our pharmacy leaders as moderators.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
From the 2020 Midyear Clinical Meeting, this podcast features how the University of Maryland Medical Center established dynamic inventory assessment was utilized to monitor usage demands of the compounded items. Due to the shift from patient specific compounding to batching due to meet COVID-19 demands in staffing, they effectively managed inventory in parallel with in-time utilization as well as respond to operational needs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast Jennifer and Daniel Cobaugh will discuss Jennifer’s life journey as a transgender woman.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a conversation with the research grant teams from the ASHP Foundation New Practitioner Pharmacists Leadership Grant. Burnout syndrome and depression can have a detrimental impact on pharmacists. The project studied the relationship between grit and burnout in hospital pharmacists. It also included an assessment of depression. Topics discussed during the podcast include, lessons learned during their project, future implications, and further implementation for research, and the impact of the ASHP Foundation grant in the project. Also included is advice for those submitting for this grant and the impact the research will have.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on personal financial literacy topics such as creating a financial plan, understanding retirement vehicles and identifying resources for continued self-education. This episode is the first release of a three-part series.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores how the Advocacy and PAC Advisory Committee pushed for advocacy as a professional responsibility policy statement and why it is important for pharmacists to advocate for their profession.
Take action on the Pharmacy and Medically Underserved Areas Enhancement Act by telling your members of Congress to co-sponsor the provider status legislation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Kelly Brunk and Daniel Cobaugh will discuss Kelly’s journey from a career as a professional dancer followed by a promising pharmacy career. They will hit upon Kelly’s’ career and life experiences, and his guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As acute care resuscitation specialists, EM Pharmacists are uniquely equipped to assist with disaster preparedness not only in their institution but also in their health system and their community. This podcast focuses on medication disaster preparedness topics such as disaster carts, strategic national stockpile, and antidote stockpiles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will serve the purpose to explain how to get involved nationally with ASHP’s Pharmacy Student Forum and to encourage student pharmacists across the country to apply to advisory groups. We will be discussing with student advisory group chairs on their involvement and experiences.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode of Educator Essentials, we talk with residency program directors and preceptors regarding the impact of COVID-19 on resident onboarding. Learn how clinical training variations affect incoming residents, and how to foster a positive culture amongst the challenges of the pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
On this podcast, we host three ASHP Fellows and discuss topics including the role of pharmacists as frontline providers, pharmacists impact on patient care during the pandemic, and advice and encouragement for new practitioners after a year of primarily virtual training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum and guest speakers as they share advice for pharmacy students, residents and new practitioners on how to develop your CV to pursue non-traditional career paths in industry and consulting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Status epilepticus is a true medical emergency that can lead to severe morbidity and mortality despite appropriate therapy. Rapid and aggressive treatment along with identifying any underlying causes are paramount to successful management and are cornerstones of ED management. This podcast will discuss strategies for the management of status epilepticus and pitfalls in the care of these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ellen Revak presentation from the 2020 Midyear Clinical Meeting explores managing pharmacist burn out during by describing experiences as her institution, include what went wrong early on, what environmental factors contributed, lessons learned during the process, and key takeaways to consider.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the recent activity on the advancement of pharmacist recognition on the state and federal levels. Kasey Thompson and Tom Kraus discuss how the environment has changed on this issue and where pharmacist recognition is being advanced.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today's episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Indu Lew, Karen Lin, and Nancy T. Yam share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals.
This podcast is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The rising demand for telehealth services significantly increased during the COVID-19 pandemic by providing safer access to and delivery of care for both patients and providers. Even after the pandemic, it is anticipated there will be ongoing demand for the use of telehealth as a major means of healthcare delivery. This podcast explores ASHP offerings which advance practice and optimize medication outcomes through the use of telehealth.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of ASHP’s popular podcast with pharmacy leadership, host Paul Abramowitz, ASHP CEO, discusses the important roles pharmacy professionals play in healthcare policymaking with ASHP President Tom Johnson and Kathy Pawlicki, ASHP immediate past president. The ASHP leaders talk about the tremendous impact pharmacy practitioners have made over the last year on the development of healthcare policy and the various ways practitioners can contribute to public health policymaking.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As the COVID-19 pandemic continues to impact the way hospitals and health-systems approach daily activities, many institutions are looking to move pharmacy order verification responsibilities to remote locations. Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire built and managed a remote pharmacy team prior to the pandemic and has been able to leverage this experience to maintain their pharmacy operations during these challenging times.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Guest editors Joseph Cesarz and Scott Canfield discuss the recently published AJHP Theme issue on Specialty Pharmacy and cover topics ranging from the necessity to publish a second Specialty Pharmacy theme issue to the existing challenges and future opportunities within Specialty Pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode features tips for pharmacy technicians focused on how listeners can prepare themselves for advancement in their careers. In this podcast, we discuss how to express interest to a manager, career development paths, skills enhancement and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Paul Walker, Vickie Powell, Jeffrey Clark, and Yvette Morrison will discuss the Report on the ASHP Task Force on Racial Diversity, Equity, and Inclusion with host and AJHP Editor in Chief Daniel Cobaugh. They will focus on the genesis of the Task Force and the Report’s recommendations, particularly as they relate to pharmacy leadership and students and schools and colleges of pharmacy, and the effect these recommendations will have on patient care overall.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will help students, residents, and pharmacists better understand strategies to best utilize their time in order to prepare for interviews. Pharmacists will share their strategies on what worked best for them to help guide you through the interview process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This two-part podcast series will provide listeners with a review of updates to the diabetes treatment guidelines. Speakers will provide an overview of guideline updates, evaluate treatment options, and discuss methods of addressing issues related to affordability and access to medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The focus of the podcast will be a description of clinical pharmacy services integration and transition into a telehealth environment, specifically, a multidisciplinary hepatitis clinic at an academic medical center during COVID-19. Speakers will also address integration of students, residents, and fellows into a telehealth model.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a conversation with the research grant teams from the ASHP Foundation New Practitioner Pharmacists Leadership Grant. Their topic of research is Evaluation of Burnout Among Pharmacy Residents in the United States. Learn about burnout versus exhaustion, and what the researchers uncovered in their study of residents across the United States.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Careers in ambulatory care pharmacy practice have shifted from solely focusing on direct patient care to management of interprofessional teams, advocacy, and educating learners. In this Practice Journeys episode, we hear from Danny Fu – Manager, Ambulatory Care Pharmacy at Atrium Health and learn more about his career path, involvement with ASHP, and vision for the future of ambulatory care pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The focus on this podcast will be on providing updates on the available COVID-19 Vaccines with EUA, with particular emphasis on the most recent one to be approved: Johnson & Johnson’s Janssen vaccine. This podcast will cover information related to storage requirements, preparation and administration instructions, and efficacy and safety data. This podcast will compare and contrast the three available vaccines (Pfizer, Moderna, and J&J) to summarize their similarities and differences. Finally, this podcast will include brief information regarding anticipated EUA updates such as new age approvals for the Pfizer vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will cover basic definitions of emotional intelligence and its importance in a role of pharmacy leadership. The speakers will reflect on their own experiences building emotional intelligence while developing relationships with colleagues as new practitioners and how it helps augment successful crucial conversations. Lastly, the speakers will provide practical advice and resources for new practitioners to learn more about this topic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Through a series of podcasts, members of the Section of Specialty Pharmacy Practitioners discuss the state of specialty pharmacy during the COVID-19 pandemic and how practice continues to adapt and evolve. During this podcast, speakers highlight strategies to engage team members and assess employee satisfaction and wellness as new staffing models emerge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
While COVID-19 has impacted patient insurance statuses and ability to pay for high-cost medications, rural patients have encountered this barrier for years. During this podcast a primary care physician and clinical pharmacist will discuss the impact of patient assistance programs in allowing all patients access to guideline recommended therapies, as well as how to implement this service into your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the reintroduction of provider status legislation by Congress. Tom Kraus and Doug Huynh discuss what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In Part Two of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coagulopathy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Acute elevations in intracranial pressure from brain injury or illness can be life-threatening or lead to significant morbidity. Rapid identification and lowering of the intracranial pressure with directed therapy in the form of hyperosmolar therapy while awaiting definitive management of the underlying cause is essential in many cases. This podcast will discuss the selection between mannitol and hypertonic saline, logistics of storage and administration in the emergency department, goals of therapy, and monitoring parameters.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
For this special Mother’s Day episode, we are highlighting the unique relationship between mothers and daughters who also happen to both be pharmacists. They share experiences and how pharmacy has influenced and bonded them together in a unique way.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The listeners will learn about two current auto verification projects at two different academic health systems. The speakers will provide recommendations on the successful implementation of auto verification along with addressing challenges with implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The management of patients with major/life-threatening bleeding related to the use of direct-acting oral anticoagulants does not stop with reversal of the anticoagulant. Learn from the perspective of a neurocritical care pharmacy specialist about considerations in providing comprehensive care and continued assessment to patients after these bleeding events.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A discussion with two front line leaders who will draw on their own experiences and knowledge as to how to effectively delegate as a leader. This podcast will cover three different scenarios a leader will encounter: delegating to a direct report, delegating to a boss or delegating up, and delegating to peers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of the Pharmacy Leaders series podcast, host, Bruce Scott MS, FASHP, along with Katherine Miller, Pharm.D., MBA, DPLA, FASHP, and Brandy Snyder, Pharm.D., BCOP, MBA, DPLA discusses how to make the most of your leadership journey. This podcast will explore high performing teams and leadership development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As a part STI Awareness month, our content matter experts sit down to discuss recent changes in the CDC treatment guidelines and discuss the impact these have on patients and the role the pharmacist can play in implementing these new changes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidity and mortality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
There is a gap between supply and demand for available organ transplants, resulting in a substantial impact on public health. Listen as transplant pharmacists discuss April’s National Donate Life Month and how pharmacists and pharmacy students have a fundamental role in promoting organ donation awareness.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management and how to address the barriers of ICU patient care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, discusses finding mentors to help you grow, learn and develop as a leader and putting those leadership traits into practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
During this podcast, speakers describe post-operative nausea and vomiting (PONV) risk stratification and synthesize the latest PONV guidelines to guide appropriate medications and non-pharmacologic therapies. They also explore the consequences of PONV and its effects on both the patient and the healthcare system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
This podcast provides members an overview of the impact of a recent federal court decision on PGY-1 residency program disallowances. We’ll cover what the ruling means for programs under audit and what comes next with CMS advocacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Both CCM and RPM are attractive opportunities for pharmacists to improve patient centered outcomes in collaboration with supervising providers. Physician Fee Schedule (PFS) changes and the ongoing Public Health Emergency (PHE) present both opportunities and barriers for growth and implementation. The purpose of this Podcast is to highlight examples of how pharmacists have navigated these changes and implementation stages so far.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying an unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
In this interprofessional conversation, expert faculty discuss evidence supporting quantitative neuromuscular monitoring (NMM) versus qualitative NMM, which quantitative monitors are available in the U.S., and evidence/guidelines supporting monitoring preferences. NMM and complete neuromuscular blockade (NMB) reversal in patients at high risk for residual NMB (rNMB), including elderly and obese patients, will also be discussed.
To learn more about neuromuscular blockade and reversal visit www.ashpadvantage.com/nmbreversal/.
This podcast is provided by ASHP and supported by Merck.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
This podcast will explore considerations for preceptors, experiential sites, and pharmacy students for IPPE and APPE learning experiences during the COVID-19 pandemic. Speakers will review strategies to ensure consistent learning opportunities and also discuss methods that were implemented in the event a learner or preceptor tested positive for coronavirus.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, along with Kimberly Boler BS, CPhT, CSPT, DPLA, and Sam Calabrese MBA, FASHP discusses the role of pharmacy technicians as leaders. This podcast explores whether leaders are born or made and the non-negotiable qualities of a successful leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
Harm reduction is a public health strategy designed to reduce the adverse consequences associated with drug and alcohol use. The goal for providers is to work with individuals to minimize the harmful effects of drug use and to promote safer use in a compassionate, non-judgmental manner.Dr. Courtenay Wilson will discuss evidence-based strategies to reduce harm for individuals that abuse drugs and alcohol.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Interdisciplinary rounding teams are a common occurrence within health-systems. In this podcast, listeners will hear from a medical resident and a medical student about their experiences on working on an interdisciplinary team and discuss their appreciation for the pharmacy team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The COVID-19 pandemic has required pharmacist preceptors to rethink how to deliver APPE and resident rotations within our health systems. This podcast will explain a successful model implemented within an ambulatory care setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will focus on leading through rapid change as a result of Covid-19. The main topics include change within various pharmacy services, including hospital closures, mergers and acquisitions, restructuring pharmacist responsibilities and modification or elimination of current pharmacy services. In addition to discussing changes, this podcast will discuss lessons learned, opportunities that arose and efforts to reactivate services that were discontinued.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management affected by drug shortages and discuss patient-specific challenges associated with medication shortages for COVID-19 patients requiring mechanical ventilation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the increased use of direct-activity oral anticoagulants (DOACs) over the last decade, it is inevitable that emergency departments are seeing more patients with DOAC-related bleeding. Get an inside look at pharmacists’ strategies for optimizing reversal of DOAC-related bleeding in various ED settings.
To learn more about this initiative, visit www.ashpadvantage.com/stopdoacbleed
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Janet Mighty, Dawn Moore, and Christy Norman will share their insights on their professional journeys as pharmacists, association leaders, and African-American women.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, Elyse Macdonald shares her experiences and best practices for combining remote work and patient care and how to continually engage staff during the transition from and back to working in person.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The goal of the human microbiome project is to better understand the microbial components of our bodies and how this interface between micro-organisms and humans contribute to normal physiology and disease predisposition. In this podcast, we will explore a classic microbiome disruption disease, namely C difficile infection. Looking at C diff infection through the lens of the microbiome, we will explore the pathophysiology, treatment, and future of this important and devastating infectious disease.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The human microbiome is arguably one of the most ambitious scientific projects conducted by mankind of all time. The goal is to better understand the microbial components of our bodies and how this interface between micro-organisms and humans contribute to normal physiology and disease predisposition. The goal of this podcast will be an informative discussion on the interactions between bugs and bodies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Janet Mighty, Dawn Moore, and Christy Norman will share their insights on their professional journeys as pharmacists, association leaders, and African-American women.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast highlights the essentials from the 2020 Midyear Clinical Meeting presentation and will help pharmacists develop strategies to overcome common barriers seen with immunization program, recommend adaptable pharmacy workflows for inpatient and outpatient pharmacy systems to increase immunization rates and assess pharmacy practice implications of current COVID-19 vaccine developments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode, we will review the ISMP Best Practice #8 recommendations for Smart Pump Use and describe the process used at one health system to implement these recommendations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of ASHP’s popular podcast with pharmacy leadership, host Paul Abramowitz, ASHP CEO, discusses the ASHP Section of Pharmacy Educators with ASHP President Tom Johnson and Marie Chisholm-Burns, Chair of the Section. The ASHP leaders talk about the formation of the section, the section’s goals, and what they hope to accomplish.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Maria Carias, Kisha Gant, Thuy McKitrick, and Kyana Stewart as they discuss the importance of advocating for yourself in both personal and professional settings. They share personal experiences, observations, and tips gathered along the way.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We chat with Australian pharmacists Drs. Kaitlyn Watson and Libby Mc Court about their interesting research and backgrounds as Disaster Specialists as well as their participation in the newly released ASHP Crisis and Pandemic Management Certificate.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The importance of advancing the role of a pharmacy technician cannot be understated. Advantages to establishing a pharmacy technician career track include skills growth, allowing employees to be in the job they want and aligning technician job descriptions and expectations. In this featurette from the Midyear Clinical Meeting. In this episode, listeners will be able describe components of career ladders used by organizations for climbing to the next rung and learn about successful implementation of a technician ladder within a health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series takes a deeper dive into the Match process, focusing on preparing for Phase I, next steps post-Match, and approaching Phase II and beyond. We’ll talk about strategies and advice to help you through your Match process. In this final episode, we discuss strategies for navigating and thriving in Phase 2 and the “Scramble."
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This presentation from the 2020 Midyear Clinical Meeting shares how to apply best practices in maintaining the integrity of temperature-sensitive vaccines during transport, distribution, and administration, strategies on how to operationalize COVID-19 vaccine distribution, allocation, and administration decisions as well as how to develop a plan for engaging stakeholders across the care continuum for COVID-19 vaccine distribution, allocation, and administration decisions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series takes a deeper dive into the Match process, focusing on preparing for Phase I, next steps post-Match, and approaching Phase II and beyond. We’ll talk about strategies and advice to help you through your Match process. In the second episode, we discussed important steps that newly-matched residents should take to set themselves up for a successful transition into their residency positions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Preview this BCPPS recertification offering from the Midyear Clinical Meeting. This episode will expand the pharmacist’s knowledge, assessment, and application of modifications to the routine immunization schedule for pediatric patient including accelerated immunization schedules designed to expedite immunization or to get those who have fallen behind back on track. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Visit (insert link here) to purchase the recertification product.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Preview this BCCCP, BCPPS, and BCPS recertification offering from the Midyear Clinical Meeting. This episode highlights and discusses the statistical guidelines published on p-values and statistical reporting and their impact on the publishing and interpretation of medical and scientific literature. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Visit (insert link here) to purchase the recertification product.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast allows members to listen to ASHP’s Vice President of Government Relations and Director of Legislative Affairs on the strategy for 2021 on pushing ASHP’s federal priorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Several clinical algorithms use race as an input, with varying degrees of impact on access to care. This podcast episode serves to raise awareness about this issue, explain some practical considerations pharmacists can implement when using clinical algorithms, and provide additional resources for listeners who want to learn more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session from the 2020 Midyear Clinical Meeting will describe the significant challenges and other issues related to the pharmaceutical supply chain and the distribution of pharmaceuticals during the COVID -19 pandemic as well as the opportunities and tools for pharmacists to utilize that have helped pharmacists adapt their clinical practice in providing care to their patients via telehealth.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This session from the 2020 Midyear Clinical Meeting will describe the significant challenges and other issues related to the pharmaceutical supply chain and the distribution of pharmaceuticals during the COVID -19 pandemic as well as the opportunities and tools for pharmacists to utilize that have helped pharmacists adapt their clinical practice in providing care to their patients via telehealth.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Jade Bryant, Michelle Carrasquillo and Jennifer Tryon as they discuss the importance of self-awareness, self-reflection, and building your executive presence. They share personal experiences, observations, and tips gathered along the way.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss how Student Societies of Health-System Pharmacists (SSHP) leaders have successfully executed PAI week at their college or school of pharmacy. A panel of members from different student societies around the nation share their insights to help every SSHP plan the best PAI week yet.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, we chat with Jessica Skelley, Pharm.D., BCACP, Associate Professor at Samford University McWhorter School of Pharmacy about ways to define learner roles within the interprofessional learning environment and ensure that pharmacy students and residents are afforded learning opportunities to maximize their growth and role within the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This three-part podcast series will take a deeper dive into the Match process, focusing on preparing for Phase I, next steps post-Match, and approaching Phase II and beyond. We’ll talk about strategies and advice to help you through your Match process. In the first episode “Ready, Set, Match!”, we’re talking about what you need to know about the Match and how to prepare for it.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Through a series of podcasts, members of the Section of Specialty Pharmacy Practitioners discuss the state of specialty pharmacy during the COVID-19 pandemic and how specialty pharmacy practice has changed. During this podcast, speakers discuss student and resident education during and beyond the COVID-19 pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The American College of Healthcare Executives announces the prestigious James A. Hamilton Book of the Year Award annually to an impactful and highly regarded book about management or healthcare. The 2021 winner is “Taking action against clinician burnout: A systems approach to professional well-being.” This publication was released by the National Academies of Sciences, Engineering, and Medicine after completion of an 11-month consensus study examining scientific evidence regarding the causes of clinician burnout, the consequences of burnout for clinicians and patients, and interventions to support clinician well-being and resilience. Our guest for this podcast served on the consensus study and will share important insights from the report and the implications for the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast provides an update on the 340B litigation to which ASHP is a party. Tom and Paula break down the rulings and explain where we go from here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Janet Carmichael, Joseph DiPiro, and Rita Shane will discuss the 2021 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Daniel Cobaugh. They will focus on the Report’s findings and recommendations related to big data, patient safety, and health disparities as well as its relationship to the Vizient High Value Pharmacy Enterprise Framework and its role in strategic planning for pharmacy departments.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will describe how you can evaluate which activities to pursue and thoughtfully determine which ones will help you achieve sustainable success. It also explores how to approach systematically evaluating an opportunity to optimize efficiency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast episode traces the unique professional journey of Jasper (Jay) Watkins, III. A retired Lieutenant Colonel in the U.S. Army, Watkins recently took office as a member of the Gwinnett County, Georgia Commission. Listeners will hear highlights from Watkins’ more than two decades in pharmacy practice, his motivation for transitioning to a different aspect of public service, and the ways he thinks pharmacy will influence his time in office.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the nuances of rate and rhythm control in atrial fibrillation. The Early Rhythm Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4) Trial that was published in October 2020 will also be discussed. For today’s debate, Danielle will promote rhythm control while Riley argues that rate control remains the strategy of choice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast reviews the newly revised ASHP Guidelines on Emergency Medicine Pharmacist Services. Originally released in 2011, a group of emergency medicine clinical pharmacy specialist content experts conducted a literature search for updated supporting evidence and updated the recommendations to establish reasonable goals on attainable best practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this presentation from the 2020 Midyear Clinical Meeting, content matter experts describe clinical trial designs for COVID-19 vaccine candidates, identify important documentation requirements and safety surveillance measures and actions, outline opportunities to address vaccine hesitancy, calculate the number needed to vaccinate to stop widespread community transmission of SARS CoV-2 and discuss clinical implications related to COVID-19 vaccine(s) made available through Emergency Use Authorization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
MCM COVID-19 Presentation: Roadmap to a COVID-19 Vaccine: Clinical Considerations for Ensuring Safety and Efficacy Part 1Vaccine Clinical Trial Design and Vaccine Development During a Pandemic
In this presentation from the 2020 Midyear Clinical Meeting, content matter experts describe clinical trial designs for COVID-19 vaccine candidates, identify important documentation requirements and safety surveillance measures and actions, outline opportunities to address vaccine hesitancy, calculate the number needed to vaccinate to stop widespread community transmission of SARS CoV-2 and discuss clinical implications related to COVID-19 vaccine(s) made available through Emergency Use Authorization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In today's episode, we take listeners on a deeper dive of specific details of FDA Emergency Use Authorizations: what they are, what they are not, how they are determined, specific nuances that they may subsequently enact, and how they are determined for approval. The topic is intended to be general around EUA’s, but COVID-19 specific examples are highlighted as well as those that have brought public attention to the EUA process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This two-part podcast series provides listeners with a review of updates to the diabetes treatment guidelines. Speakers share an overview of guideline updates, evaluate treatment options, and discuss methods of addressing issues related to affordability and access to medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this interprofessional conversation, expert faculty discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal strategies during the intraoperative phase of care and neuromuscular monitoring. Patient risk factors and mitigation of post-operative complications will also be discussed.
To learn more about neuromuscular blockade and reversal visit www.ashpadvantage.com/nmbreversal/
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
February 7-14 is the Congenital Heart Defects (CHD) Awareness Week. Join members of ASHP’s Pediatric Section Advisory Group as they discuss CHD, the care of children and adults with CHD, the role of pharmacists in the care of patients with CHD, and general clinical pearls for caring for these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Front-line informatics pharmacists and health-system IT leaders share COVID-19 Emergency Use Authorization treatments and vaccines informatics pearls. Topics discussed will include standard IT and operational procedures for EUAs, EHR and infusion pump builds, compliance and documentation, and their tips on preparing for the next wave of EUAs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this ASHP podcast, student members discuss ASHP’s Experiential Education program and dive into the ins and outs of an APPE rotation in association management. ASHP Pharmacy Student Forum Advisory Group members Rachael Crusius and Zach Krauss, engage with past ASHP externs about their virtual or in-person experiences and talk about how this rotation helped them to grow both professionally and personally in their pharmacy journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The COVID-19 pandemic has caused changes in all practice settings of healthcare. The ambulatory setting has experienced some of the largest practice changes and advances. In this episode, we will explore how two ambulatory pharmacy leaders have navigated practice changes during this pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will describe important considerations for health systems of varying size regarding the handling and distribution process of the COVID-19 vaccine. The listeners of this podcast, organized by the Section of Pharmacy Practice Leaders Advisory Group on Strategy & Industry Disruptors, will hear from three different health systems on their lessons learned regarding the allocation of the COVID19 vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Vicki Basalyga, ASHP Director of Clinical Specialists and Scientists, chats with team members from AMA and ASHP about the upcoming six-week summit and the combined efforts by both organizations to advance pharmacogenomics in the healthcare field.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listen in as content matter experts share “pearls” of wisdom in this fast-paced, fun format. This session features practitioners in Emergency Medicine and is brought to you by the Section of Clinical Specialists and Scientists Advisory Group on Emergency Medicine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode will provide members a quick refresher on payer mandated alternative distribution models, commonly known as brown bagging and white bagging. We will review potential risks and benefits inherent to alternative distribution models and explain key factors motivating payers and manufacturers to adopt these methods. Finally, we will focus on certain situations where payer mandated policies can negatively affect patient care and what can be done to avoid such scenarios.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Specialty Pharmacy State of Practice in Hospitals and Health Systems – Future Directions Summit will bring together key stakeholders to discuss how to advance health-system specialty pharmacy practice to optimize patient health outcomes. The interprofessional summit will feature focused discussions and recommendations on key areas in specialty pharmacy. Speakers will share an outline of the summit and the anticipated outcomes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the first episode of “season two” of ASHP’s popular podcast with pharmacy leadership, host Paul Abramowitz, ASHP CEO, discusses the preliminary recommendations from the ASHP Task Force on Racial Diversity, Equity, and Inclusion with ASHP President Tom Johnson and Paul Walker, Chair of the Task Force. The ASHP leaders talk about the need to address the range of current and historical issues facing Black Americans, and to assess issues of intolerance and inequity that impact other minority groups represented within the organization’s membership and the overall profession of pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In today's episode, the NYCSHP share their story & lessons learned in their wellbeing and resilience journey. Our speakers discuss how they have engaged their peers and chapter members in the prevention of burnout and building resilience during the pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This Midyear Clinical Meeting session led by Erin Fox and Jeff Little teaches how the listener how to compare legislative and regulatory advocacy issues at the state and nation level and recommend appropriate advocacy strategies for current patient care issues.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Through a series of podcasts, we will discuss the current state of Specialty Pharmacy during the COVID-19 pandemic and how specialty pharmacy practice has changed. During this podcast, we will discuss on-site and remote staffing models, rotating staff, and other staffing considerations during and beyond the pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In June 2020, a new consensus guideline was published in the American Journal of Health-System Pharmacy that changed therapeutic drug monitoring recommendations for vancomycin from troughs to AUC. This change has created significant controversy across the nation. Today, we are hoping to settle some of these controversies.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Listen in as content matter experts share “pearls” of wisdom in this fast-paced, fun format. This session features practitioners in Informatics and is brought to you by the Section of Pharmacy Informatics and Technology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Chaffee and Dr. Tharp discuss with William Zellmer, Contributing Editor for AJHP, the creation and work of a pharmacy compounding compliance team. The article under discussion appears in the June 1, 2020, issue of AJHP.
Recorded April 11, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
https://www.ashp.org/ajhp-voices
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Pamela Schweitzer discusses with William Zellmer, Contributing Editor for AJHP, opportunities for expanded Medicaid coverage of pharmacist services and the challenges in obtaining that coverage. The article under discussion will appear in the March 1, 2021, issue of AJHP.
Recorded October 27, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
Dr. Stephen F. Eckel and Dr. Tyler A. Vest discuss with William Zellmer, Contributing Editor for AJHP, the importance of keeping up with practice-enhancing publications about the medication-use process. The article under discussion will appear in the January 15, 2021, issue of AJHP.
Recorded October 14, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
A meaningful organizational commitment to workforce well-being and resilience from leaders in healthcare organizations and departments is critical to mitigating burnout. As our country experiences extraordinary surges with COVID-19, it is more important than ever to bolster the resilience of our nation’s healthcare workforce and systems. Join us for this podcast that will outline action steps that leaders can take to “fix the workplace” and not just “fix the worker.”
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast episode, Dr. Bryan Hayes, Director for the PGY-2 Emergency Medicine Pharmacy Residency Program at Massachusetts General Hospital discusses his recent publication “Improving Burnout Through Reducing Administrative Burden: a Pilot of Pharmacy-Driven Medication Histories on a Hospital Medicine Service” and reviews ways that student and resident learners can be utilized as pharmacy extenders of care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacy professionals have a transferable skill set that can be applied in a variety of settings. From health-systems to the community to research and education, pharmacists and pharmacy technicians are assets to the healthcare team and patient care delivery no matter the discipline.
In this episode, we speak with Ishmael Qawiy, Pharm.D. MBA, BCACP about his career journey and his experience transitioning from patient care delivery to working on global health projects in the non-profit sector.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast explores the ASHP Executive Fellowship in Association Leadership and Management, a paid 12-month postgraduate program at ASHP headquarters in Bethesda, Maryland. In this postgraduate program, fellows are immersed in all aspects of not-for-profit management, while developing their leadership and communication skills, problem-solving techniques, and professional growth. Hear from current and recent graduates of the program about how the mentorship from ASHP Senior Leadership and a variety of experiences in association management through this fellowship provided them an invaluable career opportunity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physici
Today's episode provides members with an update on the U.S. Supreme Court’s decision in Rutledge v. PCMA. We cover what the Court’s ruling against PBMs means for pharmacy practice, and we talk with Rep. Buddy Carter about where PBM regulation goes from here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
With the combination of the 2020 influenza season and the COVID-19 pandemic, both patients and pharmacy professionals need to be vigilant about protecting themselves. In this podcast, Drs. Martin Bishop and Lauren Cimino discuss the important role ambulatory care pharmacists will play during the unprecedented 2020 influenza season.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Joel Hennenfent, Pharm.D., M.B.A., BCPS, FASHP, sits down with Ali McBride, Pharm.D., M.S., BCPS, to discuss biosimilar formulary implementation/integration and reimbursement challenges.
To learn more about Formulary Management Strategies visit www.formularytoolkit.org
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
At the intersection of two substantial public health challenges, practitioners are faced with reducing suffering from pain while also minimizing harm associated with high-risk analgesics. Dr. Michele Matthews reviews the role of buprenorphine in acute and chronic pain management, the pharmacodynamics of buprenorphine, and clinical pearls for its use in practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Droperidol has come back to the market after several years of being unavailable. Today's episode will discuss its potential place in practice, along with practical considerations, such as dosing and monitoring.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Healthcare has been required to update the interface standard for e-prescribing by CMS on 1/1/2020, but what does it actually mean or change? The purpose of this podcast is to answer that question.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode is a recording of the Mindfulness and Meditation for Pharmacists and Pharmacy Technicians webinar from ASHP eLearning (no CE for podcast)
Activity Date: 10/2/2019
ASHP has been committed to supporting the well-being and resilience of the pharmacy workforce for decades. We have been even more focused on supporting members the last few years given recent evidence and impact of burnout on patient safety and the healthcare workforce. During COVID-19, demands and stress on the pharmacy workforce have increased to an even greater extent. Prior to the upcoming virtual Midyear Clinical Meeting, we offer you an opportunity to pause & participate in a guided heart rhythm meditation led by ASHP member, Lisa Wilhelm.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Midyear Clinical Meeting has gone virtual! Are you a student or resident preparing for the virtual showcase or PPS? Find out tips and tricks for navigating the virtual showcase, PPS, and virtual poster presentations. The podcast will feature a sneak-peek into ASHP's recent webinar ASHP Midyear Clinical Meeting Goes Virtual - Tips and Tricks for Navigating the Virtual Showcases.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In today's episode, we provide members with a breakdown of what the election results mean for pharmacy practice. We discuss key Congressional committees, agency leadership, and what it all means for ASHP advocacy priorities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today's episode explores considerations worth taking into account when deciding to implement a medical surveillance program as recommended by the USP Chapter Standard.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
White bagging is a major patient safety issue driven by payers within hospitals today. Candy Tsourounis, Pharm.D., FCSHP sits down with Joel Hennenfent, Pharm.D., MBA, BCPS, FASHP to discuss those safety issues and best practices on how to prevent white bagging to keep our patients safe.
To learn more about Formulary Management Strategies visit www.formularytoolkit.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum Resident Advancement Advisory Group as they share tips and tricks for Midyear participants to enhance their virtual experience. These ASHP volunteer leaders offer advice on how to prepare for the virtual Midyear Meeting, along with do and don’ts for virtual experiences and interviews.
Other resources to promote on web posting:
- Tips for a Successful Virtual Interview / MCM Checklist
- ASHP Midyear Clinical Meeting Goes Virtual - Tips and Tricks for Navigating the Virtual Showcases - 11/16/2020
- Student Perspectives - Etiquette Tips for Virtual Interviews and Networking During Residency Season
- ASHP Intersections - Tips for Students: Getting the Most Out of the 2020 Midyear Meeting
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join the Section of Pharmacy Practice Leaders Frontline Leaders Advisory Group as they discuss COVID-19 vaccine administration, allocation, and uptake by patients and health care workers. Five of the group’s members discuss:
Identifying healthcare workers and high-risk patients that should receive the vaccine first and track vaccine-related data
Working with your state in setting up health systems as a vaccine administration site(s)
- Vaccine storage requirements and how many locations will store the vaccine
- Addressing the issue of determining mandatory vaccination of healthcare workers and how institutions plan administration of employees
- Operationalizing your vaccination process to patients
- Educating medical staff and other disciplines on clinical information about the vaccine
- How to dispel myths and ensure that truthful information is shared with employees or patients
- Pharmacy involvement in the preparation, distribution and administration of the vaccine
- Moderator: Bill Kernan, PharmD. MBA., FASHP, Executive Director of Pharmacy, Cleveland Clinic Florida
- Speaker: Nathan Ash, PharmD. MBA, BCPS, VP, Acute Care Pharmacy, Bon Secours Mercy Health
- Speaker: Lyndsey Clark, PharmD., MBA, DPLA, Pharmacy Manager, Transitions of Care and Emergency Services, Michigan Medicine
- Speaker: Ryan Naseman, PharmD. MS., BCPS, Senior Director of Pharmacy, University of Kentucky Healthcare
- Speaker: Jennifer Noped; PharmD., MBA, MHSA, BCPS, Pharmacy Manager - Medication Strategy Center, Wake Forest Baptist Health
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The year 2020 has proven to be a year like no other. From a global pandemic to concerns surrounding social injustice, we have been forced to slow down and conduct a self-assessment on how best to take care of ourselves, our families, and our patients. In this episode, we speak with Carleton B. Maxwell Pharm.D., BCPS, DPLA, FNPhA about his career journey, balancing personal and professional life during this time of change, and his vision for the future of pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Much of the world has turned to virtual communication over the last 9 months. This includes quality and regulatory agencies as well. This podcast will highlight the journey of 2 specialty pharmacies who underwent a virtual URAC accreditation, touch on lessons learned, and provide recommendations for other members.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Host Sara White, MS, FASHP, discusses the latest addition to ASHP’s Letters family of books, Letters from Leaders in Pharmacy: Advice from Pharmacy Leadership Academy Graduates, Faculty, and Mentors, with co-editors, Susan Teil Boyer MS, RPh, FASHP, and Bruce Scott MS, FASHP. In this podcast, the editors discuss how they brought together a group of seasoned and up-and-coming leaders to share their career journeys and lessons learned along the way. The editors also share advice from their own leadership journeys.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tune in to ASHP's new innovation podcast series to learn more about new and emerging sciences and the vital roles that hospitals and health-system pharmacy practitioners play in influencing innovations in pharmacy. The inaugural episode, A Closer Look into the ASHP Innovation Center, features insights from ASHP Chief Operating Officer and Senior Vice President Kasey Thompson, Sophia Chhay, assistant director of the ASHP Innovation Center, and Vicki Basalyga, director of ASHP's Section of Clinical Specialists and Scientists, who discuss the genesis of the ASHP Innovation Center, focus areas and goals, and how you can get involved.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Difficult conversations, building your team, optimizing patient care and outcomes – what is the essential ingredient? Effective Communication. Learn strategies to elevate your skills in any situation – including remote interactions during a pandemic!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of Veterans Day, ASHP Official is highlighting four pharmacist members who volunteered to join the military in service to our nation. In this episode, we speak with Peter Wills, Kaye Dunham, Norman Hooten, and David Price about their inspiring stories and the remarkable journeys they embarked on to become a pharmacist that all began with their decision to enter the military.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Standardize 4 Safety is the first national, inter-professional effort to standardize medication concentrations to reduce medication errors, especially during transitions of care. It establishes standard concentrations for intravenous (IV) and oral liquid medications for patients of all ages in settings ranging from hospital to home. Hospitals and health systems are encouraged to adopt these standard concentration lists—developed by panels of health care experts—to improve patient safety and decrease medication errors. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
You are ready to go live with USP —your Hazardous Drug List is complete, your Assessments of Risks are finalized, everyone has agreed on how you will handle these drugs and the PPE that will be worn, and policies have been updated. Your workgroup is ready to discuss how you will communicate to your healthcare team that this medication is hazardous and requires special handling precautions. There are several opportunities for communication to consider: auxiliary labels, transport bags, EHR comments, automated dispensing cabinet alerts, storage containers (including carousels and refrigerators), signs, and other drug information resources. The following list describes different discussions to have with your Information Technology (IT) team and work group on how to communicate that medication is hazardous.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this ASHP podcast, Fellowship Program Leaders from across the nation, discuss how their pharmacy fellowship recruitment models will adapt during the COVID-19 pandemic. Find out what fellowship interviews could look like for you, and hear valuable tips and strategies to succeed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will provide members a quick refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as trace and trace. Get up-to-date on upcoming pharmacy requirements, as well as the latest on FDA enforcement delays.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode is a recording of the ASHP COVID-19 Series (No CE) (Webinar)
Activity Date: 10/14/2020
ASHP has been committed to supporting the well-being and resilience of the pharmacy workforce for decades. We have been even more focused on supporting members the last few years given recent evidence and impact of burnout on patient safety and the healthcare workforce. During COVID-19, demands and stress on the pharmacy workforce have increased to an even greater extent. ASHP is planning several webinars that will give listeners tools and resources to cope during this time.
Clinical practice during crisis can be both challenging and rewarding. We have changed the way we work, learn, and live. We must be mindful of how we lead, connect to others, and care for ourselves. Here we will talk about tools needed for clinician and team resilience during challenging times.
Presenters Lead Presenter:
- LCDR Tarah B. Lewis, DNP, BSN, Assistant Professor, Psychiatric/Mental Health Nurse Practitioner Program, Uniformed Services University (USU), Bethesda, MD
Other Presenters:
- LTC JoEllen Schimmels, DNP, RN, PMHNP-BC, CNE, FAAN, Assistant Professor, Psychiatric/Mental Health, Nurse Practitioner Program, Uniformed Services University (USU), Bethesda, MD
- LTC Regina Owen, DNP, PMHNP-BC, Assistant Professor, Psychiatric/Mental Health Nurse Practitioner Program, Uniformed Services University (USU), Bethesda, MD
Moderators
The webinar will be moderated by ASHP staff members: Christina Martin, Pharm.D., M.S., CAE, Director, New Practitioners Forum and Anna Legreid Dopp, Pharm.D., Senior Director, Clinical Guidelines and Quality Improvement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Joel Hennenfent, Pharm.D., M.B.A., BCPS, FASHP, Chief Pharmacy Officer & Associate Administrator for Laboratory and Medical Imaging, sits down with Karl Gumpper, MSMI, RPh, BCPS, CPHIMS, FASHP, Pharmacy Informatics Manager at Boston Children’s Hospital, to discuss aspects of integrating biosimilars into pharmacy IT systems, a challenge that every hospital is working through.
To learn more about Formulary Management Strategies visit www.formularytoolkit.org
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In preparation for the ASHP Virtual Midyear Clinical Meeting, this episode of Research in Pharmacy podcast provides advice for presenting a professional poster in a virtual environment. As a student pharmacist or resident member, find out how you can best prepare to showcase your research work. Following the podcast, check out a number of ASHP resources to help you prepare:
- ASHP Research Resource Center
- ASHP Pharmacy Research Page for Students and New Practitioners
- ASHP Webinars:
- Development of a Professional Poster Presentation
- Essentials of Practice-Based Research for Pharmacists
- ASHP Publications:
- The Essential Guide to Pharmacy Residency Research
- Tips for a successful poster presentation& accompanying infographic
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Technologies, such as continuous glucose monitoring, smart pens, and apps, increasingly are used in the management of type 2 diabetes. Listen as diabetes experts discuss how their patients are using these technologies to meet the tandem goals of achieving glucose control and minimizing hypoglycemia.
To learn more about strategies for improving the insulin initiation experience and overcoming barriers to insulin therapy, visit www.ashpadvantage.com/startinsulin.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
A discussion with two front line leaders who have recently gone through a significant change in their respective workplace environments. Dr. Stump will discuss unplanned anticoagulation clinic changes as a result of the Covid-19 pandemic and Dr. Chambers will discuss a planned construction move. The integration of a few different change management theories will be used to explain how these leaders effectively led change in their institutions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Research is an integral part of a pharmacist’s professional development. Listen in as ASHP’s Gina Luchen and ASHP Foundation’s Barbara Nussbaum share resources, training and grant opportunities offered by ASHP and ASHP Foundation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this ASHP podcast, Residency Program Directors and pharmacy educators from across the nation, discuss key etiquette strategies during virtual interviews and networking. Find out how you can stand out and achieve your professional goals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this ASHP podcast, Residency Program Directors and Preceptors from across the nation discuss how their pharmacy resident recruitment models will adapt during the COVID-19 pandemic. Find out what residency interviews could look like for you, and hear valuable tips and strategies to succeed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
North Dakota was one of the 5 jurisdictions selected to do a pilot for COVID-19 vaccine planning. We chat with contacts from North Dakota who were at the table for those planning discussions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
: Elizabeth Pogge, Professor at Midwestern University and Gina Luchen, ASHP’s Director of Academic Programs discuss the importance of creating precepting habits that stick. Dr. Pogge addresses common preceptor challenges and pearls in preparation for ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
What do innovation, 3-D printers and an old federal reserve bank vault in Philadelphia have to do with Pharmacy? Join Vicki Basalyga as she sits down with the co-founder of the Health Design Lab and Director of Innovation Design at Thomas Jefferson Rob Pugliese, as he shares how his experience as a pharmacist prepared him to step outside his comfort zone and create a space built with the purpose of merging together design-studio ethos with science-oriented discipline to foster innovation in healthcare.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In celebration of National Pharmacy Week, ASHP Official is highlighting pharmacy practice leaders. In this episode, we speak with Jessica Skelley – 2020/2021 Chair of the ASHP Section of Ambulatory Care Practitioners and Assistant Professor of Pharmacy Practice at Samford University McWhorter School of Pharmacy about her career journey, balancing personal and professional life, and her vision for the future of ambulatory care pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will discuss the recent data published on the potential role of SGLT2 inhibitors for patients with heart failure with and without diabetes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The 340B program is under attack from CMS and drug manufacturers. Tom Kraus and Jillanne Schulte-Wall help you understand recent threats to the program and how ASHP is fighting back.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
HHS just released a series of new policies including a new health plan proposal, drug importation rules, and changes to Medicare billing. Tom Kraus and Jillanne Schulte-Wall provide a roundup of these policy changes and help you understand how they are likely to be implemented and the challenges they will face.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Melissa Ortega and Maria Carias will discuss Melissa’s journey as a pharmacist of Latin heritage. Melissa will share her family’s Puerto Rican history, how she came to a career in pharmacy, and how being a Latina has enhanced her abilities as a pharmacist, leader, and mentor.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Michelle Carrasquillo and Maria Carias will discuss Michelle’s journey as a pharmacist of Latin heritage. Michelle gives listeners a glimpse into her upbringing as a Puerto Rican American and dives deep into why cultural competence is especially important for healthcare providers who care for racially diverse populations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP is drawing on the PAI 2030 recommendations to promote “focused initiatives” intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. The focused initiatives are time-bound, aligned with the PAI 2030 recommendations, and intended to help speed adoption of best practices in pursuit of large-scale change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Christopher Medlin and Maria Carias will discuss Chris’ journey as a Mexican American pharmacist. They will discuss Chris’ experiences as a Latino growing up in Texas and now treating patients along the Mexican American border, and his thoughts on how to increase recruitment of Latinos into the pharmacy workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Rita Shane and Charles Daniels discuss the clinical aspects of health care and its fundamental role in effective leadership.
Date recorded: January 23, 2018
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join the Section of Pharmacy Practice Leaders Multi-Hospital Pharmacy Executives Committee as they discuss COVID-19 vaccine administration, allocation, and distribution. The Committee’s fourteen multi-hospital pharmacy executives joined by Health-System Pharmacy Administration and Leadership Residents discuss:
- Concerns about resistance to accepting the vaccine
- Organizational planning to manage patients’ that may not have received the COVID-19 vaccine
- Considerations around mandating COVID-19 vaccination for all employees
- How pharmacists and technicians fit into organizations’ planning for tiered selection
- Logistics of the supply chain (including management of vaccine once on-site and the associated capital equipment and disposables)
- Role of the pharmacy as it relates to the management of COVID-19 vaccines and vaccination
- Engagement with state departments of health
- Interoperability with immunization information systems/registries and EHRs considering the management of the various COVID-19 vaccine formulations
Special acknowledgement to the podcast virtual roundtable participants: (Chair) Richard Myers, Pharm.D., M.B.A., BCPS; (Vice Chair) Christy Norman, Pharm.D., M.S., BCPS; Brian Cotter, M.S., R.Ph.; Jordan Dow, Pharm.D., M.S., FACHE; Connor Hanson, Pharm.D.; Eleni Kalivas, Pharm.D.; Kevin Krueger, Pharm.D., M.B.A.; Dave Lacknauth, Pharm.D, M.S., M.B.A.; Indu Lew, Pharm.D.; Tim Lynch, Pharm.D., M.S., FABC, FASHP; Karen McConnell, Pharm.D., FCCP, FASHP, BCPS; Shawn Osborne, Pharm.D., M.B.A., CMRP; Binita Patel, Pharm.D., M.S.; Kuldip Patel, Pharm.D.; Matthew Pond, Pharm.D., M.B.A.; Suzanne Shea, RPh, M.B.A.; Rebecca Taylor, Pharm.D., MBA, BCPS, FASHP; (ASHP Staff - David Chen, R.Ph., M.B.A. and Anna Legreid Dopp, Pharm.D.)
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Nick Gentile, ASHP’s Director of PAC and Grassroots Engagement, and Tom Kraus, ASHP’s Vice President of Government Relations, analyze the arguments before the Supreme Court in Rutledge vs PCMA, and share a perspective on how the court might rule.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Michael Wolcott, Director of Educational Resources & Scholarship at the University of North Carolina Adams School of Dentistry & UNC Eshelman School of Pharmacy and Gina Luchen, ASHP’s Director of Academic Programs discuss the importance of a growth mindset. Dr. Wolcott addresses common preceptor challenges and pearls in preparation for ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP Director of Academic Programs Gina Luchen discusses with ASHP Summer Interns Ella Domingo and Delaney McGuirt about their experience as the 2020 ASHP Summer Interns. The podcast covers virtual student leadership opportunities during COVID-19 and their unique networking, project, and professional opportunities throughout their virtual internship. Find out more information about the internship and how to apply here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In recognition of National Sickle Cell Awareness Month, ASHP sits down with Shenandoah University Professors Clarence Moore and Rebecca Andersen as they share the mechanisms behind Vaso-Occlusive Crisises and how pharmacists play an important role in managing medication therapies in this critical population.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The biosimilars represent a significant value improvement opportunity for health system formularies nationwide. This podcast will review the biosimilar challenges facing health systems and strategies that can be used to increase biosimilar adoption.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Lindsay Davis, Associate Professor at Midwestern University and Gina Luchen, ASHP’s Director of Academic Programs, discuss the five key concepts to consider when implementing Socratic dialogue in one’s precepting practice. Dr. Davis addresses common preceptor challenges and pearls in preparation for ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join SPPL HSPAL member Amanda Lyon as she converses with ASHP Past President & 2020 recipient of the ASHP Honorary Membership, Marianne Ivey. This podcast highlights elements from Dr. Ivey’s Harvey A.K. Whitney lecture, including an understanding of how to be a successful influencer, highlighting strategies to develop influencing skills, and reflections on the future of pharmacy.
- ASHP Honorary Membership Award – 2020 Recipient, Marianne F. Ivey
- Harvey A.K. Whitney Award Lectures – Shifting Pharmacy's Paradigm (Marianne F. Ivey)
- Expanding the pharmacy enterprise: Leadership needed
- ASHP Foundation New Practitioner Pharmacist Leadership Development Grant (Supported by the Marianne F. Ivey Leadership Development Fund)
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Insulin is an important therapeutic option in the management of type 2 diabetes, yet patients are often reluctant to start insulin because they are afraid of hypoglycemia. Listen as diabetes experts discuss how pharmacists help patients allay that fear.
To learn more about strategies for improving the insulin initiation experience and overcoming barriers to insulin therapy, visit www.ashpadvantage.com/startinsulin.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This podcast will outline the difficulties the USPS is having delivering medications to patients. We will delve into what the federal government is doing to fix the difficulties and how ASHP is engaging with legislators and regulators to help the USPS.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP Director of Academic Programs, Gina Luchen, discusses with student leaders Alexsandra Nilges from the University of Kentucky College of Pharmacy, Anita Yang from the University of North Carolina Eshelman School of Pharmacy, Jennifer Rose from the University of New Mexico College of Pharmacy, and Kiley Margolis from Temple University School of Pharmacy on their SSHP’s advocacy efforts and legislative action to advance the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In Today’s episode student pharmacists Nima Ataei and Aaron Johnson sit down with the Corporate Assistant Vice President of Pharmacy Services for MedStar Health, Dr. Bonnie Levin. Dr. Levin will be discussing the important aspects and nuances of the administration side of pharmacy as well as the steps you need to take to become successful in pharmacy administration. Dr. Levin will also touch on a myriad of topics such as working at an institution highly regarded around the world, tips for prospective students, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
(part of ASHP SPPL HSPAL Proactive Practice Advancement Series)
Join SPPL HSPAL member Armando Cortes as he converses with past ASHP John W. Webb Lecture Award Recipient. Patricia Kienle. This podcast highlights elements from the lecture as she describes nimble leadership in pharmacy, provides examples on how we use nimble leadership during a global pandemic, and notes resources for individuals in pharmacy leadership roles.
ASHP resources for show notes:
- Nimble leadership: A framework for future success (Patricia Kienle)
- Leadership Self-Development Resource Center
- Leadership Planning and Readiness in COVID-19
- Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In February of 2020, the Society of Critical Care Medicine published the first Pediatric Surviving Sepsis Guidelines. This document offers guidance on several key drug-related issues in the care of children with sepsis which can help pharmacists ensure appropriate care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Suzanne Larson, Director of Experiential Education at Midwestern University College of Pharmacy, and Gina Luchen, ASHP’s Director of Academic Programs discuss important feedback skills for pharmacy educators. Dr. Larson addresses common preceptor challenges and pearls in preparation for ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join SPPL HSPAL member Niaz Deyhim as she converses with ASHP Past President & 2020 recipient of the ASHP Honorary Membership, Daniel Ashby. This podcast highlights elements from Mr. Ashby’s Harvey A.K. Whitney lecture as he reflects on the direction of the pharmacy profession, highlights areas of practice innovation, and emphasizes pharmacy workforce roles in the dynamic healthcare landscape.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the final episode of the Truth in Transformation podcast series, ASHP President Tom Johnson talks to ASHP CEO Paul Abramowitz about the last step in the transformation process—acting on your truth. Learn how pharmacists need to embrace the many opportunities available to them in order to elevate their role throughout the healthcare system on ASHP Official.
he information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As an original sponsor of the National Academy of Medicine’s Action Collaborative on Clinician Well-Being and Resilience, ASHP is proud to represent pharmacy in interprofessional efforts to address this critical workforce and patient care issue. Join ASHP’s Christina Martin, Director of New Practitioners Forum, and Anna Legreid Dopp, Senior Director of Clinical Guidelines and Quality Improvement, as they review key 2020 updates to ASHP and NAM well-being initiatives and highlight resources to support and care for the pharmacy workforce through COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Han Le, an ASHP resident extern alum, as she interviews one of her Health-System Pharmacy Administration and Leadership (HSPAL) program mentors on executive presence. The conversation reflects on what executive presence is, identifies examples of how to evaluate and practice related soft skills, and provides advice for new practitioners or new leaders to consider when developing executive presence.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Training our team members for leadership – whether on project teams or more formally with “L”eadership roles - can be challenging when tools and resources are needed. Fortunately, through members sharing best practices, guidelines, and webinars, ASHP has content already available! This podcast will describe how members of the Emerging Leaders SAG put together a “curriculum” for training team members in leadership roles by referencing ASHP resources.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists trained in toxicology will discuss the only clinically significant scorpion (Centruroides sculpturatus [Bark scorpion]) envenomations in the southwestern United States; specifically Arizona. Basic behavior descriptions of scorpions: active times of the year, how/when they are encountered, preventative measures. Emphasis on treatments of scorpion envenomations: pre-hospital first aid, monitoring, labs, antivenom. Current clinical data regarding antivenom (Anascorp®), practical tips, bedside experience, and pearls. ): Pharmacists trained in toxicology will discuss the only clinically significant scorpion (Centruroides sculpturatus [Bark scorpion]) envenomations in the southwestern United States; specifically Arizona. Basic behavior descriptions of scorpions: active times of the year, how/when they are encountered, preventative measures. Emphasis on treatments of scorpion envenomations: pre-hospital first aid, monitoring, labs, antivenom. Current clinical data regarding antivenom (Anascorp®), practical tips, bedside experience, and pearls.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join podcast hosts Vicki Basalyga, Eric Maroyka, and Melanie Smith with content planners Christina Martin and Gina Luchen as they sit down to take a look at the COVID-19 content ASHP has recorded over the past 6 months and share their favorites you might have missed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Tyler Vest, Kellie Musch, Megan Adelman, Claire Latiolais, and Carolyn Magee (2019-2020 ASHP New Practitioners Forum Executive Committee Members) as they reflect on student-to-resident and resident-to-practitioner transitions. They share advice related to the job transitions, relocation, mentorship, well-being, and more, plus ASHP resources that supported them along the way!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacists trained in toxicology will discuss the most common snake (Crotalus [rattlesnakes]) envenomations encountered in the southwestern United States; specifically Arizona. Basic behavior descriptions of rattlesnakes: active times of the year, how/when they are encountered, preventative measures. Emphasis on treatments of rattlesnake envenomations: pre-hospital first aid, monitoring, labs, antivenom. Current clinical data regarding antivenoms (Anavip® vs. CroFab®), practical tips, bedside experience, and pearls.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about transformation as a necessary step in the advancement of the profession, especially as the practice of pharmacy continues to evolve. The ASHP leaders share how crisis often creates new opportunities. They also highlight the many ways ASHP supports members in today’s ever-changing healthcare landscape.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Elyse MacDonald reviews the important statistical consideration for evaluating the incredible amount of literature released and what descriptors are important for the wide variety of COVID-19 tests on the marketplace.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum Career Development Advisory Group as they share ‘dos’ and ‘don’ts’ for updating and managing your CV as a student, resident, or new practitioner. Speakers will review the preparation process for developing CV content throughout your career and highlight ASHP CV resources available to you as an ASHP member.
This episode was recorded April 2020
ASHP Resources highlighted in the podcast to include in show notes:
- CV Transition Toolkit - https://www.ashp.org/Pharmacy-Student/Career-Development/CV-Development/CV-Transition-Toolkit
- CV Review Program - https://www.ashp.org/Pharmacy-Student/Career-Development/CV-Development
- CV Transformation Through Career Transitions - https://www.ashp.org/-/media/assets/pharmacy-student/docs/Student-CV-Documents/psf-cv-career-transitions-guidance-document.ashx?la=en&hash=632D728881B9AB29A49B017B82A5168FDE5482F8
- Mentor Match - https://www.ashp.org/New-Practitioner/New-Practitioners-Forum/Programs-and-Awards/ASHP-Mentor-Match
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hosted by the ASHP Section of Inpatient Care Practitioners Advisory Group on Small and Rural Hospitals, today's episode focuses about the impact that COVID-19 had on a critical-access hospital’s pharmacy operations and the important role of critical-access pharmacists in caring for patients with COVID-19 in this setting. Dr. Dantonio will discuss lessons learned and how the department is preparing for the second wave of COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us as we sit down with Chadi Abbas and Rafael Roman as they share with ASHP how they have adapted their pharmacy technician roles to provide quality patient care and maintain a well trained workforce during the COVID-19 epidemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about transformational presence — the concept of self-awareness and observing what is going on around you. The ASHP leaders share ways pharmacy practitioners can use transformational presence to embrace change to advance the profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Patients with opioid use disorder (OUD) require close monitoring and consistent access to care. This podcast focuses on providing care to this patient population during the COVID-19 pandemic. For more information on the pharmacist’s role in the management of OUD during the COVID-19 pandemic, as well as resources from the National Academy of Medicine Action Collaborative on Countering the US Opioid Epidemic, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP and Accreditation Services is monitoring the current COVID-19 pandemic and managing, to the extent possible, disruptions to residency training and accreditation activities. ASHP is committed to supporting pharmacy residency programs during this unprecedented time. Part 2 of this podcast will describe the program completion, onboarding/orientation process, as well as recruitment/interviews of two pharmacy residency programs in different parts of the US. To hear more about their experiences, please see the full webinar recording at ASHP elearning.org
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP and Accreditation Services is monitoring the current COVID-19 pandemic and managing, to the extent possible, disruptions to residency training and accreditation activities. ASHP is committed to supporting pharmacy residency programs during this unprecedented time. Part 1of this podcast will describe the unanticipated challenges and unique opportunities of two pharmacy residency program directors in different parts of the US. To hear more about their experiences, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Yen H. Dang and Dr. Kim P. To-Lui discuss with William Zellmer, Contributing Editor for AJHP, results from a survey study conducted to assess pharmacist views on postgraduate year 3 training. The article under discussion will appear in the September 15, 2020, issue of AJHP.
Recorded July 15, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. To learn more about the list visit https://www.cdc.gov/niosh/topics/hazdrug/default.html.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum Clinical Practice Advisory Group as they share advice for student pharmacists, pharmacy residents and new practitioners on tips and tricks for staying updated on best practices and review of the literature.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Continuous Glucose Monitors (CGMs) are quickly becoming a popular substitute for glucometers and avoid the need for frequent finger sticks to determine glucose values in patients with diabetes. This podcast will share the experiences of two ambulatory care clinical pharmacists that have incorporated CGMs into their clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
As the opioid crisis continues to affect the lives of people around the country health-systems most impacted by the crisis have taken a proactive approach in the fight. Recognizing the need for grassroots leadership to guide responsible opioid prescribing the University of Kentucky HealthCare implemented an Opioid Stewardship Program.
The host and speakers would like to give special acknowledgement of Steven Silverstein, Pharm.D., BCPS, Director of Pharmacy; Mercy Hospital and Medical Center, Chicago, IL for his assistance with the development of this podcast.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediation regimens and monitoring for toxicities. With that in mind, we sit down with our content matter experts to talk about managing patients who might be at risk for developing toxicities due to the excipients found in drugs and how pharmacists can play an important role in preventing these adverse events.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The speakers will cover a variety of hepatitis C topics, including the current landscape, the evolution of therapies available, the changing role of the pharmacist, and where they see the future of this therapeutic area.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Business Recovery Toolkit for Hospital and Health System Pharmacy shares the results of virtual roundtables were conducted in the first week of May 2020 with pharmacy leaders from across the United States to share early efforts in business recovery planning. David Chen, Assistant Vice President for Pharmacy Leadership and Planning sits down Vicki Basalyga to discuss how the toolkit was developed and the actions pharmacy leaders can take from this toolkit to recover from this pandemic and leverage the strengths of our profession to care for patients and support fiscal health for the most optimal outcomes possible.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Scott Nelson and Dr. Colin Walsh discuss with William Zellmer, Contributing Editor for AJHP, the role of artificial intelligence in pharmacy and its application to the medication-use process. The report under discussion will appear in the October 1, 2020, issue of AJHP.
Recorded July 15, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
Dr. Debra Wagner and Dr. Karen Durant discuss with William Zellmer, Contributing Editor for AJHP, the pharmacy dimensions of planning a field hospital in preparation for a second surge of COVID-19 cases. The article under discussion will appear in the November 1, 2020, issue of AJHP.
Recorded July 9, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
In this podcast Vicki Basalyga ASHP Director of Clinical Specialists and Scientists discusses with Hannah Vanderpool ASHP Vice President of Member Relations and Gina Luchen ASHP Director of Academic programs about the launch of ASHP’s newest Section of Pharmacy Educators.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about how to stand in your truth — the concept of being honest about your strengths. The ASHP leaders speak to listeners about ways pharmacy professionals can stand in their truth to step into more prominent roles on the healthcare team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Eric Tichy and Dr. Matthew Rim discuss with William Zellmer, Contributing Editor for AJHP, the 2019 trends in prescription drug expenditures and projections for 2020. The report under discussion will appear in the August 1, 2020, issue of AJHP.
Recorded June 8, 2020.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
In response to the COVID-19 pandemic, telehealth pharmacy services have been implemented in many ambulatory care clinics. Telehealth helps to provide continuity of care for patients, however, there are many elements that must be taken into consideration when providing services. This podcast highlights technology platforms used by three ambulatory care pharmacists. The discussion includes creating a workflow, patient education, and trial and error experienced with technology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In the middle of 2019, federal and state entities began investigating a national outbreak of e-cigarette or vaping, product-related lung injury. As more details surrounding this epidemic became available, the Centers for Disease Control and Prevention (CDC) released a guidance document to health care providers for providing care to patients suspected to be afflicted with this lung injury. This podcast will focus on the pharmacist’s role in these patients and how they can impact patient care moving forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum as they share advice for pharmacy students, residents, and new practitioners on manuscript development.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast ASHP Vice President of Member Relations Hannah Vanderpool interviews Daniel Cobaugh on his unique career path in pharmacy, challenges he confronted and overcame as a gay man, and his role as an advocate for LGBTQ people in pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Ina Lee, MICU Clinical Pharmacist sits down with ASHP to talk about caring for critically ill patients at Harborview Medical Center. Dr. Lee shares her topic clinical challenges, lessons learned, and successful strategies in the management of COVID-19 patients. (all while washing her hands to Happy Birthday)
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We chat with Zahra Kassamali Escobar and Rupali Jain about their experiences with their antimicrobial stewardship programs within the University of Washington Health System and the management of COVID-19, use of remdesivir, and their top clinical concerns.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The national COVID-19 pandemic has challenged health care systems, creating opportunities to respond swiftly and safely to mitigate risks and impact. One area where this can be noted is in the provision of home infusion services. Today’s podcast focuses on how home infusion providers responded to the public health crisis, including practice model adjustments and associated outcomes. For more information on lessons learned and future projections, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
COVID-19 has up-ended established work practice across industries, resulting in major changes and creating new flexibilities and opportunities. Hospitals and health systems are ground zero for some of the biggest shifts, particularly the rapid transition to telehealth and the embrace of new technology. In this podcast, we talk through one of the most beneficial new flexibilities to emerge during the pandemic – virtual supervision of pharmacists’ services. We’ll discuss why virtual supervision is helpful for our members, how it intersects with other important regulatory flexibilities and advocacy priorities, what we’re doing to ensure virtual supervision becomes permanent, and how members can help advocate for that change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with ASHP President Tom Johnson about servant leadership, which is the concept of listening, putting others first, and being empathetic. The ASHP leaders speak to listeners about how servant leadership applies to the pharmacy profession and why it is an important practice for pharmacy professionals.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP has been committed to supporting the well-being and resilience of the pharmacy workforce for decades. We’ve been even more focused on supporting members the last few years given recent evidence and impact of burnout on patient safety and the healthcare workforce. During COVID-19, demands and stress on the pharmacy workforce have increased to an even greater extent. This podcast will introduce the concept of Critical Incident Stress Management (CISM) and will identify resources and tools available to apply CISM components to individual wellness and in preparing for crisis support. For more information on CISM, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Lindsey Kelley and Daniel Cobaugh will discuss Lindsey’s journey as a pharmacy leader who also happens to be a lesbian woman. They will hit upon Lindsey’s career experiences, insights from her letter in Letters from Women in Pharmacy, and her guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The national COVID-19 pandemic has challenged health care systems, creating opportunities to respond swiftly and safely to mitigate risks and impact. As pharmacy leaders and caregivers across the nation continue to manage the COVID-19 pandemic, this podcast focuses on an example of how a multi-regional health system responded to the public health crisis. For more information on lessons learned to date from the Providence St. Joseph Health System, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Jorge Garcia, Leyner Martinez, and Daniel Cobaugh will discuss their unique experiences as a couple who are leaders in health-system pharmacy practice. They will hit upon their early career experiences, navigating residency as a couple, balancing the demands of family and career, and their advice for LGBTQ people in pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP sits down with Amanda Condon-Martinez to discuss the intricacies of caring for transplants patients during COVID-19. Dr. Condon-Martinez shares her experiences and best practices for ensuring this vulnerable patient population doesn’t slip through the cracks.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Glen Gard and Daniel Cobaugh will discuss Glen’s journey as a pharmacy technician and leader who also happens to be a gay man. They will hit upon Glen’s career experiences, his leadership role in the ASHP Pharmacy Technician Forum, and his guidance for other LGBTQ pharmacy technicians, student pharmacists, residents, and pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this podcast, Alexander Gilmer and Daniel Cobaugh will discuss Alexander’s journey as a pharmacist who also happens to be a transgender man. They will hit upon Alex’s experiences as a student and resident, his interactions with his patients, and his guidance for other LGBTQ student pharmacists, residents, pharmacists, and pharmacy technicians.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Continuous Glucose Monitors (CGMs) are quickly becoming a popular substitute for glucometers and avoid the need for frequent finger sticks to determine glucose values in patients with diabetes. This podcast will offer guidance on building pharmacy services around CGM utilization to better care for patients with diabetes and support providers in diabetes care management.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The Adaptive COVID treatment trial (ACTT) is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. This podcast discusses what’s next by introducing baricitinib and the ACTT-2 Trial Design. To learn more about the clinical experience with remdesivir, supportive care for COVID-19 patients, and discussion of remdesivir clinical trial results from the Pharmacy Team at Nebraska Medicine, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Most of us are familiar with applying process improvement techniques to pharmacy operations, but what about clinical services? In this episode, we’ll be talking about one health system’s journey in systematically modifying workflows and electronic health record functionality to maximize efficiency.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP has been committed to supporting the well-being and resilience of the pharmacy workforce for decades. We've been even more focused on supporting members the last few years given recent evidence and impact of burnout on patient safety and the healthcare workforce. During COVID-19, demands and stress on the pharmacy workforce have increased to an even greater extent. This podcast focuses on an overview of the Headspace meditation app, which is available as an ASHP member benefit. For more information about tools and resources to cope during this time, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The measles outbreak in 2019 throughout the United States and the world demonstrates how vaccinations help keep preventable diseases at bay. For this Therapeutics Thursday podcast, our content matter experts discuss how pharmacists understand vaccination hesitancy and how pharmacists can play an important role in promoting vaccination.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join members of the ASHP New Practitioners Forum as they share advice for pharmacy students, residents and new practitioners on how to prepare for a journal club presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Pharmacy Residencies have not been immune to the impact that the COVID-19 pandemic. Thankfully, the ASHP Staff from the Accreditation Services Division are here to address many of the questions that RPDs, preceptors, residents, and prospective residents may have.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
In this first episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with incoming ASHP President Tom Johnson about the challenges of writing his inaugural address during rapidly changing times.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The ASHP Patient Surge Management During a Pandemic Toolkit for Hospital and Health System Pharmacy provides a compilation of ASHP tools and resources created in response to COVID-19 as well as the many lessons learned from pharmacy leaders as they shared their experiences in surge management. David Chen, Assistant Vice President for Pharmacy Leadership and Planning sits down Vicki Basalyga to discuss how the toolkit was developed and how pharmacist can use the toolkit at their institution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Healthcare clinicians and leaders are forced to make challenging decisions related to prioritizing medication use during times of limited access, requiring careful consideration to ensure patients with the greatest need receive medications while responsibly rationing supply. Lately, however, hospitals and health systems are being called upon to determine criteria for use for medications used to treat SARSCoV-2 infection (COVID) and medications for supportive care. This podcast focuses on the role of pharmacy and pharmacists in resource utilization oversight. If you would to hear more from leaders who have operationalized committees like this to make these important decisions in their institutions, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
COVID-Care Certified is the latest addition to ASHP’s COVID-19 resources designed to support those on the front lines of patient care. Melanie Smith, Director of the Section of Ambulatory Care Practitioners bring us the highlights for this 15 hour “COVID Care Certified” course that helps prepare pharmacists and pharmacy technicians for managing clinical and operational challenges during this pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The Emergency Department (ED) is an important resource and front liner to individuals seeking treatment for opioid use disorder (OUD). Emerging evidence about initiating buprenorphine in the ED suggests that it may help OUD patients transition to treatment programs. Also, there is an ongoing discussion about the best approach to MAT in the ED setting.
This podcast will discuss buprenorphine use for opioid use disorder in the ED, including drug indication, dosing, and contraindications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Rena Gosser, Clinical Ambulatory Care Manager at Harborview in Seattle, Washington returns to our ASHP podcast to talk with us about how her institution is leveraging telehealth as a part of managing transitions of care and ensuring that patients in the ambulatory care setting are receiving the best of care.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Hosted by the ASHP Section of Pharmacy Practice Leaders, today's episode focuses on coaching and leading frontline staff. Our discussion centers on leadership topics within pharmacy practice, including the business of pharmacy, development of leadership skills and career transitions, and more.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Seattle was one of the first cities in the U.S. to treat COVID-19 patients. Rena Gosser, Clinical Ambulatory Care Manager at Harborview in Seattle, Washington shares lessons learned, clinical concerns, and plans for the safe reopening of some clinical services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode is a recording of the ASHP COVID-19 Series (No CE) (Webinar)
Activity Date: May 8, 2020
NYU Langone's pharmacy teams were instrumental in the interprofessional response to the rapidly changing demands in the care of COVID-19 patients. Navigating the evidence-based medicine and emerging evidence was a key aspect of the pharmacy team’s role and is the focus of this podcast. If you would like to learn more about how clinical leaders from NYU Langone kept pharmacists engaged at the bedside and positively impacted the organization, please see the full webinar recording at ASHP elearning.org.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today on ASHPOfficial, we chat with student leaders across the nation about their perspectives on the COVID-19 pandemic. In this podcast, we will dive into how students are adapting to the virtual learning model and how student societies are coping with the changing environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
We chat with Dr. Lisa Deal, Director of Pharmacy, Sun Behavioral Health Delaware in Georgetown, Delaware, about the unique aspects of managing mental health disorders during the COVID-19 pandemic. Considerations for both patient and clinician mental health will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today on ASHPOfficial, we chat with student leaders across the nation about their perspectives on the COVID-19 pandemic. In this podcast, we will dive into how students are adapting to the virtual learning model and how student societies are coping with the changing environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Remdesivir has been added to the FDA Emergency Use Authorization list for the treatment of hospitalized patients with severe COVID-19 disease. As such, pharmacists may have questions about the practical and operational aspects of the procurement and utilization of this medication. This podcast focuses on investigational drug services, dose conservation, and clinical experiences with remdesivir. In order to learn more about early information on the clinical use of and access to Remdesivir for the treatment of patients with COVID-19, please see the full webinar recording at ASHP elearning.org.
*Recorded on 5/13
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Jillanne Schulte Wall, ASHP Senior Director, Health & Regulatory Policy and Mary Ann Kliethermes, ASHP Director, Medication Safety & Quality, discuss CMS’s recent telehealth changes, the resulting regulatory flexibilities that are helpful to our members and their patients, and ASHP’s next steps on telehealth advocacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP sits down with Dr. Jill Starykowicz, PharmD, BCCCP, Clinical Pharmacy Specialist, Medical/ Cardiac Intensive Care Unit and Director, PGY2 Critical Care Pharmacy Residency at Advocate Lutheran General Hospital in Park Ridge, Illinois as she discusses cytokine storm in critically ill COVID-19 patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Anticoagulants are moving to the frontline in some patients with COVID-19 as emerging data shows pro-thrombotic complications occurring. Many of these agents are weight based and require lab monitoring for efficacy and safety. Unfortunately, obesity is an ongoing epidemic in the US as well and potentially worse outcomes in those with COVID-19. It is imperative that pharmacists have an understanding on how the pharmacokinetics can be altered in patients that are obese or large body weight, along with the recommended dosing weight to use.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
While it is not uncommon to occasionally have adult-sized patients in children’s hospitals, some are preparing to support the care of more adult patients in the event of COVID-19 surge in their region. This means that pharmacists who traditionally only care pediatric patients will be caring for adult patients without conditions that are associated with pediatrics diseases. Our guests today are pediatric pharmacists from across the country who will share with us their experiences and plans to safely care for patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Due to the COVID-19 pandemic, our pharmacotherapy clinic had to rapidly create new workflows for telehealth services to allow for continued care of our patients, while minimizing their possible exposure to COVID-19. We will be discussing how we have rapidly converted our face-to-face pharmacist visits to telehealth visits to minimize patient exposure in the ambulatory care clinics, as well as, pharmacist/provider exposure to patients unnecessarily. In addition, we will discuss the types of telehealth visits provided, the roadblocks we have encountered/lessons learned and current reimbursement for such services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
CAR-T cell therapies have the potential to transform cancer treatment. Their unique toxicities require rapid recognition and specialized treatment. Collaboration between multiple disciplines is needed for the optimal management of patients undergoing CAR-T cell therapy. The purpose of this podcast is to discuss key issues that non-oncology practitioners in acute care settings will need to be familiar with to appropriately treat patients whom underwent CAR-T cell treatment and are experiencing adverse effects related to treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Jennifer Phillips and Jennifer Locker about managing resilience and well-being of staff members during the COVID pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP sits down with Drs. Amie Blaszczyk, PharmD, BCGP, BCPS, FASCP, Associate Professor and Division Head-Geriatrics at Texas Tech University Health Sciences Center in Dallas, Texas and Dana Carroll PharmD., BCGP, BCPS, CDE, Clinical Professor at the Auburn University Harrison School of Pharmacy in Auburn, Alabama as they discuss geriatric practice considerations in the long term care and ambulatory care settings at this time.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Today on ASHPOfficial, we chat with Dr. Amanda Margolis, PharmD, MS, BCACP and Dr. Marina Maes, PharmD, BCPS, BCACP, assistant professors at the University of Wisconsin-Madison School of Pharmacy in the pharmacy practice division. Dr. Margolis and Dr. Maes dive into how they are adapting to this evolving situation and share key insights into what teaching and practice model looks during COVID-19.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join ASHP for a discussion concerning the updates from the 2019 IDSA/ATS Community Acquired Pneumonia Guidelines published in October of 2019. These guidelines are an update to the previous 2007 guidelines with new information on outpatient and inpatient management, as well as topics the previous guidelines did not address, such as aspiration pneumonia and the use of corticosteroids.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Due to the COVID-19 pandemic, ambulatory care clinics have transitioned to telehealth services to allow for continued care of patients, while minimizing possible exposure to COVID-19. This podcast will explore the implementation and expansion of telehealth pharmacy services in two different ambulatory care clinics in response to the COVID-19 pandemic. Speakers will discuss the types of telehealth visits provided, the roadblocks encountered, lessons learned, and reimbursement.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Eric Maroyka sits down with Elaine Snow to discuss how her team amends the evidence table and works with ASHP to ensure that pharmacists are working with the most up to date information concerning patient care. Listen in as they explore ASHP’s Assessment of Evidence for COVID-19 Related Treatments and how pharmacists can apply this information to their practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ASHP sits down with Dr. Amy L. Dzierba, Pharm.D. FCCM, FCCP, BCCCP, Clinical Pharmacy Manager of Adult Critical Care at New York-Presbyterian Hospital Columbia University Irving Medical Center to discuss the Society of Critical Care Medicine’s Guidelines on managing critically ill COVID-19 patients and how pharmacists can apply what is in these guidelines to their practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
This episode is a recording of the ASHP COVID-19 Series (No CE) (Webinar)
Activity Date: April 17, 2020
This activity describes the journey of Mount Sinai Health System and Montefiore Health System, as well as the coordinated efforts of the New York City’s Pharmacy Leadership. Mr. Sosnowski and Mr. Pinto will share experiences and responses to this surge that will help hospitals and health systems prepare for the rapid changes and challenges facing hospitals during this pandemic.
Objectives: * Managing Patient Surge * Managing Drugs and Supplies * Coordinating Staff and Working with Interprofessional Teams * Patient and Family Experience * Community Engagement and Hospital’s Role * Surge Management: Facilities and Patient Transfers * COVID-19 Exposure – Healthcare Leader’s Perspective
Speakers: * Joseph Pinto, R.Ph, M.S., MHA, DPLA, Executive Director of Pharmacy Operations, Mount Sinai Health System, New York, NY * Frank P. Sosnowski, B.S.Pharm., M.S., Senior Director of Pharmacy, Montefiore Medical Center, Bronx, NY * Moderator: David Chen, B.S.Pharm., M.B.A., Assistant Vice President for Pharmacy Leadership and Planning, Office of Member Relations, ASHP, Bethesda, MD
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Dr. Melinda (Mindy) T. Burnworth, Pharm.D., BCPS, FASHP, from Midwestern University College of Pharmacy-Glendale and Dr. Janet Lee, Pharm.D, MPA, MBA, of the Department of Pharmacy – The Johns Hopkins Hospital, Baltimore, Md. and as they chat members of ASHP’s Office of Government Relations team to demystify the Hill, lobbying and advocacy on behalf of pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Two of New York Presbyterian's Critical Care Pharmacists, Karen Berger and Amy Dzerba sit down with ASHP's Vicki Basalyga and discuss their experiences caring for critically ill patients in thier intensive care units and their strategies for sedation, anticoagulation and how they share successful strategies across a health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join us for a discussion of ASHP’s advocacy engagement with FDA, DEA, and CMS to address shortages and create regulatory flexibility to allow for an effective COVID-19 response.
This episode is a recording of the ASHP COVID-19 Series (No CE) (Webinar)
Activity Date: April 16, 2020
This activity describes the journey of Holy Name Medical Center, a 361-bed hospital in Teaneck, NJ. Holy Name Medical Center was one of the first hospitals to experience a massive surge of COVID-19 patients. Nancy Palamara, Pharm.D; Director of Pharmacy Services, Infusion Therapy & MS Services will share experiences and responses to this surge that will help hospitals and health systems prepare for the rapid changes and challenges facing hospitals during this pandemic. Objectives: * Managing Patient Surge * Managing Drugs and Supplies * Coordinating Staff and Working with Interprofessional Teams * Patient and Family Experience * Community Engagement and Hospital’s Role * COVID-19 Exposure – Healthcare Leader’s Perspective
Speakers: * Nancy Palamara, Pharm.D., Director of Pharmacy Services, Infusion Therapy & MS Services, Holy Name Medical Center, Teaneck, NJ * Moderator: David Chen, B.S.Pharm., M.B.A., Assistant Vice President for Pharmacy Leadership and Planning, Office of Member Relations, ASHP, Bethesda, MD
Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Laura Truhlar on lessons learned and advice to share related to workforce well-being.
There has been a renewed interest in managing COVID-19 patients with septic shock and the use of vitamins and anti-oxidants such as Vitamin C and Zinc. Listen to our 2018 Midyear Clinical Meeting presentation by Craig Whitman and Lee Skrupky as they describe the mechanisms of action, toxicities, and pharmacokinetic considerations of vitamin C, thiamine, selenium, zinc and vitamin E in sepsis. They evaluate the literature describing the effect of vitamin or antioxidant supplementation on outcomes in patient with sepsis. The core concepts from this presentation can help pharmacists recommend appropriate vitamin or antioxidant supplements in patients with sepsis.
Today on ASHPOfficial, we chat with Eric Maroyka about the transformation of our frequently accessed COVID-19 Resource Center into a new microsite that intuitively organizes the resources needed to effectively plan and respond to the pandemic. The microsite includes resources available to pharmacists related to treatment and supportive care, drug information, surveillance and tracking, knowledge and skill development, planning and readiness, advocacy efforts, and infection prevention. ASHP will continue to enhance the site with new and updated content, which remains open to all healthcare professionals engaged in the COVID-19 response.
Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Anne Nguyen on lessons learned and advice to share related to workforce well-being.
This podcast discusses the data regarding the use of Vitamin D supplementation for indications outside of bone health. We also review the different formulations of Vitamin D supplementation.
COVID-19
ASHP is committed to supporting you in the response to the COVID-19 pandemic. We have launched a new COVID-19 Resource Center microsite that is updated regularly and have opened access to our evidence-based online resources and tools on ashp.org, making them widely available to all pharmacists and healthcare professionals. Our COVID-19 Community on Connect serves as a forum for any healthcare providers to ask questions, share experiences, post resources, and more. Thank you for all that you are doing for your patients and your community.
ASHP sits down with Dr. Jawad Saleh, B.S., PharmD, BCPS, BCCCP, Clinical Manager of Pharmacy Services and Dr. Lucas T. Schulz, PharmD, BCIDP, Clinical Coordinator – Infectious Diseases and Critical Care Pharmacist as they discuss ICU creations in their institution, medication management and workflow modifications in this patient population as well as the transformations, highlights and pharmacy survival in amidst COVID-19.
We chat with CPT Julian Rodriguez, a U.S. Army active duty pharmacy officer about his field hospital experience in support of humanitarian relief efforts during the aftermath of Hurricane Maria. The lessons shared may assist with planning considerations for those hospitals anticipating the need to expand capacity by standing up field hospitals in response to the COVID-19 pandemic.
Listen in as ASHP interviews our interprofessional panel from the 2019 Well-Being Collaborative. In this podcast, you will hear their reactions to the National Academy of Medicine (NAM) consensus study, identify interventions needed to support clinician well-being and resilience, and recognize evidence-based systems interventions for patient care for clinicians to apply in team-based care models.
COVID-19 ASHP is committed to supporting you in the response to the COVID-19 pandemic and is regularly communicating updates on this crisis. We have opened access to our evidence-based online resources and tools on ashp.org, making them widely available to all pharmacists and healthcare professionals, and our COVID-19 Resource Center is updated frequently. Additionally, our podcast is currently featuring COVID-19 related content on a regular basis. ASHP has also launched a new COVID-19 Community on Connect, which serves as a forum for any healthcare providers to ask questions, share experiences, post resources, and more. Thank you for all that you are doing for your patients and your community.
What does Alcohol Withdrawal Syndrome have to do with COVID-19? Many states have considered liquor stores non-essential and as a result, people may not be able to drink as they normally would. Alcohol withdrawal can be a serious and life-threatening condition where benzodiazepines and barbiturates are standard of care. Recent evidence has emerged with ketamine as a potential option for patients with severe withdrawal. This podcast will discuss its potential place in practice, along with practical considerations, such as dosing and monitoring. David Zimmerman will be serving as the interviewer.
ASHP chats with pharmacist Andrew Smith at St. Barnabas Hospital in the Bronx and Attending Physician Jonathan St. George at New York Presbyterian Hospital who are deep in the trenches in New York City and treating record numbers of COVID-19 patients. They will share their experiences and success in managing the surge of COVID-19 patients including clinical and operational considerations that can be applied across the country.
ASHP chats with pharmacist Andrew Smith at St. Barnabas Hospital in the Bronx and Attending Physician Jonathan St. George at New York Presbyterian Hospital about their experiences with airway management in patients during the COVID-19 surge. Listen in as they share their strategies for patient care and medication decision making during this evolving pandemic.
We chat with Lucas Schulz about what pharmacists should be evaluating when it comes to all of the rapidly emerging studies and data surrounding the treatment of COVID-19 patients. Our content matter experts provide recommendations on how to critically assess and potentially apply information to these studies into real practice situations.
Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Lisa Wilhelm, Medication Safety and Compliance Specialist, Penn State Milton S. Hershey Medical Center, Hershey, PA, on lessons learned and advice to share related to workforce well-being, maintaining health, and (trying to) stay resilient during these complex times.
Treatment approaches to COVID-19 are rapidly changing, often based on data that are based on case reports and studies that are poorly designed and not adequately powered. There has been an increased interest in the use of chloroquine and hydroxychloroquine for the treatment based on COVID-19 based on studies where they have been found to be efficient on SARS-CoV-2. This weekend, the FDA has approved the use of these two anti-malaria drugs to treat patients infected by the new coronavirus. While clinical trials are needed to provide scientific evidence that these treatments are effective and safe, pharmacists are starting to see patients taking these medications, often without a prescription and with no regard to dosing regimen and concurrent medication regimens. We chat with Bryan Hayes on the management of patients who present to the ED who may have taken toxic doses of these agents.
Dave Warner, ASHP Director of the Center on Practice Development and Brad Pierson, ASHP Senior Director of CareerPharm discuss CareerPharm Rapid Connect, a new free service, to alleviate staffing shortages during this crisis. With the emergence of the COVID-19 pandemic many areas such as NY, NJ, WA, and CA to name a few are hard hit to care for an enormous number of critically ill patients. Many facilities are faced with staffing shortages due to sheer volume, staff illnesses, and caring for patients with or without COVID-19. Dr. Warner and Mr. Pierson discuss this new platform to unite individuals and facilities to help alleviate staffing shortages.
How do we prioritize what goes where and to who when we don’t have enough to go around? We welcome back Dr. Ken Richman, Professor of Philosophy and Health Care Ethics and IRB Chair at MCPHS University to talk about how ethics play an important role when it comes to the fair distribution of scarce life-saving resources.
Join nationally recognized drug shortage expert Erin R. Fox, Pharm.D., BCPS, FASHP, Michael Ganio, Senior Director, Pharmacy Practice and Quality, and Tom Kraus, Vice President of Government Relations, as they discuss recent updates on drug shortages related to COVID-19 and the impact the recent federal relief law will have on managing the supply chain.
Today we talk with Susan Goodin, Head of Pharmacy Practice, Patient and Investigator Engagement, and the Innovation Strategy Lead in Biotherapeutics Development for Janssen Research and Development. Our focus is to talk about her experiences during her 25-year career while at the Rutgers Cancer Institute of New Jersey in managing drug shortages and discussing ethical considerations in prioritizing care and lessons learned from the oncology perspective.
In today’s episode of ASHPOfficial, host Tom Kraus, Vice President, Office of Government Relations at ASHP interviews Kathryn DiBitetto, vice president of the government relations team at 340B Health. 340B Health is a nonprofit organization of more than 1,400 hospitals and health systems that participate in the 340B Drug Pricing Program. Kathryn strives to educate policymakers about the program, and, today, speaks directly to listeners about ways they can advocate for 340B.
COVID-19 ASHP is committed to supporting you in the response to the COVID-19 pandemic and is regularly communicating updates on this crisis. We have opened access to our evidence-based online resources and tools on ashp.org, making them widely available to all pharmacists and healthcare professionals, and our COVID-19 Resource Center is updated frequently. Additionally, our podcast is currently featuring COVID-19 related content on a regular basis. ASHP has also launched a new COVID-19 Community on Connect, which serves as a forum for any healthcare providers to ask questions, share experiences, post resources, and more. Thank you for all that you are doing for your patients and your community.
Dr. Eric Maroyka, Pharm.D., BCPS, Senior Director, Center on Pharmacy Practice Advancement sits down with Dr. Ryan Roux, Pharm.D., M.S., Vice President of Pharmacy at The University of Texas MD Anderson Cancer Center to discuss COVID-19 preparation, response, and mitigation lessons learned to share with the field.
In this third installment of the series, Dr. Roux discusses lessons learned and key planning considerations for hospital and health-system pharmacy leaders with respect to pandemic planning, response, and mitigation. The coronavirus pandemic is stressing our healthcare system infrastructure, has the potential for a devastating economic fallout, and will test the outer limits of healthcare worker resilience. The potential and actual surge in COVID-19 patients is threatening the capability and capacity of the US healthcare system as well as the safety and welfare of healthcare workers.
Listen in as ASHP chats with Mike Ganio, Senior Director, Pharmacy Practice and Quality, about drug shortages and supply chain management as they relate to COVID-19. Mike shares the impact of pandemic related shortages, chronic shortages, and best practices for managing shortages at your institutions.
In our latest episode, Dr. Eric Maroyka, Pharm.D., BCPS, Director, Center on Pharmacy Practice Advancement sits down with Ross Thompson, M.S., R.Ph., Vice President and Chief Pharmacy Officer, Tufts Medical Center to discuss COVID-19 preparation, response, and mitigation lessons learned to share with the field.
In this second installation, Mr. Thompson discusses lessons learned and key planning considerations for hospital and health-system pharmacy leaders with respect to pandemic planning, response, and mitigation. The coronavirus pandemic is stressing our healthcare system infrastructure, has the potential for a devastating economic fallout, and will test the outer limits of healthcare worker resilience. The potential and actual surge in COVID-19 patients is threatening the capability and capacity of the US healthcare system as well as the safety and welfare of healthcare workers.
Please join Dr. Vicki Basalyga, Pharm.D. BCPS, BCPPS, Director of the Section of Clinical Specialists and Scientists for today’s special edition podcast on COVID-19. Today we will be chatting with Dr. Ken Richman, Professor of Philosophy and Health Care Ethics and IRB Chair at MCPHS University in Boston about the ethics of research on COVID-19 during the 2020 pandemic.
In our latest episode, Dr. Eric Maroyka, Pharm.D., BCPS, Director, Center on Pharmacy Practice Advancement sits down with Dr. Christopher Fortier, Pharm.D., FASHP, Chief Pharmacy Officer, Massachusetts General Hospital to discuss COVID-19 preparation, response, and mitigation lessons learned to share with the field.
Dr. Fortier discusses lessons learned and key planning considerations for hospital and health-system pharmacy leaders with respect to pandemic planning, response, and mitigation. The coronavirus pandemic is stressing our healthcare system infrastructure, has the potential for a devastating economic fallout, and will test the outer limits of healthcare worker resilience. The potential and actual surge in COVID-19 patients is threatening the capability and capacity of the US healthcare system as well as the safety and welfare of healthcare workers.
In today’s episode, we chat with Elaine Snow, BS Pharm., Editor-in-Chief of AHFS Drug Information® (AHFS® DI™) and Handbook on Injectable Drugs® (HID™) and Dr. Seth Strawbridge, Pharm.D. and Clinical Informaticist on the eHealth Solutions Team in ASHP’s Publishing Office about the amount of literature currently published on COVID-19, AHFS®, and other ASHP Resources.
Today on ASHPOfficial, We chat with Eric Maroyka about the current resources available to pharmacists to help manage the operational and clinical considerations for COVID-19.
COPD remains the fourth leading cause of death in the U.S. and National costs attributed to COPD treatment and care are projected to increase by 53% through 2020-from $32 billion to $49 billion. Joining this Therapeutic Thursday are four expert clinicians discussing the interprofessional approaches to managing patients with COPD and issues to discuss when transitioning patients out of the inpatient care setting to home or long-term care facilities.
In celebration of International Women’s Day, ASHP Official will be re-releasing interviews from the Women in Pharmacy Leadership series. In this episode, recorded in February 2018, Sara J. White and Melissa Murer Corrigan explore the value of exposure to varying opportunities and how opening up to broad experiences can help transcend your pharmacy degree and lead to unique career paths.
Melissa Murer Corrigan, B.S.Pharm., FAPhA, FASHP, is President, Manville Heights LLC. She is also an Adjunct Assistant Professor in the Department of Pharmacy Practice for the University of Iowa College of Pharmacy.
Sara J. White, M.S., is a retired Director of Pharmacy for Stanford Hospitals and Clinics.
Date recorded: February 8, 2018
Date originally released: March 2018
Re-Release: March 3, 2020
This episode will describe the role and journey of several African-American women pharmacy leaders and the social and political environment affecting the opportunities for these practitioners. It will also explore the role of pharmacy education in improving diversity and inclusiveness in the workforce as well as the ongoing issue of health disparities and opportunities to address the problem.
Please join, Dr. Dave Zimmerman, associate professor of pharmacy at Duquesne University and an emergency medicine pharmacist at the University of Pittsburgh, Medical Center, Mercy Hospital. In today's episode, we will hear from Dr. Kate Champa PGY2 emergency medicine resident at Massachusetts General Hospital, Dr. Louisa Sullivan PGY2 emergency medicine resident at Valleywise Health, and Dr. Tiffany Jomoc PGY2 emergency resident at Touro college of pharmacy, Saint Barnabas Hospital as they provide a recap from the emergency medicine pearls presented at this year's ASHP Midyear Clinical Meeting and Exhibition.
Chronic obstructive pulmonary disease (COPD) is a progressive life threatening lung disease that causes breathlessness that is characterized by a persistent reduction of airflow. COPD remains the fourth leading cause of death in the U.S. and National costs attributed to COPD treatment and care are projected to increase by 53% through 2020-from $32 billion to $49 billion. Joining this Therapeutic Thursday are four experts who treat patients with COPD.
Join John E. Clark, Pharm.D., M.S., FASHP, and Gregory Bond, Ph.D., as they discuss the background of pharmacy schools at Historically Black Colleges and Universities (HBCUs) and the education of African-American pharmacists. Dr. Clark walks listeners through the rich foundation of HBCU pharmacy schools and discusses how the social and political environment and the lack of access to healthcare influenced both the closure and creation of HBCU pharmacy schools. He calls on us to share the story of pharmacy schools at HBCUs widely so the experiences and contributions of African American pharmacists becomes American history for everyone.
New Mexico is seeking to expand reimbursement for its pharmacist clinicians. Join Tom Kraus, Vice President, Office of Government Relations at ASHP, Dr. Joe Anderson, Assistant Dean for Curricular Affairs and an associate professor of pharmacy practice at the University of New Mexico College of Pharmacy and Dr. Melanie Dodd, Associate Dean for Clinical Affairs and associate professor for geriatrics at the University of New Mexico College of Pharmacy as they discuss New Mexico’s approach to advanced pharmacy practice.
The CDC recently released critical updates to the Core Elements of Hospital Antibiotic Stewardship Programs. First released in 2014, CDC’s Core Elements for Hospital Stewardship Programs offer providers and facilities a set of key principles to guide efforts to improve antibiotic use and, therefore, advance patient safety and improve outcomes. Hosted by Anna Legreid Dopp, Director of Clinical Guidelines and Quality Improvement, we are joined by two experts from the CDC to provide an overview of these timely updates.
As an original sponsor of the National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience, ASHP is proud to represent pharmacy in interprofessional efforts to address this critical workforce and patient care issue. Today, ASHP’s Christina Martin, Director of New Practitioners Forum, speaks with Charlee Alexander, Senior Program Officer at NAM, about the creation and launch of the Collaborative. The importance of an organization's leadership supporting their workforce's well-being is highlighted through case studies at the Ohio State University and the Virginia Mason Kirkland Medical Center in Washington.
Questions about what CMS’s recent comment request on removing barriers to clinicians practicing at the top of their license means for you? We’ve got answers! We’ll talk through CMS’s goals for scope of practice deregulation, ASHP’s advocacy efforts in response to the CMS comment request, the potential outcomes of these efforts, and our next steps to advance pharmacists’ scope of practice.
Join Jennifer N. Clements, Pharm.D., FCCP, BCPS, CDE, BCACP, of Spartanburg Regional and Zach Weber, Pharm.D., BCPS, BCACP, CDE, of Purdue University College of Pharmacy as they discuss care transitions for patients with diabetes.
Join Jodi Taylor, Associate Professor and Department Chair of Pharmacy Practice at Union University and her guests, Dr. Daniel Lewis, Pharmacy Manager at the Heart and Vascular Institute at Cleveland Clinic; Dr. Luke Miller, Director of Pharmacy at Ascension Seton Hays; and Dr. Anne Nguyen, Pharmacy Manager at Houston Methodist West Hospital. Jodi and her three guests discuss what it takes and what it means to move from being a clinician to a manager.
Join PGY2 EM graduates as they continue the discussion of their past experiences pursuing residency and the after residency job market. This episode focuses on seeking employment post-residency and how this differs from the residency search experience. This episode is part of a two part series. Traversing Midyear, Interviews, The Match, and More - A PGY2 EM Perspective Part I focuses on offering guidance and tips for others seeking a similar career path and will cover utilizing your time at Midyear efficiently, the role of PPS, interview tips and tricks, and what to expect during and after The Match.
Join PGY2 EM graduates as they discuss their past experiences pursuing residency and the after residency job market. The discussion focuses on offering guidance and tips for others seeking a similar career path and will cover utilizing your time at Midyear efficiently, the role of PPS, interview tips and tricks, and what to expect during and after The Match. This episode is part of a two-part series that will also cover seeking employment post-residency and how this differs from the residency search experience.
Join members of the ASHP New Practitioners Forum as they share advice for the 2019 ASHP Midyear Clinical Meeting in Las Vegas, Nevada. We will discuss everything from what to wear, what to pack, navigating the showcases, and more.
The Midyear Clinical Meeting is the largest gathering of pharmacy professionals, and pharmacy students, in the world! This is THE event to make influential connections, prepare for a residency, sharpen your CV, and set yourself up for a successful career.
This episode discusses the recent data regarding the use of oral antibiotics for serious gram-negative infections as step-down therapy.
As an original sponsor of the National Academy of Medicine’s Action Collaborative on Clinician Well-Being and Resilience, ASHP is proud to represent pharmacy in interprofessional efforts to address this critical workforce and patient care issue. Join ASHP’s Christina Martin, Director of New Practitioners Forum, and Anna Legreid Dopp, Director of Clinical Guidelines and Quality Improvement as they discuss our commitment to fostering and sustaining the well-being, resilience, and professional engagement of pharmacists, pharmacy residents, student pharmacists, and pharmacy technicians.
Join Amanda Condon as she interviews the authors of the ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation as they share the journey of developing these guidelines along with practice tips and recommendations for solid organ transplant pharmacists. Our authors will also touch upon pitfalls to avoid, metrics, and what they see in the future for solid organ transplantation.
Join David Zimmerman and Aimee Mishler as they discuss how they use lidocaine as an adjunct or alternative therapy as a part of their pain management strategy in their Emergency Department. We'll be discussing the mechanism of action, safety, and monitoring as well as the ideal patient population for a new way of using an old drug.
Today on ASHPOfficial, Tom Kraus interviews Erin Fox, who is the Senior Director of Drug Information and Support Services at the University of Utah Health. She is the 2019 Zellmer Lecture Award winner and a national expert on drug shortages. Erin advises a member of congress and has worked with ASHP to inform policies on drug shortages. Tom and Erin discuss how drug shortages affect patient care, as well as how the FDA and congress can minimize the resulting impact.
(1:04) In mid-2017 there was a large increase in the number of drug shortages, specifically to do with quite common products. Erin explains how frustrating the problem is, because it isn’t going away, and her team is currently monitoring 280 drug shortages. Manufacturing issues to do with quality or reduced output are triggering the shortages. Many of the issues seen by the FDA, including birds flying around in sterile environments, mold on walls, and metal shavings in vials take years to rectify. The manufacturers themselves devise their own processes to comply with guidelines, but the FDA only inspects when companies intentionally do not follow their own processes or falsify data. Economics also plays a role, as common drugs that hospitals use are treated as commodities. Hospitals are incentivized to use the lowest-cost products, because they are reimbursed on a DRG basis. The competition for these contracts with hospitals leads to some companies being underwater on the commodity-based drugs, meaning they will focus more of their efforts on other drugs with higher margins.
(6:07) To incentivize quality, it’s important to include transparency. Currently, there is no requirement that a manufacturer release where its products are being produced, so that when there is a health concern, purchasers can avoid the quality issues. By adding transparency, purchasers can decide to buy higher quality items with fewer shortages and recalls, which are also costly. The FDASIA (Food and Drug Administration Safety and Innovation Act) Law was also introduced in 2012 to improve disclosure from companies to the FDA about drug shortages. The FDA can use the data to try to stop shortages in the future, but once a shortage is reported, it’s difficult to solve, because other countries or companies do not have enough product to share with a market as large as the US.
(9:30) When drug companies contract outside manufacturers, there is no requirement to disclose which manufacturer produced a company’s product. Added transparency here would also allow for quality to be rewarded in the future. When a contract manufacturer is responsible for multiple companies’ supplies of the same drug, any service interruption can cause a massive drug shortage. To add to this weak link in the supply chain, there is no requirement from the FDA for contract manufacturers to have a continuity plan in the event of a shutdown. Commenting is open on the docket now and asking a manufacturer about contingency planning would be an excellent way to use FDA quality metrics to rate a manufacturer higher.
(12:47) 503B compounding pharmacies can help with drug shortages but can’t begin work until the drug appears on the FDA shortage list. The FDA takes time before a drug appears on its list and the compounder will then need an additional three-four weeks to make a good batch. The compounders don’t have much insight into what drugs may be put on the shortage list and how long they will be on the list, such that they may be stuck with a large batch that they can no longer sell. Other tools the FDA can deploy include asking other manufacturers to ramp up production of drugs and assisting in moving a manufacturers application to the front of the line if necessary.
(17:10) There are a few ways to think about national security as it relates to drug shortages. The first is to ask: do we have enough drugs if we need to send our soldiers to war, and do we have enough to take care of our own patents and to keep the hospitals running? The second aspect to consider is where the foreign sources for drug manufacturing come from and what the fallout would be if those sources cut off supply. Most antibiotics source raw materials from China, for example.
Outbound Links & Resources Mentioned
Learn more about ASHP’s policy solutions to reduce drug shortages at: https://www.ashp.org/Advocacy-and-Issues/Key-Issues/Drug-Shortages
Takeaways in Today’s Episode
- The frequency of drug shortages being reported is increasing, and Erin’s team is currently monitoring 280 active drug shortages.
- Drug shortages are a result of quality issues at manufacturing facilities and glitches in the manufacturing process when one company holds a large market share of a product.
- The FDA will inspect drug manufacturers when processes are not being followed or data are being falsified, which is an increasing problem.
- Hospitals are in a race to the bottom in terms of drug costs, due to the DRG structure.
- To incentivize quality, transparency in the drug manufacturing process is required.
- In 2012, ASHP supported the FDASIA Law to pass, which required manufacturers to disclose if there was going to be a shortage or stop on production.
- On low-cost products, it’s easier for contract manufacturers to have a shortage than to invest time in a what-if/backup plan.
- The FDA was hopeful that 503B compounding pharmacies could help with drug shortages, but the time required to produce the drugs is at least a few weeks, by which time the drug may have come off the list and the compounders can no longer sell it.
- There have been increasing conversations lately to do with national security as it relates to drug shortages.
- More than 80% of raw materials for drug manufacturing come from foreign sources.
- Consolidation of manufacturers leads to more fragility in the supply chain, particularly for injectables.
- The FDA is closest to being able to predict shortages but requires more data points and transparency from suppliers and manufacturers to obtain a predictive model.
We also want to make listeners aware that legislation was recently introduced that incorporates several of these priorities.
The introduction of this legislation is a first step to advancing these policy priorities. To become law, the legislation will need to be approved by the full Senate and the House of Representatives.
Listeners can see ASHP’s policy solutions and let congress know they support this legislation by following the link in the show notes to this podcast, or in the advocacy section of ASHP.org.
William Zellmer talks with lead author, David Taber, about a pharmacist-led intervention that is enabled by technology. The aim is to improve medication safety in patients who have received kidney transplant.
May 27, 2019
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
William Zellmer speaks with author Glen Schumock and Lee Vermeulen about national trends in prescription drug expenditures and projections for 2019.
Recorded May 15, 2019.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
William Zellmer talks with authors, Joshua Raub and Raymond Yost, about creating and validating an index tool to assess patient risk of 30-day readmission.
Recorded February 8, 2019.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
William Zellmer speaks with author Brad Laible about the development of an antimicrobial stewardship program across a rural health system.
Recorded November 14, 2018.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
William Zellmer speaks with author Courtenay Wilson about identifying factors necessary for establishing clinical pharmacy services in primary care practices.
Recorded August 16, 2018.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
William Zellmer talks with author, Julie Groppi, about the intervention capture template used at the Department of Veterans Affairs that allows pharmacists to document their clinical interventions within the electronic health record.
Recorded April 2, 2018.
AJHP is the official journal of the American Society of Health-System Pharmacists.
www.ajhpvoices.org
Sara White talks with Melissa Murer Corrigan about how being open to new experiences and opportunities allowed her to transcend her pharmacy degree and enjoy a unique career path. Melissa is Vice President, Social Impact, at the ACT Center for Equity in Learning in Iowa City, Iowa.
Date recorded: January 23, 2018
Rita Shane and Charles Daniels discuss the clinical aspects of health care and its fundamental role effective leadership.
Date recorded: January 23, 2018
Michelle Corrado, Holly Phillips, and Christine Vogt discuss their experiences completing post-graduate degrees and certificates, and progressing through leadership roles while also managing families and motherhood.
Date recorded: November 15, 2017
Kelly Martin visits with Amanda Beck and Elaine Strauss about their experiences with Health System Pharmacy Administration (HSPA) residencies. They each discuss their journey and give insights about how skills learned during their HSPA residency have helped to shape their careers. Amanda and Elaine close out by sharing advice for anyone considering this residency type.
Date recorded: May 31, 2017
Sara J. White speaks with Sara Beis and Jacalyn Rogers regarding the importance of Mentorship. Sara W. discusses how mentor/mentee roles change throughout ones career, and Sara B. and Jacalyn delve into their mentoring relationship – recounting how it began, how they keep it going, and what they each take away from the relationship.
Date recorded: June 15, 2017
Hannah Vanderpool, Pharm.D., M.A.
Vice President, Member Relations
ASHP
Hannah Vanderpool shares with Sara J. White how she and her pharmacist husband manage their careers and family responsibilities - raising two young daughters. Hannah also discusses how she manages work-related travel and why she chose to work for ASHP. Hannah shares some anecdotes about how she and her husband are helping their daughters to grow up to be successful. Since Hannah is the ASHP Staff Secretary for the Women in Pharmacy Leadership Steering Committee, she discusses its work and accomplishments as of the Spring of 2016.
Date recorded: March 23, 2016
Susan Teil Boyer, M.S., R.Ph., FASHP
Pharmacy and Healthcare Consultant
Lead Surveyor, ASHP Accreditation Services
Sara J. White and Susan Boyer explore the value of her Masters/Residency program for her career and life, which includes raising a son with her husband. Since Susan has served on the ASHP Board of Directors and the Washington State Board of Pharmacy, she shares what these positions entail and offers advice for people interested in such experiences. Susan also compares the roles of a Director of Pharmacy, Vice President of a health-system, an ASHP Accreditation Lead Surveyor and a Community Pharmacy Practice Accreditation (CPPA) Surveyor.
Date recorded: March 24, 2015
Debra S Devereaux, MBA, R.Ph., BCACP, FASHP
Senior Vice President
Gorman Health Group
Deb Devereaux describes to Sara J. White how she successfully shared a leadership position when her two children were young. She identifies how she set it up and ensured its success. She also shares advice for both men and women regarding integrating their careers and life. Deb has been active in professional organization leadership and served as both a member and President of the ASHP Board of Directors. She also discusses how to manage involvement in such volunteer commitments. If you are interested in non-traditional careers you will be interested in this interview.
Date recorded: March 29, 2016
Rita K. Jew, Pharm.D., MBA, FASHP
Director of Pharmacy
Mission Bay Campus UCSF Health
Associate Clinical Professor
UCSF School of Pharmacy
Sara J. White visits with Rita Jew about how she integrated her a career with her personal life, which involves children and elder care. Rita describes the transition from her role as a clinical practitioner to leadership positions, and discusses her involvement with the ASHP Section of Clinical Specialists and Scientists, for which she served as the Chair of the Executive Committee. Rita also shares the significances of being a Fellow of ASHP and the process for becoming a Fellow.
Recorded:March 25, 2016
Metta Lou Henderson, B.S. Pharm; M.S., Ph.D; Hon. D.
Professor of Pharmacy Emerita, and Associate Dean (retired) for
Pharmacy Student Affairs
Raabe College of Pharmacy, Ohio Northern University
Research Professor, Department of Pharmacy Practice and Science
College of Pharmacy, The University of Arizona
Sara J. White talks with Metta Lou Henderson about her book "American Women Pharmacists: Contributions to the Profession." Interesting stories of successful women from colonial times to the present are shared, including a woman who owned 11 drugstores plus a warehouse in 1915, and how a woman pharmacist who was fired because she became pregnant responded. Metta Lou discusses the history of hospital pharmacy and noted that of the 153 founding members of ASHP in 1942 44% were women primarily Catholic sisters. The impacts of women pharmacists such as Gloria Neimeyer Francke, who was the first Executive Secretary of ASHP, and Sister Mary Gonzales Duffy, who was the first female ASHP President, are discussed along with others.
Date recorded: March 23, 2016
Mike F. Powell, M.S., FASHP Executive Director, Pharmacy and Nutrition Services Nebraska Medicine Associate Dean for Hospital Affairs UNMC College of Pharmacy Nebraska Medical Center
Sara J. White speaks with Mike Powell about the current impetus for ASHP to focus on Women in Pharmacy Leadership through a Steering Committee and his work in this area. Mike provides the male perspective on the initiative and the changing demographics in the profession.
Recorded: March 21, 2016
Pharmacotherapeutic disparities: Racial, ethnic, and sex variations in medication treatment
Author Elizabeth Hall-Lipsy discusses disparities in medication treatment with William Zellmer, Contributing Editor for AJHP. Ms. Hall-Lipsy describes the research she conducted with Dr. Marie Chisholm-Burns into the relationships between pharmacotherapeutic disparities and the race, ethnicity, and sex of patients.
The article under discussion appears in the March 15, 2010, issue of AJHP.
For more information visit www.ajhp.org.